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Preface to the 4th Edition
It is now eight years since the last edition of this
booklet and this new version is a substantial
revision of that earlier material.  Two new
chapters have been included; a separate one on
MDMA ('Ecstasy') and a totally new entry on
Methadone reflecting the increased importance of
these two drugs.  Some chapters are merely
updates of previous versions because there is
little new data or information to be included,
while for others e.g. on the Cannabis drugs, there
has been a substantial revision reflecting new
scientific knowledge and data. 
The aim, as always, has been to provide the non-
technical reader with jargon-free (well almost!)
background information on legal, medical, social
and historical facts about drugs used for non-
medical purposes in Ireland.  The title was
deliberately phrased to indicate that the booklet
does not represent "the" facts about drug misuse
but rather that it presents as much of the
available information as possible.  It is not
encyclopaedic in nature because all of the
information on drug use in Ireland is not
available.  It has been pointed out previously, that
much drug use is illicit in nature and thus
hidden.  The fact that the drug scene changes on
a regular but unpredictable basis also creates
difficulty, as does the complexity of the
phenomena that underpin drug misuse by
human beings.  This booklet is about just one
aspect of problem drug use, namely the role of
the drug, even though it is recognised that the
role of the individual and of the social
environment in which they find themselves are
also key influences on drug use. 
This briefing has been written so as to be a
background resource for those such as teachers,
healthcare and welfare professionals, community
and other voluntary groups who seek basic
factual information about the effects of the
chemicals we call drugs on the human body.  It is
a compilation of a vast amount of information
published in official reports, textbooks, research
journals and documents from various
individuals, groups and agencies.  Normal
academic practice and courtesy requires that I
acknowledge the immense debt owed to many
different individuals and I am glad to be able to
record my appreciation of the skill, dedication
and efforts of all those who work has been drawn
upon to create this publication.  A purely
academic approach would be to cite each and
every reference within the text but this would, I
believe, result in a text which would be less than
friendly for the non-academic, non-technical
reader.  Therefore, in this new edition, I have
included for the first time, a bibliography of the
most important print and electronic sources of
information upon which this compilation is
based.  This in no way diminishes my feeling of
indebtedness to my colleagues in the laboratory
and non-laboratory sciences all over the world
whose research work and scholarship I have
attempted to incorporate into this publication. 
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Facts about Drug Misuse in Ireland
The Place of Drug Information in Drug
Prevention Programmes
A significant proportion of the information in this
briefing was compiled as part of training
programmes for key drug education workers
such as 1st and 2nd level teachers, who are
involved in Drug Prevention activities.
Prevention efforts aimed at minimising
experimental drug use, or at reducing the
progression to regular use and thereby lowering
the number of individuals who develop
problematic dependent patterns of drug use, are
a crucial part of society's response to the misuse
of drugs.
School-based programmes are a key element in
these prevention approaches and the
GovernmentÕs National Advisory Committee on
Drugs (NACD) recently published a report on
these programmes, the Executive Summary of
which is reproduced below by kind permission.
Entitled "Drug Use Prevention.  An Overview of
Research" the report highlighted the fact that
many of the Irish school based programmes such
as the "Walk Tall" programme for primary schools
and the "On My Own Two Feet" programme at
second level were consistent with best practice in
the area.  The report cautions that having experts
warn young people about the dangers of drug
use is quite ineffective in preventing subsequent
experimentation.  Therefore merely providing
copies of this booklet to young people will not
constitute effective drug education.  However, it
must also be pointed out that a number of
surveys of drug users (e.g. the 1995 ESPAD study
and the 1997 Keogh Report) highlighted that a
worryingly large number of young Irish people
had very little knowledge of the consequences of
drug taking when they started to experiment.  If
young people are to make informed responsible
choices about drugs through the school and
community based programmes now available,
then those choices must be based on a full
knowledge of the consequences of decisions to
use drugs.  The information of drug taking in
general and on the individual drugs included in
this booklet can help provide that basic
knowledge, which can be included as part of, but
not instead of a comprehensive prevention
programme.  Previous editions have been used as
a resource for pupils undertaking small projects
on drugs and this may be a worthwhile approach
because the NACD report recognises that
children should be actively involved rather than
merely passive recipients of information.  The
report also highlights the need to include legal
drugs since it is known that an exclusive focus on
illegal drugs has limited effectiveness.  This
important fact has been borne in mind in the
preparation of this publication.
Drug Use Prevention - An Overview of
Research - Executive Summary
This report summarises the main findings of
research in Ireland and abroad relating to drug
use prevention.  The main risk factors for drug
use are identified and several approaches and
strategies for preventing use and misuse are
examined.  Based on the evidence presented here,
a number of conclusions and recommendations
are put forward. 
The main conclusion is that there is no single
Ôdrug problemÕ with one dramatic solution.
Rather, what is called the drug problem is
comprised of varying degrees of involvement
with a variety of substances, arising from several
influences many of which are unrelated to each
other.  For these reasons, the main
recommendation is that there is a need to target
and prevent use of the most dangerous
substances.  
The most serious drug problems involve opiates
and are largely associated with deprivation.
Addressing this problem requires a
comprehensive approach involving not only
family and community factors but also broad
socio-political influences, especially educational
opportunities.  Targeted initiatives to tackle the
social origins of these drugs problems should
involve inter-agency co-operation and have
community involvement.  Particular attention
should be given to the structural planning of
inter-agency co-operation on a scale and intensity
that is commensurate with the gravity of the
problem.  There is also a need to continue with
supply reduction measures particularly as these
have an important influence on the perception of
what is acceptable.  Furthermore, there is a needC
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Chapter 1 - The Place of Drug Information in 
Drug Prevention Programmes
to include legal drugs as part of the policy since
experience has shown that an exclusive focus on
illegal drugs has limited effectiveness.  
There is a need to raise public awareness of the
importance of deprivation as a predisposing
factor for the most damaging forms of drug
misuse.  This will act as a prelude to widespread
acceptance of the necessity for the major
resources that will be needed to deal with these
problems.  In this context, there is a major need to
help vulnerable families in order to prevent their
childrenÕs drug misuse.  It is also essential that
prevention of early school leaving should be at
the core of intervention.  Attention should also be
given to how life and employment skills can
contribute.   It is also recommended that drug
prevention becomes a central feature of initiatives
to address Health Inequalities in the context of
the National Anti-Poverty Strategy as well as
integrating programmes that attempt to address
social exclusion, especially those that focus on
school (Breaking the Cycle) and on families
(Springboard).  
Notwithstanding the targeted programmes to
deal with the causes of the most damaging forms
of drug misuse, there is also a need for broadly
based programmes focusing on the experimental
drug use that is not uncommon among young
people from all social backgrounds.  The
evidence reviewed here shows that fear based
messages are not appropriate in programmes
including classroom programmes.  While it seems
plausible to have experts warn young people
about the Ôreal factsÕ of the dangers of drug use,
the indications are that this is quite ineffective in
preventing subsequent experimentation. 
Instead there should be a continued investment
in approaches that emphasise personal and social
development, stress social skills and enhance
decision-making.  In particular, school
programmes should ensure that children are
actively involved rather than merely passive
recipients of information.  It should be noted that
many of the Irish school based programmes to
address drug misuse have been consistent with
best practice in this regard.  The developments in
Social Personal and Health Education are
especially to be welcomed. 
There is considerable evidence that school
programmes on their own are unlikely to have a
major impact without community backing.  There
is a need to take into account the views of parents
and other interested parties as well as having
innovative strategies to reach marginalised young
people who may have left school.  Drug
prevention should take place in community
settings such as youth clubs, community centres,
and sports clubs and in workplaces where
additional skills and knowledge are needed.
Within school programmes, the regular classroom
teacher should take the primary role in drug
prevention education, with appropriate input
from others including professionals as well as
people from the local community with relevant
expertise.  Schools need to develop policies with
regard to drug prevention.  Such policies should
include not only illegal drugs but also legal drugs
and may be most effective if they involve groups
of schools and are holistic in nature, rather than
simply indicating sanctions for drug use. 
The evidence reviewed in this report suggests
that the mass media have until now, had a
relatively limited role in prevention.  It would
seem that there is very little value in drawing
attention to the dangers of drug use in media
promotions since, they may only convince those
people who are already disposed to believe the
message.  Furthermore, they can create an
impression that Ôsomething is happeningÕ in
relation to prevention.  There is a need to explore
new ways of using the mass media more
effectively, in the context of the statement of the
National Drugs Strategy.
Source: Dr. M. Morgan (2001) Drug Use
Prevention; overview of research National
Advisory Committee on Drugs 
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Introduction
This section is designed to provide you with
background information on the legal, medical,
social and historical facts about drugs used for
non-medical purposes in Ireland.  It is not
intended to be a definitive study of problem drug
use in Ireland.      
Definition of a drug
A drug can be defined as a chemical that causes
changes in the way the human body functions
mentally, physically or emotionally.  This
description includes many materials we normally
think of as drugs, as well as things we might not
usually consider to be drugs, such as coffee, tea,
alcohol, solvents and tobacco.
Where drugs come from
Drugs may be obtained in a number of ways:
- they may be extracted naturally from plants
such as opium, cannabis and coca
- they may be prepared from natural materials
by semi synthesis such as heroin which is
easily made from the morphine extracted from
opium
- they may be totally man-made such as
amphetamines and the tranquillisers.  
The most widely used drugs, both legal and
illegal, are plant products or easily prepared from
plants, many of which grow readily in different
parts of the world.  Many of these plants have
long been used by humans and formed the basis
of medicine for centuries.  Today we still use
medicinal or drug plants but in addition we have
available an increasing list of very powerful
synthetic medicines produced by pharmaceutical
companies all over the world and an increasing
number of synthetic drugs produced by
underground designer drug chemists.
How drugs are used
We use these drugs in different ways, such as in
medicines to relieve pain, to treat cancers, to
alleviate heart disease or to cure infections.  Some
drugs are used to help us cope with the anxiety
and stresses of life, while others are used for
recreational purposes, to help us relax and enjoy
ourselves.  Drugs, when properly used, can be of
enormous benefit in the treatment and prevention
of disease in both humans and animals.  
There is, however, a price to be paid for the
benefits, which are often short lived, of the drugs
we consume.  This is because of one fundamental
fact - there is no such thing as a safe drug; all
drug taking involves an element of risk, harm
and disease.  Unfortunately drugs are frequently
misused, leading to a variety of medical, social
and economic problems.  
Definition of drug misuse
Drug misuse can be defined in a number of ways.
In this publication the term is taken to mean the
use of any drug, legal or illegal, which damages
some aspect of the userÕs life; whether it is their
mental or physical health, their relationship with
their family, friends or society in general or their
vocational functioning as students or as workers
both inside and outside the home.  
This definition includes not only the use of illegal
drugs but also the dangerous use of legal drugs
such as alcohol, the use of tobacco, the harmful
use of prescribed medicines by exceeding the
recommended prescribed dose and the illegal use
of legal drugs such as drinking and driving or
smoking cigarettes in a no-smoking area.  
The fact that a drug is legal and socially
acceptable does not mean that it causes less harm
or damage than an illegal drug.  Indeed, it
appears that as the use of a particular drug
becomes more acceptable, it is used by people
more often and in greater amounts, with greater
adverse consequences for the userÕs health and
well being. 
How drugs work
Many drugs are believed to work by fitting in to
receptor sites within the cells of the body.  This
works similar to how a key fits into a lock.  At
this site a drug can either cause an effect or it can
block an effect.
Different receptors have been identified for
different classes of drugs for example the opiate
receptors, a benzodiazepine receptor and a
number of cannabinoid (cannabis) receptors.  The
interaction between a drug and its site of action
depends on how well it fits the shape of the
receptor as well as by the amount of the drug
taken.
Types of drugs
Some of the large numbers of psychoactive drugs
calm the mind, others cause excitement, while
others can offer complex mental experiences.  ItC
ha
pt
er
 2
 - 
D
ru
gs
 a
nd
 D
ru
g 
R
el
at
ed
 P
ro
bl
em
s
4
Chapter 2 - Drugs and Drug Related Problems
is, however, possible to catalogue these different
drugs into a small number of separate classes or
types.  While each individual drug will be
different, its overall effects will be those of its
class, producing these by attachment to the same
type of Ôreceptor sitesÕ in the brain.  They will
produce much the same type of withdrawal
symptoms and different drugs within the same
group can be effectively substituted for one
another and thus relieve the withdrawal
symptoms which occur with the other drug.
Most mood altering drugs can be placed in one of
five main categories.  Although some, such as
cannabis, tobacco and solvents, must be
considered separately as they do not easily fit
into the following classification:
Opiates Ð these are described as narcotic
analgesics because they are strong painkillers and
because they produce a feeling of euphoria and
sleepiness.  Included are opium and its
derivatives: morphine, codeine and heroin, as
well as the synthetic opiates such as methadone,
buprenorphine and pethidine.
Depressants Ð are also known as sedatives and
include drugs such as alcohol and barbiturates,
which have in common the ability to decrease
brain activity causing sleepiness and in some
cases relief of anxiety.
Minor tranquillisers Ð such as Valium¨ and
Ativan¨ known collectively as Benzodiazepines,
have much the same general effects as the
depressants but it is now recognized that
addiction to tranquillisers is totally different to
that which occurs with other depressants.
Stimulants Ð are drugs that elevate mood,
increase wakefulness and give an increased sense
of mental and physical energy.  Included in this
group are cocaine, amphetamines and caffeine.
Hallucinogens Ð produce a spectrum of strange
intense visions and voices referred to as
hallucinations.  Drugs such as mescaline, LSD
and psilocybe mushrooms usually do not give
rise to dependence but because of their intense
effects on mental functioning they can be
extremely hazardous.
Cannabis Ð drugs such as marijuana or hashish
can have actions that are both depressant and
euphoriant.
Tobacco Ð contains the drug nicotine, which can
have both stimulant and sedative effects,
depending on the userÕs personality and mood.
How drugs are taken
There are many different ways of taking drugs
including eating, drinking, chewing, smoking,
nasal inhaling, sniffing, injecting into the skin
(subcutaneous), injecting into the muscles
(intramuscular), and injecting into the veins
(intravenous).  
The route of administration determines the
speed, duration, intensity of action and also the
safety of the drug.  This is because the amount of
drug absorbed and distributed within the body
depends on the way the drug is taken.  This in
turn affects the amount of drug arriving at the
site of action.  The onset of drug action is rapid if
the drug is taken by smoking, nasal inhalation or
by intravenous injection and slower if it is by
chewing, eating or subcutaneous injection.  
The type of drug also determines the route of
administration.  For example, alcohol is taken by
drinking, whereas, heroin is usually taken by
injection or smoking.  Cocaine and cannabis may
be taken by several routes.  Injection of drugs is
the most dangerous route of drug taking partly
because of the risk of a fatal overdose associated
with the higher concentrations of drug that can
be achieved, particularly with intravenous
injection.  Also proper injections need technical
skill and many self-injectors are at risk because
their lack of hygiene and use of non-sterile
injection technique results in the spread of
diseases when more than one person shares the
same needle and syringe.  These diseases include
Hepatitis and the Acquired Immune Deficiency
Syndrome (AIDS).
The effects of drug use 
Most people who use drugs on an occasional
basis suffer no permanent ill effects from the
drugs they use.  Many benefit when they use
medicinal drugs in the correct way. There are,
however, very serious risks in using drugs and a
large part of this publication is about these and
how they arise.  Risks apply to all or most of the
drugs described in this booklet, though each drug
has its own particular set of risks.  
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Most of these drugs are mind or mood altering,
psychoactive drugs, but they affect not only the
brain but also other parts of the body.  Thus
physical as well as mental effects have to be
considered.
Statements about the effects of a particular drug
are statements about what usually happens with
most people when they take that particular drug.
But the effect of any drug on the human body is
difficult to predict because it depends on a
number of different factors such as:
¥ the type of drug
¥ the dose or amount of drug taken
¥ the physical and mental condition of the drug
taker
¥ the environment in which the drug is being
used
¥ the mechanisms controlling the entry and
removal of the drug from the body
¥ the use of other drugs at the same time.
Drug Doses
The interaction between a drug and its site of
action depends on how well it fits the shape of
the receptor as well as the amount of the drug
taken.  As this amount or dose is increased, new
unwanted and often damaging effects begin to
occur.  
Many of the problems caused by drugs are
directly related to the effects of increased dosage.
By taking too much of a drug you run the risk of
a frightening experience such as the
panic/anxiety reaction to high strength cannabis,
or more seriously you are at risk of a fatal
overdose.  For example, the use of cocaine by
South American Indians in small amounts as a
result of the chewing of coca leaves is generally
believed not to be particularly harmful.
However, the smoking of highly purified and
concentrated cocaine in the form of ÔcrackÕ can
result in sudden death or rapid development of a
serious addiction problem.  
If you take a mood-altering drug frequently, in
high doses, for a long time, it is likely to destroy
your perception of reality so much that normal
functioning and development is damaged.
Finding and keeping a job may be difficult and
normal desires for food, sex and warmth may be
dulled.  Reactions to pain, fatigue and discomfort
may also become muted, leading to self-neglect
and malnutrition which is often damaging to
health.  
The importance of the dose of drug cannot be
overemphasized in understanding some of the
controversies associated with drug use.
Repeatedly there are reports of a new drug fad or
craze suggesting that the drug causes little harm.
It is only when the drug becomes more popular
and it is used more often and at higher doses that
the harmful effects begin to appear. 
Individual Reactions to Drugs
Individuals react to drugs in different ways
because the effectiveness of the mechanisms
controlling the arrival and departure of the drug
at the target site in the body differ.  This
effectiveness varies due to age, gender, body
weight and nutritional status.  Exposure to
cigarette smoke and other environmental pollu-
tants can also alter the bodyÕs responses to drugs
as can interactions with other drugs and food. 
In the young, absorption of drugs and their
circulation in the bloodstream is less effective
than in adults.  Similarly, elderly people react to
drugs in a different way to younger people and
usually require lower doses of drugs.  
Lighter people tend to experience greater effects
and greater dangers from the same amount of
drug than heavier people. Malnourished drug
users are likely to have abnormally high levels of
drugs in their blood because of a reduced level of
fat to store the drug.  Drug abusers who neglect
their diet are also more likely to suffer poisonous
reactions to the drug.  Those that are dependent
on alcohol or heroin and whose compulsive drug
use results in self-neglect may be particularly at
risk from drug overdoses.  
Men and women also react differently to drugs.
For example men and women differ in their
reaction to alcohol.  This is because men are
heavier on average than women and their higher
muscle content is associated with higher body
water content.  When men consume alcohol there
is therefore a dilution in blood alcohol
concentration (BAC).  Women however tend to
have a higher BAC because they have lower body
water content resulting from their lower muscle
content and higher ratio of fat.  They also appear
to differ in the speed with which they break
down alcohol in the lining of the stomach.  For
these reasons the same dose of alcohol willC
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produce a 25-30% higher BAC in an average
woman than in a man so that, if a man drinks six
standard drinks (3 ÔpintsÕ) of alcohol and a
woman four standard drinks, they will both have
similar blood alcohol levels.  Women therefore
given similar levels of consumption get drunk
faster and are more vulnerable to alcohol-related
problems such as liver, brain, heart disease and
alcohol dependence than men.  Conversely a high
food intake, particularly of protein, can slow
down the absorption of alcohol and result in
lower BAC levels.
Interactions With Other Drugs
Studies of drug misusers in Ireland show that
many take a variety of different drugs in what is
known as polydrug abuse.  This polydrug abuse
makes it difficult to assess the likely effects of any
one particular drug on an individual.  This is
because, if two drugs are taken together, it is
possible that their combined effects could be the
same as, smaller than, or greater than the sum of
the effects of the individual drugs.  
The commonest drug taken in combination with
others is alcohol.  The risks of a fatal overdose are
very high with drug and alcohol combinations,
whether it is methadone and alcohol or other
mixtures.  Another common mixture is alcohol
and cannabis, in this case the depressant sleep-
inducing effects of alcohol are increased by
cannabis and this has implications for work and
traffic safety.  Since drugs remain in the body for
varying periods, often hours or days, the two
substances donÕt even have to be taken at the
same time.  
In general terms the effects of combinations of
drugs are little understood and uninvestigated,
therefore the advice to any drug user must be to
avoid mixing drugs. 
A DrugÕs Actions Depend on More Than the
Drug
A drugÕs actions on the brain are influenced not
only by the nature of the drug, but also by the
personal characteristics of the individual, by the
immediate setting in which the drug use occurs,
by the expectations of the user and by larger
cultural influences surrounding the drug use.
For example, a mild drug experience with
hallucinogenic mushrooms for one user may turn
out to be a nightmare for an individual who is
mentally unstable and who may be pushed over
the brink into mental illness. 
The surroundings in which the drug is consumed
also influences the effects.  For example, a person
using alcohol in a quiet relaxed atmosphere may
become sleepy, whereas if they drink the same
amount in a cheerful exuberant atmosphere they
may feel stimulated and more extroverted.  All of
these factors contribute to the unpredictability of
the effects of, and damage from, the use of drugs
and can be a source of confusion about the actual
risks associated with a particular drug.
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The Hazards of Drug Misuse 
Introduction
The hazards associated with drug abuse have
traditionally been described in terms of the risk
of a fatal overdose combined with the risk of
addiction and these are very significant dangers
with many drugs.  In addition, attention is being
increasingly paid to a range of other drug-related
medical, social and financial problems.  
Overdoses
It is usual to assess the hazards of a given drug in
terms of physical toxicity with the associated
risks of fatal overdoses.  Many drugs have a high
overdose potential, for example: 
Heroin and other opiates,
Cocaine,
Alcohol,
Solvents,
Alcohol and tranquilliser combinations.
However, many other harmful drugs such as LSD
and cannabis are not lethal poisons.  
Adulteration and Fake Drugs
When people buy a legally prescribed drug or
medicine, they are virtually guaranteed that the
medicine supplied is the right amount of the
right drug, because of strictly enforced controls
and scrutiny.  On the other hand, anyone who
buys a drug on the ÔstreetÕ (the illegal black
market) has no guarantee that what is bought is
what they think they are buying and the resulting
risk of an overdose is great.  
The sale of fake, contaminated and
misrepresented drugs is common.  Some of the
fakes are ingenious and comic, such as henna
sold as cannabis resin or lentils sold as L.S.D.
Others are a hoax, such as roasted banana skins
called Ômello yelloÕ.  Others are dangerous such
as the selling of the anaesthetic Ketamine as
ecstasy.  The misrepresentation of drugs means
that many drug users are taking drugs they
would not normally take or wish to take.   
The most serious case of substitution we have
had in Ireland is the case where strychnine was
mistakenly used as cocaine, resulting in one
death and seven cases of strychnine poisoning.
Contamination of street drugs especially of
heroin and cocaine is common.  Other drugs as
well as non-drug materials are all used to ÔcutÕ or
increase the bulk and thus the profitability of the
merchandise.  These ÔcutsÕ or diluents can cause
damage when injected into veins, and in America
it is believed that many heroin deaths were really
due to a reaction to quinine used to dilute the
heroin. 
These factors add greatly to the unpredictability
of the effects of, and damage from, the use of
drugs without medical supervision.  In general,
therefore, it cannot be predicted that the effect of
a drug on a given individual will match those
described in a briefing such as this, especially if
the person is particularly vulnerable due to
existing mental or physical conditions.
Dependence and Addiction
Another well recognized hazard is the risk of
ÔaddictionÕ or more properly dependence.  The
World Health Organisation (WHO) introduced
the term Ôdrug dependenceÕ in 1964 in an attempt
to break away from a narrow extreme view of
addiction centred almost exclusively on
morphine and where other forms of drug
addiction were downgraded in importance.  
The 1964 approach proposed that each drug type
should be seen as giving rise to its own particular
type of dependence, such as dependence of the
opiate-type and dependence of the cocaine-type
among others.
The 1964 definition of drug dependence was as
follows:
ÒA state psychic and sometimes also physical
resulting from the interaction between a living
organism and a drug, characterized by
behavioural and other responses that always
include a compulsion to take the drug on a
continuous basis in order to experience its
psychic effects, and sometimes to avoid the
discomfort of its absence.  Tolerance may or may
not be present.Ó  
Physical dependence may result from the bodyÕs
adaptation to the repeated use of the drug and if
the drug is abruptly stopped there is a rebound
effect resulting in physical symptoms of illness
commonly called ÔwithdrawalÕ.  
Psychological factors play a very important role
in dependence through the reinforcing nature of
many drugs, this means the reward in terms ofC
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pleasure, the feeling of well being or calmness
which may be obtained when the drug is taken.
Many drugs are known to result in compulsive
drug use after repeated and sometimes even
occasional use, such as heroin and other opiates,
alcohol, minor tranquillisers, nicotine, cocaine,
amphetamine and cannabis.  
Dependence is more likely when a drug is
injected than when taken in other ways.  This is
due to a combination of factors including the
regular use of high doses, the ÔrushÕ with the
experience of immediate satisfaction, and the
meaning of the injection ritual to the user.  For
some, the injection routine may become as
important as the effect of the drug, and if no
drugs are available almost anything will be
injected.  Nevertheless, dependence can occur
with any method of drug use.  Dependence does
not always occur or may take some time to
develop.  
It is increasingly recognized that all embracing
terms such as ÔaddictionÕ or ÔdependenceÕ are too
broad to adequately describe the variety of
compulsive drug using behaviours.  Instead,
attempts have been made to describe a series of
ÔDrug Dependence SyndromesÕ that may include
some or all of the following elements:
¥ Tolerance
¥ Withdrawal symptoms
¥ Withdrawal relief
¥ Subjective awareness of compulsion to
continue use
¥ Salience of drug taking relative to other
activities
¥ Relapse
¥ Tolerance
As a result of repeated drug use, the human body
adapts to the drug in different ways.  It could
eliminate the drug more quickly or the cells of
the brain could adapt to the drug with the result
that it is necessary to increase the amount of drug
consumed to obtain the same level of drug effect.
As a result of this tolerance to the drug, a heroin
addict can take up to 100 mg or more in one
injection, which is 10 times the normal medical
dose and is a dose which would undoubtedly kill
a non drug user.
¥ Withdrawal Symptoms.
These are the bodyÕs reactions to the sudden
absence of a drug to which it has adapted.
Withdrawal symptoms tend to be the opposite of
the effects of the drug itself; for example,
withdrawal of a depressant drug can cause
excitement, whereas withdrawal from a stimulant
may result in depression.  Such effects vary from
the alcohol ÔhangoverÕ to the fatigue and
depression associated with stimulants and the
chills, pains and influenza-like symptoms of
heroin withdrawal.  With some drugs, such as
barbiturates, there is the risk of convulsions and
even sudden death during withdrawal.
¥ Withdrawal Relief.
There are three ways of abolishing withdrawal
symptoms.  One is time, as the body returns to
normal functioning without the drug.  The
second is to take another dose of the drug such as
the use of alcohol in the form of the so-called
Ôhair of the dogÕ to cure a hangover or the
smoking of an early morning cigarette to abolish
the irritability and mild agitation associated with
nicotine withdrawal.  In the case of opiates, the
use of the next ÔfixÕ of heroin to abolish
withdrawal is a key-reinforcing element in the
addiction process.  The third approach is to
substitute a related drug, for example methadone
for heroin. 
¥ Subjective Awareness of Compulsion to
Continue Use.
This is where an individual becomes aware that
they are using a drug continually either because
of the need to avoid withdrawal or because of
external cues such as television commercials and
pictures of syringes or because of anger,
frustration and anxiety.
¥ Salience of Drug Taking Relative To Other
Activities.
This is where the compulsion to continue using
the drug overcomes all other considerations, be
they legal, family, health, moral or financial.  One
example would be a cigarette smoker who
continues to smoke despite a heart attack or other
serious health problems.  In the case of a heroin
addict this salience would manifest itself in a
total preoccupation with drugs, where the whole
day is spent looking for drugs to buy, selling
drugs, and stealing from friends, family,
employers, in order to get money for the next
ÔfixÕ. C
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¥ Relapse.
The tendency for drug dependent persons who
have abstained from drug use for a period of time
to resume drug taking after treatment is
extremely high.  This is one of the reasons why
treatment of addiction is so difficult.  Increasingly
it is being recognized that drug dependent
persons will require treatment and rehabilitation
on several occasions during their drug-using
careers.
Newer Concepts
In more recent times a broader view of
dependence has placed less emphasis on
physiological factors such as tolerance and
withdrawal and more emphasis on drug related
behavioural changes such as loss of control over
drug use, being unable to stop using the drug
when the user wishes, as well as continuation of
use despite clear evidence of harmful health or
personal consequences.  These concepts have
now been incorporated into the International
Classification of Diseases (ICD-10) criteria for
drug dependence and also into the nine criteria in
the Diagnostic and Statistical Manual on Mental
Disorders (DSM IV) for drug dependence.  On
this basis it is likely that most pleasure-inducing
psychoactive drugs can result in compulsive
dependent use.  The risk of dependence
developing does however vary from drug to
drug.  For example studies in heroin users show
that many can give up heroin easier than they can
give up nicotine.
Drug-related Problems
Introduction
Drug dependence and drug misuse are not
synonymous.  Drug dependence is only one
feature of drug misuse; other aspects are
important in their own right.  Drug problems can
occur in the absence of dependence.  A dangerous
drug such as LSD can cause serious problems and
yet has low dependence potential.  It is also
possible for individuals to suffer harm even
though they are not dependent on the drug.  On
the other hand, some individuals may be
dependent on drugs but because of the
circumstance of the drug use may not necessarily
come to serious physical harm, e.g. a doctor or
nurse using sterile pharmaceutical grade opiates.  
In assessing the damage that drugs cause it is
essential to look beyond dependence per se and
carefully analyse how individuals are actually
harmed by their drug use.  An overemphasis on
dependence, which is difficult to treat, may result
in the neglect of more effective ways of
preventing and treating much of the problems
caused by drugs.  Therefore a broad view of
problem drug use must take into consideration,
not only the harm from dependence and
overdoses but also the following aspects Ð
¥ Drug use and crime
¥ Drug related diseases
¥ Drug use and pregnancy
¥ Behavioural changes
¥ Family disruption
¥ Drugs and Crime.
There is a general perception that drug use is
associated with crime.  There is no clear-cut
explanation for this because on the one hand it is
generally recognized that no drug has inherent
crime-causing properties, yet on the other it is
beyond dispute that many opiate dependents are
heavily involved in crime.  
One survey that compared heroin users with non-
users in Dublin reported that heroin users were
about three times more likely than non-users to
have been arrested for robbery and/or assault.  In
another Irish study, approximately 60% of the
heroin users had been arrested for robbery,
although the majority of those arrested reported
that their first arrest occurred before they began
to use drugs.  A recent study in Dublin reported
that 58% of heroin addicts had been in trouble
with the law before they ever used heroin.
It is highly probable that it is the high cost of a
drug like heroin on the black-market which
influences the amount of crime against property,
so-called acquisitive crime, commonly associated
with heroin users.  In Ireland, for example, it has
been estimated that a heroin user with an
established dependency could be using between
€25 and €250 worth of drugs every day.  It is not
surprising therefore that many such dependants
are forced into a life of crime involving male or
female prostitution, burglary, petty theft,
shoplifting and particularly drug ÔpushingÕ in
order to pay for their drugs.
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However, the perception that virtually all
acquisitive crime is drug related is at odds with
international and Irish studies that show that
drug related robberies are significantly lower
than generally recognized.  A report by the
Garda in 1997 estimated that while drug users
committed 66% of detected crime, the percentage
actually committed to buy heroin was 43%.  This
figure is approximately double the figures for the
Netherlands, Norway or the U.K.  There is little
or no evidence that the majority of cannabis or
ecstasy users commit such crimes to pay for their
drugs of choice. 
In general heroin users tend not to commit
violent crimes, partly because of the sedative
effect of the drug.  The Garda report confirms
this, showing that non-heroin users committed
most violent crime. In some cases addicts in
withdrawal may use violence or the threat of
violence in the course of a robbery in their
desperation for drugs and/or money. 
There are other drugs whose effect on mental
functioning may lead to violent crime against
individuals. Angel Dust or PCP is a drug that can
cause frightening violent homicidal attacks. The
paranoia associated with amphetamine and
cocaine use could also result in physical violence.
However, the drug most often implicated in
violent crimes is alcohol. It is now widely
accepted that alcohol has a direct effect on
aggression in humans. International research into
9,000 violent crimes reported from 11 different
countries found that nearly two thirds of violent
offenders were drinking at the time of the crime.
In other countries it has been estimated that
alcohol may be involved in up to 30-50% of
burglaries; up to 70% of violent incidents; up to
50% of murders, up to 27% of road traffic deaths
and may have a role to play in many cases of
football hooliganism.
¥ Drug-related Diseases.
Illness and diseases due to drug use can be due
to the direct poisonous effect of the drug on
various parts of the body, called substance-
specific harm, or it can be due to the way the
drug is taken, called technique-specific harm.
Examples of substance-specific harm include
brain and liver damage caused by alcohol, as well
as lung and cardiovascular disease caused by
tobacco smoke and also by cannabis. Depression
and other nervous problems may occur leading
to admission to psychiatric hospitals. Many drugs
can initiate attacks of pre-existing mental illness,
for example cannabis may trigger off attacks of
schizophrenia although there is no strong
scientific consensus that cannabis ÔcausesÕ long
term mental illness.
In contrast to alcohol and tobacco, heroin has few
physically damaging effects on the body apart
from the obvious risk of an overdose. Chronic
opiate use is likely to result in constipation and
loss of libido but it does not cause harm to the
liver, heart or lungs. The major disease risk from
heroin is from the infections associated with
unhygienic practices when the drug is injected. 
The problems associated with the injection of
heroin or of any other drug can include: 
Bacterial endocarditis is a potentially fatal
infection of the valves of the heart resulting in
damage to the valve and subsequent heart
problems.
Septicaemia, abscesses or generalized blood
poisoning because of bacterial contamination of
the needle and syringe by bacteria normally
found on the skin or in the mouth or present in
unsterile water used to make an injection.  In
summer 2000, eight heroin users died in Dublin
after injecting heroin intramuscularly, Ôskin
poppingÕ. This was part of a larger outbreak of
illness in Ireland, Scotland, England and Wales
affecting 104 people and causing 35 deaths in all.
The cause of death is believed to be infection by a
type of bacterium (Clostridium novyi). The
bacteria are believed to have been a contaminant
in the heroin but the origin of that contamination
is not yet known.
Gangrene cases have been reported when tablet
forms of drugs, such as synthetic opiates are
crushed, mixed with water and injected into the
body. Ireland has the doubtful distinction of
being the first country to report misuse of a
product called Diconal¨ which was a tablet
containing a mixture of the synthetic opiate,
Dipipanone, and an anti-vomiting drug
Cyclizine.  A number of young Irish addicts lost
fingers, hands and legs through amputation
when gangrene developed. This occurred because
of the presence of various additives in the tablet
as well as the two drugs. These additives clogged C
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blood vessels leading to gangrene. 
Blindness due to fungal disease has been
reported from countries such as France and
Australia. The problem arose from the availability
of a smoking grade of heroin, probably Chinese
no.3, which did not dissolve in water. In order to
inject it, addicts used a variety of acid solutions
such as vinegar, citric acid, car battery acid or
lemon juice. The blindness occurred because
some addicts used fresh lemons that were
contaminated with mould. The mould was
injected into the body and caused blindness.
Hepatitis is an acute illness caused by a virus
resulting in an inflammation of the liver.  The
virus is spread via blood, saliva, body excretions,
by sexual contact and through shared needles
and syringes.  Prior to 1980 there were very few
cases but the numbers then began to rise rapidly
as the number of heroin users in Dublin
increased.  
According to figures complied by Dr Alan
Shattock of the Department of Medical
Microbiology, U.C.D., the overall incidence of one
type of hepatitis HBV (hepatitis B) in Ireland
quadrupled in the years immediately after 1980,
largely due to a 15-fold increase in infections in
intravenous drug abusers.  Prior to 1980 only 20%
of positive individuals were drug misusers,
whereas since 1980, 72% of positives were
associated with drug misuse.  There had been a
reduction in recent years in the number of cases
detected among drug users but studies among
intravenous drug users (IDUÕs) in Irish prisons
report prevalence rates of approximately 18%.  It
has also been reported that 36% of IDUÕs with
hepatitis infections were also infected with the
hepatitis D virus (HDV).  Such patients are likely
to suffer from more severe forms of the disease
and are more likely to need hospitalisation
because the risk of death from the acute form of
the disease is increased by HDV, as is the risk of
chronic active hepatitis and cirrhosis.  Hepatitis B
is believed to be 100 times more infectious than
HIV.  Most cases resolve spontaneously but up to
8% of positive adults and 15% of positive
adolescents develop chronic infections which
have a high mortality rate because they will
develop either cirrhosis of the liver or liver cancer
over the next 20-30 years. 
International trends suggest that 22% to 44% of
intravenous drug users test positive for HBV,
while 60% to 85% are infected with a related
virus Hepatitis C (HCV).  Figures for Dublin
show that HCV positivity ranged from 52% to
89% among drug users in treatment compared to
a seropositivity rate of 5.8% for HIV.  Hepatitis C
is much more easily transmitted through blood
than HIV, which may explain why levels of HCV
are much higher in drug users.  Sharing of
ÔworksÕ other than needles and syringes such as
spoons, filters, swabs, tourniquets, is seen as a
factor in the high levels of HCV transmission as
is the technique of ÔfrontÕ or Ôback-loadingÕ of one
syringe from a second to measure equal shares of
drug.  In 80% to 85% of cases, the infection
persists and usually leads to chronic hepatitis
that can result in cirrhosis and liver cancer.  The
European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) reports that 5% to 10% of
those chronically infected with HCV will develop
serious health problems.  Co-infection with HBV,
HIV and the use of liver damaging drugs, such as
alcohol, speed up the progression of cirrhosis.
Immunisation against Hepatitis B may help slow
down the later stages of the disease.
HIV and AIDS, the sharing of needles and
syringes also increases the risk of HIV (Human
Immunodeficiency Virus) infection and the
subsequent development of AIDS (Acquired
Immune Deficiency Syndrome).  HIV attacks the
bodyÕs immune system.  By damaging or
destroying the bodyÕs ability to fight infections
and disease, HIV makes an individual vulnerable
to various infections and forms of cancer that are
invariably fatal. 
HIV infection can be spread in a number of ways
including -
(i) sharing injection needles with an infected
person 
(ii) unprotected heterosexual or homosexual
intercourse with an infected person 
(iii) from an infected mother to her baby 
(iv) through the use of blood and blood
products from an infected personÐ N.B
there is no risk of infection through this
route in Ireland
Intravenous drug abuse is a particularly high-risk
activity because the virus can be transmitted
through infected needles, syringes, bowls or
containers used to dissolve drugs and otherC
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infected paraphernalia which are often shared by
other drug users.  A total of 2364 individuals
were diagnosed as HIV positive in Ireland
between 1986 and early 2001.  The major risk
group is clearly intravenous drug users (IDUs)
because 41% of all cases (numbering 970
individuals), were detected in this group.  The
proportion of positive cases among IDUs relative
to other risk categories such as homosexuals and
heterosexuals, has fallen in recent years.  This is
probably due to the increased availability of
programmes designed to reduce the spread of the
virus in IDUs.  However, there seems to have
been an upward trend since 1995.  The overall
levels of HIV infection among IDUs tested for the
virus range from 1.2% to 65% depending on
when and among whom the study was
conducted.  The most recent studies on IDUs in
prisons reported that 5.8% of those tested were
infected.  However, HIV is not as infectious as
many other viruses such as Hepatitis, and normal
social contact with a person with HIV or AIDS
will not lead to infection.  Cases of AIDS in drug
users account for nearly half (48%) of those who
have died from AIDS since 1982.  Since then 691
cases have been reported among all risk groups
of whom 349 have died.  
The infections associated with AIDS usually
result in death as there is no complete cure
available, although new medication combinations
have lead to improvements in life expectancy.  In
recent years there has been growing concern
about levels of Tuberculosis (TB) linked to HIV
and AIDS sufferers.  
¥ Drug use and Pregnancy.
Increasing numbers of girls and women are
becoming heavy users of all types of drugs.  The
disinhibiting effects of drugs such as alcohol and
cannabis may lead to unwanted pregnancies.  
Sometimes drug use is continued during
pregnancy.  The developing foetus will be
exposed to significant quantities of drugs and
because its ability to eliminate drugs such as
heroin, alcohol, cannabis and others is
incompletely developed, such exposure could be
more prolonged than in an adult.  In rare extreme
cases, the drug may interfere with the rapid
changes taking place in the foetus leading to
malformations.  This risk is often greatest in the
first three months of pregnancy.
The drug can also affect the unborn baby in
exactly the same way as it affects the mother, but
the babyÕs immature body is less well able to
cope.  For example alcohol, sedatives and
tranquillisers, which depress an adultÕs ability to
breathe, will also depress this function in the
foetus and also in the newborn baby.  In a
minority of cases, the baby may become
dependent on a drug such as heroin while in the
womb, if the mother is taking the drug
continually during pregnancy.  The baby will
need medical care immediately after being born
to avoid withdrawal symptoms.  This is a serious
problem in Dublin, where, prior to 1980, only one
or two pregnant girls sought treatment for
addiction during pregnancy.  By 1984, however,
this had risen to 54.  A study of 45 such mothers
revealed that 105 children have been born to the
members of the group.
The risks in pregnancy are not the same for all
drugs.  They are most established for drugs with
depressant effects.  In general, heavy drug use
during pregnancy is associated with an increased
risk of losing the baby at birth.  This may be due
to the direct effect of the drug, or it may be
indirect because of the effect of drug use on the
health of the mother such as self-neglect and poor
nutrition.  Apart from anything else, heavy drug
users are less likely to attend antenatal clinics
early in their pregnancy.  The evidence for the
effects of moderate use of many drugs during
pregnancy is inconclusive; the best advice must
be not to take any drug, including alcohol and
tobacco and perhaps coffee during pregnancy
without consulting a general practitioner. 
¥ Behavioural Changes.
For some drugs the effect on behaviour is often
the most dangerous feature, for example the case
of a 16-year-old in London who consumed magic
mushrooms and was killed when he tried to walk
between two underground train stations.  
Many drugs change behaviour by releasing pre-
existing aggressive tendencies, for example
alcohol may reduce the normal inhibitions, which
control an individualÕs violent attitudes leading
to violence.  Behavioural effects are also a
significant feature of solvent misuse where the
intoxication caused by the fumes from aerosols,
glues and butane gas can release aggressive
tendencies resulting in anti-social violence and
vandalism. C
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Other hazards are due more to the sort of life
heavy drug users lead and the behaviour it
involves.  Their health may be damaged by living
rough, eating insufficient food and having no
sense of purpose or belonging outside of their
drug taking.  Drug misusers are believed to have
a mortality rate much higher than the general
population, not only from acute overdoses but
also because of HIV infection, accidents and
suicide.  The full extent of the deaths from all
such causes in Ireland is not yet fully known but
it is known from detailed investigations of
coronersÕ inquest reports that between 1998 and
2000 in the greater Dublin area at least 254 deaths
were detected that were opiate-related.   Men
were 8 times more likely to have died than
women.  The most frequent drug found was a
Benzodiazepine-type tranquilliser followed by
heroin, then methadone and then alcohol.   Most
of the deaths involved polydrug abuse in which
opiates, benzodiazepines and alcohol were the
main contributory causes of death.
Internationally the EMCDDA reports that opiate
injectors have a 20-30 times higher risk of death
than non-drug users of the same age.  Among
females the rate can be over 30 times higher than
in males.  There is no information as yet on the
mortality rate among Irish opiate users.
Internationally it is recognized that most deaths
occur among injectors in their late 20Õs or 30Õs.  
The presence of other drugs such as alcohol and
benzodiazepines increases the risk of death and
the rate among injectors is 2-4 times higher than
in non-injecting drug users.  The risk of death
among addicts is probably due to the lifestyle
involving as it often does, crime, prostitution and
drug pushing in order to maintain an expensive
drug habit combined with malnutrition, self
neglect, disease and over dosage, as well as the
actual drug dependence itself. 
¥ Family Disruption.
It is not just the drug user who suffers harm.  The
strain and tension arising from the deceit, lies
and manipulation associated with dependence
often leads to the break-up of families and
friendships.  
Income required for food, clothing and shelter,
might be wasted on drugs and alcohol.
Decreased productivity may further reduce
family income.  Other family obligations such as
childcare may be neglected and sexual problems
between husband and wife may occur.  Alcohol is
known to be a major factor in over 30% of broken
marriages in Britain and 52% of cases of wife
battering are said to be alcohol-related.  
Families of young people involved in solvent
abuse are particularly at risk.  This is due to the
difficulty of having to deal with an adolescent
intoxicated with solvents, assaults on members of
family, legal difficulties resulting from the abuse
and failure of the child to return home at night.
Many parents are also frightened that their other
children may imitate the abuser and start
experimenting with solvents or other drugs. 
Even with drugs, where the medical dangers
from very occasional use of low strength
products may appear slight, legal dangers
remain.  Being arrested, prosecuted and
convicted can be enough to cause great distress to
the drug user and their family, and may have
lifelong consequences.
C
ha
pt
er
 2
 - 
D
ru
gs
 a
nd
 D
ru
g 
R
el
at
ed
 P
ro
bl
em
s
14
Effects on Society in General
Introduction
The harm caused by drugs can also arise in other
ways; because they are frequently involved in
illegal activity, many drug addicts become
isolated from ordinary life, only having contact
with a small sub-group of drug using friends.
They thus find it harder to obtain or retain a job
and to find a place to live.  Increasingly they find
themselves ÔmarginalizedÕ, ostracized from
society and form an alienated minority.  As a
result, a large amount of government funds must
be spent on law enforcement and on medical
care.  The whole community pays a heavy price
for drug related crime through increased taxes
and through increased insurance premiums.  The
community also loses out because of lost
productivity due to absenteeism, unemployment
and loss of earnings.
In some Latin American countries the huge
profits amassed by drug producers and
traffickers have had a destabilizing effect on the
local economy.  As a result, some cocaine ÔbaronsÕ
have more wealth than the State and have
attempted to use this wealth and the arms it can
buy, to blackmail and terrorise the organs of
government into silence and tolerance of their
illegal activities.  The use of private armies
developed from drug money has coined the term
ÔNarcoterrorismÕ and a number of countries are
now almost completely outside the control of
their governments and in the grip of the powerful
drug barons. 
Wrong time, wrong place
Even in moderate amounts most of the drugs
mentioned in this publication damage co-
ordination, reaction time and the ability to
maintain attention, effects which can last for
hours.  No matter how the person feels, they are
not as capable as before and activities such as
driving, operating machinery, even crossing the
road become more dangerous, both to themselves
and to others.  
While there is a general awareness of the link
between alcohol consumption and road traffic
accidents, there is less appreciation of the
damaging effect of cannabis and tranquillisers on
the skills required to drive safely.  There is
increasing evidence from other countries of the
role of cannabis in particular, in road traffic
accidents and fatal train crashes.  In some studies
the percentage of those killed and injured in
crashes, who had been using cannabis, is the
same as the percentage who had been drinking
alcohol.  
The impairment caused by many drugs may last
for hours after the sought after effects have worn
off.  For example, the effect of cannabis on
driving ability persists for three to four hours
after the ÔhighÕ.  It is claimed that even single
doses of some minor tranquillisers taken the
night before, can impair driving ability the
following morning.
Drugs in the workplace
Drugs such as cannabis, alcohol, ecstasy and
tranquillisers can also impair intellectual
performance, memory and learning ability.
Therefore individuals who misuse drugs
frequently and / or during the day will be less
effective at work.  There is concern that the costs
are being paid for in terms of workplace
performance and safety.  
The harm caused to an individualÕs ability to
learn and remember vital skills damages their
ability to gain employment and the ability to
perform a job efficiently and with due regard to
the safety of themselves, their fellow workers and
the general public.  Drug misuse in the workplace
leads to problems such as Ð 
¥ increased absenteeism - drugs misusers are
missing from work up to 2.5 times more often
than non-users, 
¥ ill-health - drugs misusers are believed to lose
10 times more sick days than non-users,
¥ work accidents Ð 2 - 3 times higher in
misusers, 
¥ lower productivity Ð 24 - 33% lower in drug
users, 
¥ thefts of products, raw materials, tools or
embezzlement by white collar ÔmanagementÕ, 
¥ decreased quality of work, 
¥ management/employee difficulties due to
personality changes.  
As a result, drug misuse in the workplace results
in large financial losses, such as the estimated
€360 million in lost output in Ireland due to
alcohol misuse, not to mention the huge loss of
human potential.  
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Designer Drugs
These are chemicals in which the psychoactive
properties of controlled drugs have been retained,
but the chemical structure has been deliberately
changed by ÔdesignÕ in order to avoid prosecution
under existing drug laws.   Illegally developed
'relatives' of such drugs as Fentanyl
(Sublimaze¨), Phencyclidine (PCP) and Pethidine
are defined as 'designer drugs'.   
Alpha methylfentanyl (AMF) was the first such
drug prepared from fentanyl which is a fast-
acting powerful painkiller.   AMF, sold as 'China
White' or synthetic heroin in the US, is reported
to be 1,000 times more potent than morphine.
Other fentanyl derivatives are even more potent
with doses being measured in microgramÕs rather
than milligrams.   Reports from the US suggest
that these drugs are proliferating and represent a
serious health hazard with over 100 overdose
deaths believed to be due to fentanyl derivatives.
Another designer drug with devastating effects is
MPPP derived from pethidine, which because of
shoddy chemistry contains an impurity called
MPTP. When taken, MPTP can cause permanent
Parkinson's disease by destroying
neurotransmitters at the base of the brain.
Symptoms include seizures, inability to speak,
rigidity of the body and eventually total
paralysis.   The brain damage caused appears to
be irreversible although it may be possible to
provide temporary relief of symptoms.
A number of derivatives of Angel Dust
(phencyclidine) have appeared on the American
black market.  Drugs such as eticyclidine,
rolicyclidine, tenocyclidine, have been controlled
in Ireland since 1987, as have various fentanyl
and pethidine derivatives.   
All these designer drugs are produced in illegal
underground laboratories using ÔrecipesÕ passed
on through the grapevine and over the Internet.
The increasing sophistication of the back street
chemists represents a new danger to drug users.
Because there is little or no control on the quality
of the drugs, there is no way of preventing
disasters such as the paralysis caused by MPPP
or the overdoses caused by Ôsuper potentÕ
derivatives of fentanyl.
Drugs and Sport
The misuse of drugs not only permeates our
leisure and working lives but has also affected
sporting activities in recent years.  The increasing
competitiveness and professionalism of modern
sport with its emphasis on huge financial
incentives has led to an unwelcome and
dangerous use of many different types of drugs
to improve sporting performance.  
Most sports now prohibit the use of drugs that
are likely to give one individual an unfair
advantage over another.  The Olympic Council of
Ireland has published a list of drugs that are
restricted.  This list includes stimulants such as
amphetamine, ephedrine and pseudoephedrine
found in some cough bottles as well as narcotic
analgesics such as codeine and morphine.  Other
prohibited drugs include diuretics such as
frusemide, which increase the flow of urine and
thus fluid loss leading to a reduction in body
weight.  In addition diuretics, by increasing the
volume of urine, can reduce the concentration of
banned drugs close to or below detectable levels
through dilution.  Some drugs block excretion of
drugs through the kidney and can be used to
mask the presence of prohibited chemicals such
as probenicid.   Other drugs such as the beta-
blockers used medically for high blood pressure
can be misused to reduce nervous tremor in
sports such as shooting and archery.
A major prohibited group of drugs are the
anabolic steroids such as nandrolone, stanozolol
and testosterone among others.  They are used to
increase body weight and muscle mass and
reduce fat in athletes and body builders and also
to increase competitiveness.  The dosages used
are often many times higher than the
recommended medical doses.  Steroids can be
taken orally as tablets that are swallowed or
through tablets that dissolve under the tongue,
by intramuscular injection or through patches
applied to the scrotum.  Anabolic steroids have a
number of potentially serious side effects such as,
high blood pressure, increased cholesterol levels,
breast enlargement and shrinkage of the testes in
males, menstrual irregularities and the
development of male characteristics in women,
acne, baldness and water retention.  Teenagers
are particularly at risk because of the drugs
stunting effect on their growth.  
Increasing use is being made of hormones such as
Human Growth Hormone and Erythropoeitin
(EPO), in the former case for its anabolic effectsC
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and in the latter case to increase the number of
red blood cells and as a result the oxygen-
carrying capacity of the blood.  This is a major
help in endurance competitions such as long
distance running or cycling stage races.  
The testing of blood and urine samples is used to
detect this type of cheating.  In the case of
steroids this is particularly difficult because the
body also produces natural steroids.  Normally
the ratio of testosterone to its related
epitestosterone in the body is 1:1.  The use of
additional testosterone would increase this above
6:1 which is the maximum permitted ratio.
Further information on prohibited drugs in sport
may be obtained from the Olympic Council of
Ireland.  Athletes seriously interested in their
sport should contact their medical practitioner,
pharmacist or sporting body for advice before
they take any prescription medicine or
supplement as well as supplements or medicines
bought without a prescription called over the
counter medication (OTC). 
The Extent of the Problem
There is no satisfactory answer to a question such
as Òhow many people use drugs in Ireland?Ó  Not
surprisingly, facts and figures are more readily
available about the use of drugs such as alcohol
and tobacco that are legal.  It is much more
difficult to determine the number of Irish people
using, misusing or dependent on the various
illegal drugs such as opiates, cocaine and
cannabis.  This is in part due to the difficulty of
measuring the extent of any illegal activity.
Information on this sector of the drug scene
depends on users of illegal drugs coming to the
attention of the legal system, health services or
social workers.  
A variety of indirect and often imprecise
indicators must be collated in order to develop an
overall picture of the extent of the Òdrug
problemÓ.  However, none of these indicators,
either on their own or collectively can give an
absolute measure of the extent of the problem,
but merely give a relative measure of changing
trends over a period of time.  The indicators most
often used include the results of surveys of self-
reported drug taking among selected groups of
the population, law enforcement statistics relating
to prosecutions and seizures of drugs, and health
service data such as admissions to treatment, HIV
and hepatitis cases and drug-related deaths.  The
information is collected by the Health Research
Board for national purposes and for transmission
to the European Monitoring Centre for Drugs and
Drug Addiction which publishes an annual
report on the state of the drugs problem in the
European Union. 
In addition to data on illicit drugs, the extent of
legal consumption of medicines, alcohol and
tobacco is often indirectly relevant to the use of
illegal drugs because the use of ÔlegalÕ and
ÔillegalÕ drugs is interconnected at several levels.
At one level, it is often the case that widespread
socially acceptable drug use encourages people to
see drug use as an appropriate way of
responding to personal or social difficulties or
simply to alter mood.  On another level, the same
people who use alcohol, may also use medicines
or alcohol as part of their overall pattern of drug
use, depending on what drugs are available on
the black market at a given time.  Also it is
believed that early involvement by young people
with legal drugs is a predictor of subsequent
involvement with illegal drugs.  
A major difficulty with much of the available
information is that it is retrospective and merely
confirms what we know has happened months or
even years ago.  On the basis of the indicators at
present available, imprecise though they are, it
can be stated with certainty that there was a
rapid increase in illegal drug use in Ireland since
1979.  The 1990Õs saw the emergence of the
ecstasy phenomenon while the heroin problem
worsened.  Various estimates of the extent of
heroin use have been put forward but we have no
accurate way of knowing how many people use
heroin or how many are dependent on it and
related opiates.  All that can be stated with
certainty is that between 1990 and 1999, 12,357
people sought treatment for the first time for C
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drug related problems.  Heroin or opiate users
accounted for 61.1% of those seeking treatment
(n=7,559).  There is no way of knowing what
proportion of the total opiate-using population is
represented by this number.  It is known that
currently opiate misuse is largely confined to the
greater Dublin area.
The survey data indicates that experimentation
with drugs has increased.  A 1995 survey among
16 year olds reported that 37% had used cannabis
and 9% ecstasy.  The figure for cannabis was
three times the average for other European
countries in the study, however it did not include
data from France, Germany or the Netherlands.
The corresponding 1999 European School Project
on Alcohol and Drugs (ESPAD) study shows a
welcome drop in the experimentation rate to 32%.
A feature of the earlier ESPAD report was the fact
that Irish 16 year olds were below the European
average in their perception of the risks associated
with the use of illegal drugs, cigarettes and
alcohol. The 1999 report suggests that this is no
longer the case except for solvents.  Allowing for
under-reporting, which is inevitable with the
survey approach, survey data shows that young
Irish people use or experiment with illegal drugs
at much the same level as their counterparts in
other developed countries, except the USA where
levels of reported drug use are higher than in
Europe.  Most surveys, although difficult to
compare, suggest that about 25% of young Irish
adults (18-34) have tried illegal drugs at least
once.  The vast majority of them, therefore, do not
use or experiment with illegal drugs.  
However, there are grounds for concern about the
numbers of young people using cigarettes and
alcohol.  In this, of course, they are merely
following in the footsteps of their adult fellow
countrymen and women who spend over €5,400
million on legal drugs such as alcohol and
tobacco each year.  Many pay a high price for this
drug consumption in terms of dependence, ill
health and premature death.  With approximately
95,000 alcohol dependants, 840,000 nicotine
dependants and an estimated 22,000 at risk from
tranquilliser dependence, it is difficult not to
agree with the suggestion that most Irish people
have more to fear from legal drugs and medicines
than from illegal drugs. 
C
ha
pt
er
 2
 - 
D
ru
gs
 a
nd
 D
ru
g 
R
el
at
ed
 P
ro
bl
em
s
18
Introduction    
The availability of drugs in Ireland is legally
controlled through a number of statutes.  This
chapter will give you an overview of the key
statutes and their provisions.
The 1961 Poisons Act
The 1961 Poisons Act controls the sale of poisons
by confining their sale to authorised sellers,
which are mainly pharmacists.  Most recognised
drugs of misuse are controlled in this way, but
are also subject to further more stringent legal
controls
The 1947 Health Act
The 1947 Health Act permits the Minister for
Health to make regulations to control the sale of
medical preparations.  Several such regulations
exist.  
The Medical Preparations (Control of Sale)
Regulations restrict the sale of a wide range of
drugs to pharmacists only.  The regulations are
comprised of five schedules.  Drugs listed in
either part of the first schedule may only be made
available by retail sale on medical, dental or
veterinary prescription.  This schedule includes
amphetamine-type stimulants and barbiturate
sedatives, as well as various minor tranquillisers
of the diazepam type, all of which are also
subjected to other far more stringent controls.
The second schedule lists substances such as oral
contraceptives.  The third schedule includes
medicines that a pharmacist may not supply
under the Ôemergency supplyÕ regulations for
example barbiturates, which are controlled by the
Misuse of Drugs Acts.  The fourth schedule lists
cautionary warning notices that should appear on
dispensed medicines.  For example, various anti-
histamine drugs used to combat hay fever,
prevent travel sickness and included in some
cough bottles may cause drowsiness.
Accordingly, the latter type of product must bear
a warning that Ôthis may cause drowsinessÕ.  The
fifth schedule contains substances which cannot
be supplied by a pharmacist in an emergency at a
patient's request but which may be supplied at
the request of a G.P.
Medical Preparations (Control of
Amphetamines) Regulations 1970
The Medical Preparations (Control of
Amphetamines) Regulations 1970 prohibit the
manufacture, preparation, importation, sale or
distribution of seven scheduled amphetamine
(ÔspeedÕ) type drugs.  The Minister for Health
may grant licences for the manufacture,
importation or sale of a specified quantity of a
controlled preparation when it is needed for
certain medical conditions.
Misuse of Drugs Acts 1977 & 1984
The Misuse of Drugs Acts are intended to prevent
the non-medical use of drugs.  For this reason,
they control not just medicinal drugs but also
drugs with no current medical use.  Offences
involving the general public are covered under
these Acts.  The drugs to which the Acts apply
are specified in the schedules to the Act and are
known as controlled drugs.  The list includes, in
addition to opiates such as heroin, other
substances such as sedatives, stimulants and
hallucinogenic drugs which are liable to misuse.
The Acts define a series of offences relating to
controlled drugs including Ð 
- unlawful supply 
- intent to supply 
- the import or export 
- the unlawful production 
- the growing of opium poppies, cannabis and
coca plants
- the forging of prescriptions
- the occupiers of premises knowingly allowing
illicit traffic in drugs 
- the occupiers of premises permitting the use
of controlled drugs on their premises.  
The Acts also prohibit the unlawful possession of
drugs, but makes a distinction between
possession for oneÕs own personal use and
possession for illegal supply to another person
(ÔpushingÕ).  This latter offence carries much
heavier penalties.  
To enforce this law, the Garda have special
search powers to stop, detain and search people
and vehicles without a warrant if they have
ÔreasonableÕ cause to believe that someone is in
possession of a controlled drug.  Customs and
Excise officers have similar powers under the
Customs and Excise (Miscellaneous Provisions)
(No.2) Act 1988 which also permits intimate body
searches by a medical practitioner acting at the
request of a Customs Officer, in order to detect
smuggling of drugs in body cavities by so-called
Ôstuffers and swallowersÕ.
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Chapter 3 - Drug Laws
The Misuse of Drugs Act 1984 prohibits the
printing, or sale of books or magazines that
encourage the use of drugs proscribed in the Act,
or which contain advertisements for drug
equipment, pipes or cocaine kits.
Maximum sentences differ according to the
nature of the offence.  Sentences are greater for
pushing, illegal production or for allowing
premises to be used for producing or supplying
drugs, but are less for possession for oneÕs own
use.  For the more serious offences, maximum
penalties include life imprisonment or an open-
ended fine.  
In the case of cannabis, on the other hand, the
maximum penalty for possession for personal use
is restricted to a €381 fine for a first offence tried
in the District Court, or €635 fine on indictment,
€508 fine for a second offence with no option of
imprisonment.  If this second offence is tried
before a judge and jury, the maximum fine is
€1,270.  For third and subsequent offences the
fine is €1,270 or 12 months in jail or both. The
penalty for a third offence tried by judge and jury
is an open-ended fine or three years in jail, or
both.
The penalty for possession of all other drugs
depends on the type of court.  In the District
Court, the penalty is a maximum fine of €1,270 or
12 months in jail, or both.  In the case of a person
found guilty before a judge and jury, the
maximum fine for possession is left to discretion
of the court, which may also impose a seven-year
jail sentence, or both.
Over 70% of drug convictions involve the
possession of drugs while convictions for
ÔpushingÕ or trafficking account for about 10% of
cases before the courts.
When a person is convicted of an offence under
these Acts the Court may decide to obtain a
written medical report on the convicted person,
with recommendations about medical treatment
which the person might require arising from his
or her dependency on drugs, and also a report on
the personÕs social background, vocational and
educational circumstances.  On the basis of these
reports the Court may decide not to impose the
appropriate penalty.  It can decide to have the
person detained in a custodial treatment centre or
require them to undergo a course of medical
treatment, a course of education and training or
both to improve their social and educational
background with a view to facilitating social
rehabilitation. 
This concept has rarely been implemented.  A
refinement was introduced on a pilot basis in
2001 with the introduction of a Drugs Court
system under the aegis of the District Court.  The
idea is that these Courts would be treatment
focussed and that problem drug users charged
with non-violent offences could be diverted to
treatment programmes rather than being sent to
jail. 
Regulations made under the Misuse of Drugs
Acts divide the controlled drugs into five
separate schedules to take account of medical
practice.  These schedules allow exceptions to the
general prohibitions on the possession, supply
and use of controlled drugs.
Schedule 1. lists mainly hallucinogenic drugs that
have no medical use at present.  It also includes
some of the Ôdesigner drugsÕ.  The drugs in this
schedule cannot be prescribed by doctors or sold
in pharmacies.  The use of these drugs is limited
to scientific research or forensic analysis.
Production, supply, import and possession are
subject to special licensing.
Schedule 2. lists those drugs which may be used
for medical purposes but which are regarded as
particularly dangerous if misused.  The list
consists mainly of the opiates, both naturally
occurring ones such as morphine and synthetic
ones such as pethidine.  It also includes
amphetamines and related stimulants.  Any of
these drugs can only be legally obtained when
prescribed by a doctor, dentist or veterinary
surgeon and supplied by a pharmacist.  All
aspects of the production and supply of Schedule
2 drugs are strictly controlled and licensed.
These drugs are further subject to stringent
storage conditions in pharmacies and to strict
record keeping requirements.
Schedule 3. lists drugs to which less stringent
controls and no record keeping requirements
apply.  It contains certain dependence-producing
sedatives such as barbiturates, some painkillers
and some appetite suppressants.
Schedule 4.  lists various minor tranquillisers and
preparations of phenobarbitone containing lessC
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than 100 milligrams.  There are minimal misuse
of drugs controls applied, since these medicines
are already controlled under the Medical
Preparations (Control of Sale) Regulations made
under the 1947 Health Act.
Schedule 5. lists certain preparations of controlled
drugs to which the restrictions on possession do
not apply.  These are usually very dilute non-
injectable products some of which can be bought
over the counter (OTC) without a prescription
only from a pharmacy, for example some cough
bottles and anti-diarrhoea products that contain
opiates.
The Acts give the Minister for Health the power
to give a direction prohibiting the prescribing of
controlled drugs by a doctor, dentist or veterinary
surgeon, who has been found, after investigation
by a committee of inquiry, to have been
prescribing, administering or supplying such
drugs in an irresponsible manner.  A doctor,
dentist or veterinary surgeon against whom such
a direction is made is given an opportunity to
answer the case made against them and also has
the right of appeal to the Courts. The Minister for
Health has served seven doctors with such
directions, since 1979 when the Misuse of Drugs
Act became law.
There is a special procedure allowing the Minister
to give a temporary direction in a case of urgency.
A prohibition on prescribing under such a
direction lasts for four weeks but may be
extended for periods of 28 days at a time while a
committee of inquiry investigates the case.
International and E.U. regulations 
The processing of drugs from plants such as the
Opium poppy and the Coca plant, as well as the
synthesis of L.S.D., Ecstasy, Amphetamines and
the so-called Ôdesigner drugsÕ requires the
availability of various chemicals needed in
different stages of their production.  Article 12 of
the 1988 United Nations Convention against
Illicit Traffic in Narcotic Drugs and Psychotropic
Substances attempts to limit the supply of
precursor and processing chemicals to illegal
drugs producers.  Within the E.U., a number of
Council Regulations and a Directive
(92/109/EEC) have been introduced to give force
to the provisions of the U.N. Convention.  
In Ireland, the E.U. provisions have been
implemented by means of the European
Communities (Monitoring of External Trade in
Scheduled Substances) Regulations 1993.  The
controls in the Regulations require producers,
importers, distributors and users of 22 different
chemicals to maintain records of stock.
Government authorisation is required before
some chemicals can be exported, while for others,
such authorisation is only required if they are
being exported to certain key countries such as
Colombia, Lebanon and Myanmar (Burma). 
Advance notification of sales of chemicals such as
Ergotamine used to produce L.S.D. or Safrole
used to produce Ecstasy, allow governments an
opportunity to delay consignments pending
investigation or to veto deliveries altogether.
A person who commits an offence under these
Regulations may be fined up to €1,270 or
imprisoned for up to 1 year or may be fined and
imprisoned.  The Government has further
strengthened the controls on these 22 precursor
chemicals by designating them as controlled
drugs under the Misuse of Drugs Acts.
Criminal Justice Act 1994
The Criminal Justice Act of 1994 made provision
for the recovery of the proceeds of drug
trafficking by making it possible for the Director
of Public Prosecutions to ask a court, which has
found a defendant guilty of such a charge, to
determine whether the person has benefited from
drug trafficking.  If the court so determines, a
confiscation order shall be made to recover the
amount of money determined by the court.  
The Act defines drug trafficking offences as
including those under the Misuse of Drug Act
1977 (sections 5,15 and 20), offences under the
Customs Acts as well as the planning of the
production, supply, transportation, storage,
import or export of a controlled drug both inside
the State and elsewhere.  
The Act requires that a mandatory minimum
sentence of 10 years imprisonment be imposed on
individuals found guilty of an offence under
Section 15 of the Misuse of Drugs Act where the
offence is considered to be drug dealing and the
value of the drug or drugs amount to €12,700 or
more.  In the case of individuals who are
addicted to drugs and where their addiction was
a substantial factor in their drug dealing, the
sentence may be reviewed after five years. C
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This Act also created the offence of money
laundering which involves concealing or
disguising property representing the proceeds of
drug trafficking, transferring or removing it from
the State.  Individuals who help drug traffickers
and other criminals to launder money likewise
come within the scope of this Act.  Once found
guilty, they may be fined €1,270 or sent to jail for
12 months (District Court).  If tried in a higher
court they are liable to penalties of a fine, 14
years in jail or both.  Designated bodies such as
financial institutions and their staff must
establish the identity of those seeking to use their
services, particularly where it involves sums of at
least €12,700 and must report to the Garda where
they suspect that a money laundering offence is
involved.
The Criminal Assets Bureau Act 1996
The Government established the Criminal Assets
Bureau after the enactment of the Criminal Assets
Bureau Act 1996.  The Criminal Assets Bureau
identifies assets derived directly or indirectly
from criminal activity and aims to deprive
individuals of these assets by means of
confiscation, restraint of use, freezing,
preservation or seizure of all assets identified as
deriving or suspected to derive from such
activity.  In addition, the Bureau aims to ensure
that such individuals and their assets are
subjected to the full rigours of the Revenue Acts
including taxation.  The profits arising from drug
dealing as defined in the Misuse of Drugs Acts
are a major target for the Criminal Assets Bureau.   
The Bureau consists of members of the Garda
Sochna, Revenue Commissioners and of the
Department of Social and Family Affairs,
nominated by the respective organisations as well
as legal and technical experts.  Their identities
cannot be revealed so as to protect them and their
families from threats and intimidation.  Any such
attempt is punishable by means of a fine of €1,905
or 12 months in jail imposed by the District
Court.  Higher courts may impose fines of
€127,000 or 10 years imprisonment or both.
The Criminal Justice (Drug Trafficking) Act
1996
The Criminal Justice (Drug Trafficking) Act 1996
gave Garda additional powers of detention
where they suspected someone was involved in
drug trafficking or where they were suspected of
concealing drugs within their body.  Under the
provision of the Act a person can be detained for
up to 1 week (168 hours) initially upon the
authority of a Chief Superintendent but
subsequently by way of a warrant from a District
or Circuit Court judge.  The aim is to provide
time for the Garda to fully investigate any
alleged trafficking offences.  The Act further
allows courts to draw inferences from the failure
of an individual to mention facts to be relied on
in their defence, either before or when being
charged.  It also gives Garda power to enter and
search dance halls.
Licensing (Combating Drug Abuse) Act 1997
The power to enter dance halls was extended
further by the Licensing (Combating Drug
Abuse) Act 1997 which made provision for
measures to combat drug misuse in places used
for public dancing in licensed premises and other
entertainment venues.  It also provided the
Garda with the power to prevent unlicensed
dances such as open-air ÔravesÕ.   
In the case of a ÔraveÕ individuals involved in
organising it can be directed to leave an area and
remove any sound or lighting equipment.  Failure
to comply leads to a fine of up to €1,905 or 3
months imprisonment.  The Garda can also stop
and turn back individuals planning to attend
such an unlicensed dance.  Garda can seize
sound equipment they suspect is to be used at an
unlicensed dance and a court may order the
confiscation of the sound equipment
subsequently.
In relation to pub and dance hall licences, any
person who has been convicted of a drug
trafficking offence is disqualified from ever
holding such a licence.  A licence holder who
permits the use of the licensed premises for the
sale, supply or distribution of a controlled drug is
likely to have the licence immediately revoked by
Court Order and neither they nor the premises
may obtain a licence for five years.  The licence-
holder must have been previously warned by a
member of the Garda Sochna about the
suspicion that the premises was being used for
trafficking in drugs and the need to prevent such
activity and have been given not less than 4
weeks to take appropriate action.
Housing (Miscellaneous Provisions) Act 1997 
The Housing (Miscellaneous Provisions) Act 1997
allows housing authorities or their tenants toC
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apply to the District Court for an excluding order
against an individual engaged in anti-social
behaviour.  Such behaviour is defined as drug
dealing and/or serious violence and intimidation.
It should be noted that simple possession of
drugs for personal use does not come under this
heading.  
In such circumstances the District Court may
order an individual to leave the house in question
and not to enter or be in the vicinity of the house
or housing estate.  Such excluding orders may be
made on an interim basis and allow a more
targeted approach than the eviction of an entire
household in cases of anti-social behaviour.
Orders may be made for a maximum period of
three years but can be renewed or varied in
length.  Individuals who disobey the order may
be fined a maximum of €1,905 or sentenced to 12
months in jail or to both a fine and jail by the
Court.  
The Act also permits the housing authority to
refuse to let or sell a dwelling to a person where
the authority considers that the person is
engaged in anti-social behaviour or that the
letting would not be in the interest of good estate
management.  Health Boards may also refuse or
withdraw rent and mortgage assistance to
individuals who have been evicted, excluded or
refused housing on grounds of anti-social
behaviour.
Non Fatal Offences Against the Person Act 1992
The Non Fatal Offences Against the Person Act
1992, made it an offence to attack someone with a
syringe or to threaten them with a syringe.  On
conviction, the District Court may impose a fine
of €1,905 or 12 months imprisonment or both.  In
higher courts someone found guilty may be fined
or sentenced up to 10 years in jail.  
This Act also permits Garda to seize syringes
and penalise individuals who abandon syringes
where others are likely to be endangered.  In
these cases the District Court penalties are the
same as for attacks but on indictment the
maximum jail sentence is 7 years.  
Section 12 of this Act involves poisoning offences
of relevance to ÔspikingÕ of drinks as well as to
cases of drug-assisted sexual assault, so-called
Ôdate-rapeÕ.  Poisoning is interpreted as
knowingly administering a substance to another
person without their consent, which is capable of
interfering substantially with the personÕs bodily
functions.   Such a substance may be one that is
capable of causing unconsciousness or sleep.  The
penalty for someone found guilty in the District
Court is a fine of €1,905 or 12 months or both.
On indictment such as in the Circuit Court, there
may be a fine or 3 years in jail or both fine and
jail sentence.
Criminal Justice (Public Order) Act 1994
The Criminal Justice (Public Order) Act 1994
makes it an offence for a person to be intoxicated
in a public place to such an extent as to be a
danger to themselves or others.  The penalty for
such an offence is a fine of not more than €508.
While the word ÔintoxicatedÕ mainly relates to
drunkenness, the Act makes clear that it also
refers to other drugs, to solvents or other
substances or to combinations of substances.  The
Act also allows Garda to seize any bottle or
container that they have reasonable cause to
suspect contains an intoxicating substance.  They
can also indicate, in relation to certain events,
that those in possession of intoxicating liquor are
liable to have that alcohol confiscated.
Road Traffic (Amendment) Act 1978
The Road Traffic (Amendment) Act 1978 makes it
an offence to drive a car, motor bike, truck, pedal
cycle or animal drawn vehicle while Ôunder the
influence of an intoxicant to such an extent as to
be incapable of having control of the vehicleÕ.
Intoxicants include alcohol and drugs and any
combination of drugs and alcohol.  The word
ÔdrugsÕ here includes prescribed and over the
counter (OTC) medicines.
Merchant Shipping Act 1992
The Merchant Shipping Act 1992 (Section 24
Subsection 2) makes it an offence for the master
or a crew member of a ship to be under the
influence of alcohol or any other drug while on
duty, to such an extent that his ability to
discharge his duties is impaired.  The penalty is a
maximum fine of €1,270.
Intoxicating Liquor Acts 1988 & 2000
The supply, possession and consumption of
alcohol and tobacco by adults is permitted, but at
the same time availability is affected by taxation
and various laws, some of which are designed to
discourage young people from drinking and
smoking.  The Intoxicating Liquor Act 1988 not C
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only prohibits the sale of alcohol to those under
18, but also makes it an offence for a person
under 18 to buy alcohol or to drink alcohol in a
public place. In an amendment to the 1988 Act
the Intoxicating Liquor Act 2000 allows District
Court Justices to order the temporary closure of
licensed premises where an offence of illegal
supply to a person under 18 is proven.  The
closure can be of 7 days for a first offence and up
to a month for a second offence.  
Tobacco (Health Promotion and Protection) Act
1988 
The Tobacco (Health Promotion and Protection)
Act 1988 reinforces the prohibition on the sale of
cigarettes to those under 16.  This Act also bans
the sale of smokeless tobacco products such as
Skoal Bandits¨ and enabled the Minister for
Health to introduce Regulations in 1990
prohibiting or restricting the use of tobacco in a
large number of public areas including cinemas,
theatres, trains, schools and public buildings. The
Health (Miscellaneous Provisions) Act 2000
amended the 1988 Act by increasing the age limit
of those to whom tobacco may be sold from 16 to
18 and increases the fine to €1,905.
Unrestricted Drugs
There are some ÔdrugsÕ that we often donÕt think
of as drugs, whose availability is not subject to
any legal controls on sale or consumption.
Included in this group is caffeine contained in
drinks such as tea, coffee and cola.  
The supply of organic solvents in the form of
glues and aerosols is prohibited under Section 74
of the Child Care Act 1991, where there is
reasonable cause to believe the substance will be
inhaled by a person under 18 for the purpose of
causing intoxication.  The actual possession and
misuse of these products is not an offence,
however a member of the Garda Siochana may
seize a substance that is being inhaled by a
person under 18.  The penalty for supplying such
products to those under 18 may include a fine of
up to €1,270 or 12 months in jail. 
Informal Controls
It is said that the non-medical use of all drugs is
subject to informal controls arising from custom
and culture and from the requirements of
everyday life.  These controls are more likely to
be effective with drugs that are a familiar part of
the culture.  This may explain why coffee and tea
are made available during the working day, while
alcohol is generally reserved for after work.
However, it has often been pointed out that the
level of acceptance of excessive alcohol
consumption is very high in Ireland.
Strengthening of informal controls such as the
increasing unacceptability of drunken driving or
the hardening of attitudes to incompetence at
work due to alcohol, may be as important as legal
controls in preventing excessive, harmful or
inappropriate use of drugs.
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Introduction
Alcohol is almost certainly the oldest mood-
altering drug used by man, and has been
regarded as a food, a medicine and a drug.  The
use of beer, wine and mead was well established
before the process of distilling spirits was
invented about 800 A.D. in Arabia.
Alcoholic drinks consist chiefly of water and
ethanol (ethylalcohol) produced as the result of
fermentation by yeasts of sugars from fruits,
vegetables or grain.  Beer contains about 5 parts
ethanol to 100 parts of water, wine is about twice
as strong, sherry is four times as strong, while
distilled spirits such as whiskey, vodka or gin
consist of almost half ethanol and the rest water.
Methanol (methylalcohol) is a different type of
alcohol produced from wood and is used in
methylated spirits and surgical spirit.  A very
small number of homeless alcohol dependent
drinkers may drink ÔmethsÕ, because it is cheap.
Methanol is very poisonous and frequently
causes blindness, coma and death.  
Ethanol, as in beer, wine and spirits, is unusual in
that it supplies calories.  Ethanol provides 7
calories per gram, whereas carbohydrates and
protein provide about 4 calories per gram.
Alcohol drinks thus provide energy but little
other nourishment and for this reason are often
referred to as providing Ôempty caloriesÕ.
Legal Controls
Because alcohol is a potent drug its use has
always been regulated by society in different
ways.  Thus, licensing laws lay down when,
where and to whom alcohol can be sold, but do
not make the possession or drinking of alcohol by
adults an offence.  Other legal controls on the use
of alcohol relate to drunkenness, drunken driving
and age restrictions on the purchase and
consumption of alcohol by young people.  The
system of taxation via excise duty and VAT also
has a role to play in influencing consumption of
alcohol.  Home brewing of beer and the making
of wine, but not the distillation of spirits such as
potn is permitted, provided the beverages are
not sold.  The Government raised over €880
million from excise duty on alcohol during 2000.
Alcoholic drinks may be sold for consumption on
the premises in public houses, in restaurants,
hotels and sports or social clubs, all of which
must be licensed by a District Justice.  Licensed
off-licences sell alcoholic drinks, which cannot be
consumed on the premises.  One industry source
suggests that there are 10,000 licensed premises,
80% of which are public houses.  
Licensing laws restrict the hours during which
alcohol may be sold.  Under the Intoxicating
Liquor Act 2000 public houses may open from Ð 
- 10.30am to 11.30pm from Monday to
Wednesday and Sunday 
- 10.30am to 12.30am on Thursday, Friday and
Saturday.  
Late opening to 12.30am is also permitted on St.
Patrick's Day and on the eve of Public Holidays.
In addition to the above opening hours, a
Ôdrinking upÕ period of 30 minutes, during which
time alcohol may not be purchased, is permitted.
All public houses must close on Christmas Day
and Good Friday.  Clubs, hotels and restaurants
are permitted to serve alcoholic drinks to
members or guests until much later than public
houses provided that a substantial meal is
provided at the same time.  The number of
licence ÔextensionsÕ, which allows late drinking
during dances and festivals, being granted is on
the increase. 
The Criminal Justice (Public Order) Act 1994
makes it an offence for a person to be intoxicated
in a public place to such an extent as to be a
danger to themselves or others.  The penalty for
such an offence is a fine of not more than €508.
While the word ÔintoxicatedÕ mainly relates to
drunkenness, the Act makes clear that it also
refers to other drugs, to solvents or other
substances or to combinations of substances. The
Act also allows Garda to seize any bottle or
container that they have reasonable cause to
suspect contains an intoxicating substance.  They
can also indicate, in relation to certain events,
that those in possession of intoxicating liquor are
liable to have that alcohol confiscated.
It is an offence to drive under the influence of
alcohol.  This prohibition applies to motor cars,
trucks, motor bikes, push bikes and animal
drawn vehicles.  Since January 1994, it is also an
offence to drive with more than 80 milligrams
(mgs) of alcohol per 100 millilitres (mls) of blood.
The equivalent level in urine is 107 mg/100 ml
and in breath it is 35 microgrammes/100 ml.  
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Chapter 4 - Alcohol
The 1988 Intoxicating Liquor Act brought in new
restrictions concerning the presence of people
under 18 years of age on licensed premises and
also the sale of alcohol to such young people in
both on-and off-licensed premises. 
It is an offence to sell alcohol to a person under
18 either on or off the premises by a licence
holder or any other individual.  The penalty for a
first offence is a €1,270 fine, rising to €1,900 for
subsequent offences and the licence may also be
endorsed.  If a publican is found guilty of such an
offence the District Court may impose a
Ôtemporary closure orderÕ on the premises for up
to 7 days for a first offence and from 7- 10 days
for second or subsequent offences.  Since the
introduction of the new Act, there has been an
increase in the number of convictions for selling
alcohol to young people from 11 in 1987 to 212 in
2000.
It is an offence for someone under 18 to buy or
attempt to buy alcohol or to represent themselves
as being over 18 years in an attempt to consume
or be in possession of alcohol in any public place
other than a private residence.  
Children under 15 years are allowed into a bar
during permitted hours only if accompanied by a
parent or guardian.  It is an offence to give
alcohol to a child under five years old.     
A Garda who suspects Ôwith reasonable causeÕ an
offence relating to alcohol involving young
people has been committed, may request the
name, address and age of the people involved.
Failure to comply or the giving of false details
can result in arrest without warrant and a €64
fine.   The Garda also have the power to seize,
detain and remove without warrant, any bottle or
container suspected of containing alcohol which
is in the possession of an under-18 who is in a
public place. There were 31 such instances
reported by the Garda in 2000.  
The 1988 Act also prohibits a licence holder
employing anyone under the age of 16 to sell
alcohol.  A licence holder may only employ
people between the ages of 16 and 18 if they are
relatives or apprentices.  
The Act also permits the Minister for Justice to
make regulations concerning the issue of an Ôage
cardÕ, specifying the age of the person, to those
over 18 years old.  It is an offence to forge or alter
such an age card or to use such a forged card
with intent to deceive.  The penalty for such an
offence could be a fine of up to €1,270 or
imprisonment for up to 12 months or both.  
Prevalence and Availability
The consumption of alcohol in Ireland increased
at a greater rate than that of any other European
country, with the exception of the Netherlands, in
the ten years to 1980.  The sales of alcoholic
drinks then declined for some years but overall
there has been a 41% increase in alcohol
consumption in the ten years between 1989 and
1999.   
In 1990 we managed to consume 54.89 litres of
pure alcohol in the form of Ð 
spirits - 5.99 million litres spirits 
beer - 19.40 million litres  
wine - 15.54 million litres 
cider - 13.95 million litres.
By 2000 the amount of alcohol consumed had
risen to Ð 
spirits - 8.99 million litres
beer - 23.84 million litres 
wine - 44.29 million litres (up almost 300%) 
cider - 74.56 million litres (up by more than
500%).
In real terms the price of a pint has decreased
since 1950 and this, combined with its increased
availability in off-licences and supermarkets, is
behind the increase in alcohol consumption since
that time.  The Irish people spent €4,210 million
on alcoholic beverages compared to €2,284
million in 1990, with the average household
spending 5.48% of its total budget on alcohol.
In Ireland approximately 1.9 million people, aged
15 years and over, drink alcohol. Among EU
countries, Ireland has the highest percentage, at
25%, of people aged 15 years and over who
abstain from alcohol.  Statistics for 1999, based on
consumption, per head of population show that
we were the 3rd highest nation of alcohol
drinkers in the EU, with a total consumption per
head of 10.7 litres of pure alcohol.  However,
given the large number of total abstainers in the
population these figures may not give an accurate
picture of alcohol consumption in Ireland.  Based
on consumption by those over 15, the amount of
alcohol consumed by each adult rose from 11.21C
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litres per year in 1990 to 14.2 litres in 2000.
Alcohol-related offences have increased from
22,482 prosecutions for all types of offences
involving alcohol in 1992 to 34,887 prosecutions
in 2000.  This figure includes 10,269 prosecutions
relating to drunken driving, 2,045 prosecutions
for drunkenness, and at least 14,687 prosecutions
for being intoxicated in a public place contrary to
the Criminal Justice (Public Order) Act 1994.  
These figures do not include assaults and
murders, many of which are alcohol-related.
Garda sources suggest that 88% of public order
cases, 54% of criminal damage and 48% of cases
of offences against the person, are alcohol related. 
The advertising of alcoholic drinks is not as
strictly controlled as the advertising of tobacco.
ÔVoluntaryÕ codes of practice are in operation.
Spirits are not advertised on television.
Advertisements must use models aged 25 and
over and should not create the impression that
alcohol consumption contributes to social or
sexual success.  Excessive use must not be
encouraged, nor can the advertisements link
drinking and driving, or drinking and sexual
attractiveness.  
Mood Altering Effects
Alcohol is absorbed very quickly from the
stomach into the blood stream and starts to have
an effect within five to ten minutes.  How much
effect a drink has depends on:
¥ the type of drink
¥ how quickly it is drunk
¥ when food was last eaten
¥ bodyweight or build of the individual
¥ the surroundings of the drinker. 
The type of drinker is also important, since
tolerance develops, therefore, a frequent heavy
drinker will absorb alcohol more rapidly.  
A major factor is the amount of alcohol
consumed, which is expressed nowadays in
terms of Òstandard drinkÓ.  1 standard drink  (10
gms of pure alcohol)  is the equivalent of half a
pint of normal strength beer, or 1 glass of wine or
one single measure of spirits.  Some stronger
beers, however, may contain up to 6% alcohol
and a 500-ml can could easily contain 3 standard
drinks of alcohol.  A flagon of cider contains up
to 10 standard drinks.  The Royal College of
Psychiatrists published guidelines for what is
considered low risk drinking on a weekly basis.
For men the upper recommended limit is 21
standard drinks a week, while for women it is 14
standard drinks a week.  Above these limits
varying types of harm can be expected.  The
SLçN survey in 1998 reported that 27% of males
and 21% of females drank more than these
recommended limits and that younger drinkers
were more likely to exceed them.
After the equivalent of about 2 standard drinks a
person feels relaxed, less inhibited and more
talkative.  After 3 standard drinks co-ordination
begins to diminish, as does judgement and
decision-making skills.  More drinks, and
increasing blood alcohol concentrations, can
result in staggering, double vision and obvious
drunkenness, followed by unconsciousness.  Just
a few drinks impair concentration and co-
ordination, with driving skills severely affected.
Most drinkers could reach a blood alcohol level
of 80 mg/100 mls after only 4 standard drinks of
alcohol.  At that level studies show that there is a
10 fold risk of an accident and a 17 year old male
with a blood alcohol level between 70 mgs and
100 mgs/100mls has 40 times more risk of an
accident than a youth who has not been drinking.
Adverse Effects of Use
The effects of heavy and long-term use of alcohol
range from the development of alcohol
dependence syndrome to detrimental physical
effects on an individualÕs health.  
Heavy drinking affects the heart, causes gastric
disorders and inflammation of the pancreas.
Cancers of the upper airways and digestive tract
(mouth, throat and oesophagus) are alcohol-
related and the death rate per 100,000 from these
cancers is still around 16 per year.  
Alcohol supplies calories; as a result heavy
drinking may cause obesity with its attendant
health dangers.  This inadequate diet can result in
protein and vitamin deficiencies, damage to the
nervous system, both in the limbs causing loss of
power and sensation and in the brain causing
impairment and poor concentration.  
Deaths from suicide, drug overdoses, accidents,
and cirrhosis of the liver are common among
alcohol dependants, as is permanent brain
damage.  Studies in other countries indicate that C
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the risk of suicide is 5-10 times higher in heavy
drinkers and that up to 20% of all suicides are
committed by heavy drinkers.  Deaths from
cirrhosis of the liver have increased in Ireland
during the 1990's, as have deaths from alcohol
poisoning, alcoholic psychosis, alcoholism and
alcohol abuse, according to official statistics.   
The total cost of alcohol related problems in
Ireland is estimated to be €2.4 billion per year. 
Dependence
Prolonged heavy drinking over many years
usually leads to the development of an alcohol
dependence syndrome.  Alcohol dependence
syndrome involves a compulsion to continue
drinking, increasing tolerance to the effects of the
drug and drinking to avoid withdrawal
symptoms.  It is not possible to estimate the total
number of alcohol dependants in Ireland, but one
source suggests that as many as 95,000 of the
estimated 1.9 million drinkers will go on to
develop a problem with alcohol.  Alcohol
disorders still account for approximately 20% of
all admissions to psychiatric hospitals, although
it is recognised that as psychiatric hospital
admission policies have changed, statistics
relating to such admissions may not be a true
indicator of the problem.  In 1999, 4,859 people
were admitted to psychiatric hospitals with a
diagnosis of alcohol abuse or alcohol psychosis.
For men, alcohol disorders were the main cause
of admissions, accounting for 26% of all male
admissions.  The highest rate of admission is in
the age group 35-44 years whereas a few years
ago it was in the 45 - 55 age group.       
Sudden withdrawal from alcohol after heavy use
produces sweating, anxiety, trembling and
hallucinations known as the DTÕs.
Alcohol and driving
Alcohol is implicated in many road accidents.
One 1997 report indicated that 25% of all road
accidents and 33% of deaths were alcohol related.
The number of persons killed and injured
between 9 p.m. and 4 a.m. provides a rough
indicator of alcohol-related deaths.  In 2000, 147
people were killed during these hours.  When
account is taken of the fact that only about 13% of
road travel is undertaken during these hours and
that 35% of road deaths and 21% of road injuries
in 2000 occurred during these hours there is, as
stated in the Environmental Research UnitÕs Road
Accident Facts and Statistics (1989) Òlittle room
for doubt but that the combination of alcohol and
driving in the darkness are significant
contributory factors in road accidentsÓ.  An
accident involving a driver who fails the breath
test has been shown to be three times more likely
to be fatal than an accident involving a driver
reported to be sober.
Alcohol and Young People
The SLçN survey (1999) showed that nearly 90%
of 18-24 year olds are regular drinkers.  Younger
drinkers are more likely to drink at high risk
levels, 5 - 7 standard drinks depending on
gender, per drinking session; to drink more than
the recommended weekly limits and to report
more alcohol related problems such as assaults,
family difficulties and financial trouble compared
to other age groups.  
This pattern of alcohol consumption seems to
develop at an early age since the Health
Behaviours in School Children (HBSC) survey
reported that 50% of children have consumed
alcohol before the age of 9.  Approximately 17%
of 9 - 11 year old boys and more than 50% of all
15 - 17 year olds reported that they were current
drinkers.  
There is a difference in the overall percentage of
young people in the HBSC study who reported
current drinking (29%) and the levels reported in
the 1999 ESPAD study, which showed that 16% of
Irish 15 - 16 year olds surveyed were regular
drinkers.   Since the HBSC included 17 year olds
this may explain the difference.  The ESPAD
study highlights that there has been an increase
in the proportion of Irish students who had
consumed alcohol 40 times or more to 40%, as
compared to a similar survey published in 1995
where the percentage was 34%.  72% of Irish
students had been drunk at least once and
worryingly 23% of girls and 27% of boys were
drunk three times or more in the month prior to
the survey, which represents a significant increase
in the 5 years between the studies conducted in
1999 and 1994.  The HBSC study reported that 1%
of 9 - 11 year olds had been drunk 10 or more
times, this rose to 13% of those in the 15 - 17 year
old age group.  
A pattern of early involvement in heavy binge
drinking leading to drunkenness is reflected in
the ESPAD figure of 25% of Irish 15 - 16 year olds
reporting they had been drunk by the time they
were 13 years old.  Irish adolescents were muchC
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less likely than their European counterparts to
expect negative consequences from their drinking
and less likely to consider binge drinking, 5 or
more drinks at a time, risky for them.  They were
also more likely to combine alcohol with other
drugs.  
In addition to the behavioural and health
consequences of this drinking many Irish
adolescents face legal difficulties arising from
their attempts to buy and drink alcohol before
they are legally entitled to do so.  In 2000, it has
been reported, 44 young people under the age of
18 were prosecuted for buying alcohol, 205 for
drinking alcohol in a public place and 24 for
using false identification or pretending to be over
18 in order to buy alcohol.  
Alcohol and Women
Studies show that the majority of women will
have higher blood alcohol concentrations (BAC)
and become more intoxicated than men on a
given quantity of alcohol.  Women tend to have a
higher BAC because they have lower body water
content resulting from their lower muscle content
and higher ratio of fat.  They also appear to differ
in the speed with which they break down alcohol
because of having less of an enzyme or catalyst in
the lining of the stomach.  For these reasons the
same dose of alcohol will produce a 25-30 percent
higher BAC in an average woman than in a man
so that, if a man drinks six standard drinks (3
ÔpintsÕ) of alcohol and a woman four standard
drinks, they will both have similar blood alcohol
concentrations.  Women therefore given similar
levels of consumption get drunk faster and are
more vulnerable to alcohol-related problems such
as liver, brain, heart disease and alcohol
dependence than men.    
Alcohol in Pregnancy
Alcohol from a womanÕs blood stream can pass
through the placenta to reach her baby in the
womb.  Drinking alcohol during pregnancy is
associated with a spectrum of abnormalities
ranging from minor retardation of growth to the
fully developed Foetal Alcohol Syndrome (FAS).
FAS is found in a proportion of babies born to
alcohol dependent mothers.  Studies in other
countries indicate a level of 1-2 per thousand
births.  FAS involves three main features:
¥ reduced birth weight
¥ nervous system abnormalities which are seen
as exaggerated tremors and irritability and
borderline to retarded intelligence
¥ distorted facial features such as small head,
small eye slits and a thin upper lip.  
Many factors as well as alcohol affect the
likelihood of FAS including maternal age, socio-
economic status, nutritional status, as well as
heavy smoking of tobacco and the use of
cannabis.  
Even moderate drinking, such as 1 - 2 drinks per
day, may increase the risk of miscarriages and
stillbirths.  Some long-term studies have
established that pre-natal exposure to alcohol can
result in a reduction in I.Q. at age four, and
deficits in attention and reaction time at the age
of seven.  The minimum dose of alcohol
necessary to produce damage and the most
dangerous time in the pregnancy has not been
established.  
Although the message to pregnant women is Ôthe
less you drink, the better for you and your babyÕ,
a study in one Dublin maternity hospital revealed
that of 100 women who had given birth, only 58
were aware of the harmful effects of alcohol,
compared to 93 who knew smoking was
dangerous during pregnancy.  The study found
that only 11 stopped drinking when they became
pregnant and a number did not reduce their
consumption of alcohol at all.
Alcohol and other drugs
If alcohol is taken at the same time as other
depressant drugs, then the effects of both will be
exaggerated, including the risk of overdose.  The
drugs involved include:
Benzodiazepines
other sedatives and tranquillisers
cough and cold remedies
allergy medicines
solvents
heroin and methadone.  
Most overdose deaths in opiate users appear to
involve alcohol in addition to the opiate.  Recent
studies also indicate that when alcohol is taken at
the same time as cannabis that blood levels of
THC from the cannabis are increased. 
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Introduction
Tobacco comes from the dried leaves of Nicotiana
tabacum, a plant that can be grown in most parts
of the world including Ireland.  Most of the
tobacco used in this country comes from the
U.S.A., and almost 93% of it is used in the form of
cigarettes. Tobacco is grown in many EU
countries, chiefly Greece, Spain, France and Italy.
This tobacco industry was supported by EU
subsidies of €870 million in 1998, a reduction
from the 1991 figure of €1,351 million.  
Cigars are made from darker tobacco rolled up in
tobacco leaves.  This darker stronger tobacco can
also be smoked in a pipe.  Indeed this was the
way tobacco was first introduced into Ireland at
the end of the 16th century, from America.  The
American Indians used tobacco for medicinal and
religious purposes.  Despite warnings about its
effects on health, the use of tobacco spread
quickly.   Up to the 18th century pipe smoking
predominated until it was replaced in popularity
by snuff taking.  Cigarette smoking became a
truly popular activity with the advent of mass
production.  
In 1590 a tax was imposed on tobacco, a
precedent that continues to the present day.  The
fact that tobacco taxes are a convenient and
lucrative way of raising State revenue tends to
temper reaction to the health consequences of
long-term use of tobacco.  However, more
recently these health consequences have been
acknowledged and efforts to promote a tobacco-
free society have begun.
Legal Status
The 1908 Childrens Act prohibited the sale of
tobacco to children under sixteen, but did not
prohibit children from buying, possessing or
smoking tobacco. 
The 1908 Act was updated by means of the
Tobacco (Health Promotion and Protection) Act
1988 which reiterated the ban on sales of tobacco
to under 16Õs and increased the penalty from £2
to  £500 (€635).  This was further amended by the
Health Act 2001 which raised the age from 16 to
18 years and increased the maximum fine to
€1,905. The sale of cigarettes in packets
containing less than 10 cigarettes also attracts a
€635 maximum fine.  
Under the new legislation the Minister for Health
brought in the Tobacco (Health Promotion and
Protection) Regulations 1990 to prohibit or restrict
the smoking of tobacco in designated areas such
as aircraft, trains, public service vehicles,
hospitals & clinics, schools, public buildings
belonging to or occupied by the State, cinemas,
theatres, concert halls, the kitchens of hotels,
restaurants, as well as supermarkets and grocery
shops.  The penalty for an individual who
commits an offence under these regulations is a
€127 fine.  The owner or person in charge of a
premises who permits smoking in a designated
area, faces a €635 fine, 6 months in jail or both.
Similar regulations introduced in 1995 extended
the prohibition on smoking to other areas
including third-level colleges, TV studios, bingo
halls, amusement arcades, pharmacies, banks and
building societies.
The 1988 Act also prohibits the import,
manufacture, sale or advertising of smokeless
tobacco products such as Skoal Bandits designed
for oral use.  The commercial manufacture of
tobacco requires a licence and the maximum
content of 'tar' is legally limited to 12 mgs per
cigarette.  
However, the main legislative control over the
availability of tobacco is exercised by the levying
of excise duty and Value Added Tax (VAT).
Currently taxes account for nearly 80% of the
price of a packet of twenty cigarettes.  The
revenue generated from excise duty on tobacco
came to over €958 million in 2000.  Smuggling of
tobacco products has increased in recent years.
In 2001 over 120 million smuggled cigarettes
destined for the illegal tobacco trade were seized,
representing approximately €24 million in
potential tax lost to the Revenue Commissioners. 
The advertising of tobacco is controlled by
regulations under the 1978 Tobacco Products
(Control of Advertising: Sponsorship and Sales
Promotion) Act.  As a result the advertising of
tobacco is almost totally confined to adult
newspapers and magazines.  The Government
can curtail and control the amount of money
spent on sponsorship of sporting and cultural
events by tobacco companies.  The content of the
advertising is also controlled with a requirement
that a health warning be included on both the
packet and on advertising.  Young people are
protected because advertising is prohibited in
publications directed primarily at those underC
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Chapter 5 - Tobacco
eighteen and sponsorship of youth events is
banned.  From December 1st 1987 cigarette
advertising on shop fronts was prohibited;
tougher health warnings are required to be used
in rotation on the packs while all point-of-sale
promotional material in shops are required carry
a health warning.  The EU Directive (98/43/EU)
banned general tobacco advertising from August
2001 and newspaper advertisements from July
2002.  Sponsorship by tobacco companies must
end by August 2003 or by August 2006 for
Formula 1 Motor Racing.  The Irish government
decided to implement the directive from July
2000.
Prevalence and Availability
Cigarettes became widely used in most countries
during and after World War I, however in Ireland
they only became really popular during the
Second World War.  The number of cigarettes
smoked in Ireland peaked at 7.7 billion in 1978.
The figure has declined since then to less than 6
billion per year during the late 1980's and early
1990's.  However, the downward trend was
reversed in recent years with consumption
reaching 6.7 billion in 1997.  
Much more significant has been the change in the
relative proportion of men and women who
smoke.   In 1973, 49% of men and 37% of women
smoked.  In the 1999 SLçN survey, it emerged
that rates for men and women are now
comparable, at 32% and 31% respectively.
According to WHO the percentage of Irish
women that smoke is among the highest in the
EU.  
The SLçN survey showed that 31% of adults
smoke cigarettes while a further 7% smoke cigars
or pipes.  This is a slight increase on the 1993
figure of 28% but remains considerably lower
that the 1973 figures of 43%.  The highest levels of
39% were reported in the 18 - 34 year age group.
It was reported that while smoking was a
problem for all social classes, young people with
low incomes were more likely to smoke than any
other group.
Among children, the SLçN survey reports that
up to 13% of 9 -11 year olds are smokers, with
boys starting to smoke earlier than girls.  By the
age of 15 - 17 girls are more likely to smoke than
boys of the same age, 30% of boys versus 36% of
girls.  A report from a 1999 survey indicated that
74% of 16 year olds had smoked at least once,
that another 37% were regular smokers and that
18% were daily smokers by the age of 13.  This
high level is confirmed by the SLçN survey,
which showed that approximately one in five 14
year olds smoke.  These figures support the view
that smoking behaviour starts while smokers are
below the present legal age at which they can buy
cigarettes.
Mood Altering Effects
Nicotine gives a feeling of relaxation, allows a
smoker to face stressful situations more easily
and to carry out boring tasks efficiently.  Heart
rate and blood pressure are increased and
appetite is reduced.  First time smokers often
suffer from nausea and vomiting.
Adverse Effects of Use
Tobacco smoke contains more than 1,200 different
chemicals including carbon monoxide, nicotine
and tar.  All the carbon monoxide, 90% of the
nicotine and 70% of the tar is retained in the
lungs when smoke is inhaled.  
Nicotine is a very poisonous drug that affects the
heart, blood vessels, stomach, kidneys and the
central nervous system.  Smoking increases an
individuals risk of heart disease, heart attacks,
blood clots, strokes, bad circulation, ulcers, lung
infection, bronchitis, emphysema, and cancers of
the lung, mouth and throat.  90% of lung cancers
are believed to be caused by the cancer-inducing
chemicals of cigarette tar such as benz-alpha-
pyrene.  According to WHO, cigarettes are
responsible for 30% of all cancer deaths, 20% of
deaths from heart disease and strokes and 80% of
chronic lung diseases.  WHO have stated that the
annual worldwide toll of premature deaths
caused by tobacco is around 3 million and will
continue to rise.  
There have been no studies of the causes of death
among smokers in Ireland, but the Department of
Health estimates that over 6,000 deaths each year
are directly attributable to smoking.  Life
expectancy in Ireland is significantly below the
EU average because of our deaths rates from
heart disease and cancers.  Tobacco related deaths
among women have increased as the use of
tobacco by women has increased.  In most
affluent countries heart disease is now the most
frequent cause of death in women as well as in
men.  Lung cancer death rates in affluent C
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countries are now rising much faster in women
than in men.  
From studies carried out in other countries it is
known that on average each cigarette smoked
shortens the life of a habitual smoker by five and
a half minutes.   Heart attacks are three times as
frequent in American middle-aged men who
smoke more than 15 cigarettes per day as in non-
smokers.  A smoker consuming up to ten
cigarettes per day can expect at least a 3 to 10-
fold increase in their risk of a tumour, a risk
which rises steeply as the number of cigarettes
smoked per day increases.
Dependence 
Tolerance rapidly develops to the effects of
nicotine and people who begin to smoke tend to
increase their consumption until they smoke
regularly.  If they stop, they experience
withdrawal symptoms such as restlessness,
irritability, depression and anxiety, which can be
suppressed with nicotine.  The W.H.O. and the
U.S. Surgeon General have concluded that
cigarettes and other forms of tobacco are
addictive, that nicotine is the drug which causes
dependence and that the pharmacological and
behavioural processes that determine tobacco
dependence are the same as those that determine
dependence to drugs such as heroin and cocaine
and amphetamines.  Indeed, W.H.O. ranks
nicotine as being more addictive than heroin,
cocaine, alcohol, cannabis and caffeine. Many
heroin dependants state that it is easier to give up
heroin than it is to give up smoking.  However,
the fact that replacement products such as gum,
patches, sprays and inhalers help many but not
all those who use them to stop smoking, indicates
that there is more to the smoking habit than
simply nicotine dependence.  
Smoking and Pregnancy
Research suggests that smoking can affect
fertility.  A recent study found that decreased
fertility among women who wished to start a
family was associated with cigarette smoking.  In
addition research suggests that the risk of
impotence in men who smoke is 50% higher than
in non-smokers.    
The health effect on the foetus of maternal
smoking has been extensively studied.  Infants
born to mothers who smoke during pregnancy
weigh, on average, 200g less than those born to
non-smokers.  There is also evidence of an
increased risk of premature births, stillbirths and
early death of the newborn baby where the
mother smokes more than 5 cigarettes per day.  
In long-term follow-up studies, children of
cigarette smokers have been shown to be smaller
and to develop less well intellectually and
emotionally compared to children born to non-
smokers.  Children under 2 exposed to parental
smoking have a higher risk of developing
bronchitis and pneumonia and are at a greater
risk of Sudden Infant Death Syndrome (Cot
Death). 
Passive Smoking
The smoke that smokers take into their lungs is
called mainstream smoke.  The smoke from the
burning tobacco in a cigarette lying on an ashtray
or held between the fingers is called the
sidestream smoke.  This is environmental tobacco
smoke (ETS) inhaled by non-smokers who are
exposed to cigarette smoke at home, at work and
in leisure environments.  Because of this ÔpassiveÕ
smoking, almost all non-smokers including many
babies have traces of nicotine in their bodies.
Some children may be exposed to the equivalent
of 150 cigarettes a year through this form of
pollution.  Sidestream smoke is different to the
smoke inhaled by active smokers because it is
essentially unfiltered and as a result it has 70%
more tar, 2.5 times more carbon monoxide, 2.7
times more nicotine and up to 100 times more
carcinogenic compounds.  In the case of one,
nitrosamine, its content can be up to 830 times
higher in sidestream smoke compared to
mainstream smoke.  
There is increasing evidence that passive smoking
is a major cause of premature death in non-
smokers.  One estimate from the US puts the
figure at about 47,000 per year.  Many reports
show that non-smokers exposed to ETS are at
increased risk of developing lung and other
cancers, chronic lung disease and strokes.   A
study of children exposed to passive smoking by
their parents has indicated that they have a much
greater chance of suffering from the middle ear
disease Ôglue earÕ as well as asthma and other
respiratory illness.
Smokeless tobacco
Smokeless tobacco products include chewing
tobacco and snuff consist of tobacco mixed withC
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sweeteners, flavourings and scents.  In Ireland
snuff is usually sniffed, but in the U.S.A. it is
ÔdippedÕ, that is, held in the mouth between the
lip and gum.  In the U.S.A., sales of moist snuff
have increased recently.  It is believed that 16% of
teenage boys use snuff.  In some parts more boys
use snuff than smoke cigarettes regularly.  
One form is marketed in sachets, designed to be
held in the mouth (Skoal Bandits«¨).  There is
strong evidence that such tobacco products cause
cancer of the mouth.  It is also believed that use
of moist snuff increases the frequency of gum
recession leading to loss of teeth and of
leukoplakia, white patches in the mouth, 10 - 30%
of which have potential to become malignant.  It
is known that nicotine is released into the blood
at levels comparable to smoking cigarettes
leading to long-term nicotine dependence.  These
tobacco products also contain nitrosamine-type
carcinogens at levels higher than permitted in
food.  Lead and cadmium levels are also high and
could potentially harm a baby if the product were
used during pregnancy.  Because of concern
about the health effects of these products their
importation and distribution is banned under
Section 6 of the Tobacco (Health Promotion and
Protection) Act 1988.  
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Introduction
Caffeine is the most widely used drug
worldwide.  Some 120,000 tons are used every
year representing over 1,300 billion cups of tea
and coffee per year all over the world.  Caffeine is
a stimulant found in coffee, tea, guarana, mat,
and cola drinks, in some tonic preparations and
in many analgesic capsules and tablets.  A
chemically similar drug is found in cocoa and
chocolate.
Coffee is made from the roasted beans of the
coffee bush, which was first cultivated in the
Yemen in the 9th century.  It was introduced into
Western Europe at the end of the 16th century
and soon spread rapidly in popularity.
Approximately half of the worldÕs coffee
production is used in the U.S.A.  Coffee is the
strongest of the beverages.  One cup of ÔrealÕ
coffee, that is freshly ground beans as opposed to
ÔinstantÕ, may contain caffeine equivalent to the
minimum dose for stimulation.  Coffee beans
contain 1-2% of caffeine and a cup of ÔrealÕ coffee
contains 80-100 mgs of caffeine.  
Tea consists of the dried leaves of a shrub grown
in China, India, Sri Lanka, Kenya and other East
African countries.  It was introduced into Europe
in the 16th century initially as medicine, but soon
became a popular pick me up.  Several types of
tea-leafs are processed.  The bulk of the annual
production of 2.5 million metric tonnes of leaves
goes to make Black Tea at 78%, with 20% used for
Green Tea and the rest used as Oolong Tea.
Green Tea, which is increasingly valued for its
antioxidant properties linked to protective effects
against heart disease and cancer, is rapidly
steamed or fried to prevent any fermentation.
Black Tea is the form usually used in Ireland and
is fermented or ÔcuredÕ to give the characteristic
aroma, taste and colour of tea.  It has three times
the caffeine content of Green Tea.  Oolong Tea is
partially fermented with about 50% more caffeine
than Green Tea and is used in China and Taiwan.
A cup of tea contains 40-60 mgs of caffeine even
though tea-leaves contain only  3% caffeine.
Differences in the way the coffee and tea are
processed accounts for the final caffeine content.
Guarana and Mat leaf are prepared from South
American plants and are also used to make
beverages.  Guarana, is a dried paste made from
the seeds of a Brazilian plant, it can be
incorporated into fizzy drinks, into capsules or
tablets or chewing gum.  It has the highest
known natural content of caffeine, up to 5%,
sometimes mistakenly referred to as Guaranine.
Some Guarana tablets, capsules and drinks are
marketed with allusions to energy giving
properties.  Based on the estimated caffeine
content of 5%, most products would deliver
between 45-80 mgs of drug per usual dose.  Mat
is used because it allegedly has a lower tannin
content than ordinary tea.  It has caffeine content
of up to 2%. 
Cola drinks contain caffeine from two sources;
some is present in the form of an extract of cola
seeds, grown in West Africa and some is added
during manufacture.  The added caffeine is
produced during the process of decaffeinating
coffee.  Cola drinks generally contain much less
caffeine than coffee, but small children could be
consuming stimulatory amounts. Parents who
discourage young children from drinking tea or
coffee should also discourage them from various
forms of fizzy drinks containing caffeine.
Caffeine is also an additive in a range of Ôhigh
energyÕ or ÔstimulantÕ drinks that also contain
sugar or glucose, an amino acid called taurine
and also glucuronolactone.  The health effects of
these chemicals are largely unknown, however
concerns have been raised about their inclusion
in these products.  The labelled caffeine content
of these drinks ranges from 50-80 mgs per 250 ml
can, on this basis one can may provide the same
amount of caffeine as a cup of strong coffee.  A
recent report by the Food Safety Promotion Board
found that more than half of 11-35 year olds had
consumed one of these drinks at least once.  Over
34 million cans are sold all over Ireland in an
average year, representing 8.5 million litres of
drink.  The average weekly consumption was 3
cans but some consumed 8 cans per week.  The
Food Safety Promotion Board recommend that
these products should not be consumed with
alcohol and that those involved in exercise and
sport should not use them as thirst quenchers
because the caffeine acts as a diuretic which
increases the flow of urine from the body thus
adding to the risks of dehydration.  It is also
recommended that the labelling should state that
they are unsuitable for children under 16,
pregnant women and individuals sensitive to
caffeine.  
Chocolate is prepared from the cocoa bean grownC
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Chapter 6 - Caffeine
in the tropics, particularly on the West African
Ivory Coast.  Cocoa contains between 2-3% of
theobromine which is chemically related to
caffeine, as well as containing a small amount of
caffeine (0.2%).  
Caffeine itself is a white power used as a mild
stimulant in some medical products.  It is used in
some analgesic products, particularly for
migraine.  Caffeine is also an ingredient of some
cocaine and amphetamine substitutes sold as
stimulants and slimming aids.
Legal Status
Caffeine is subject to few legal prohibitions on its
manufacture, sale, distribution or possession in
Ireland. 
EU regulations restrict the use of the term
ÔdecaffeinatedÕ to coffee extracts containing less
than 0.3% by weight of caffeine.  Coffee is
decaffeinated when the beans are still green.
They are usually treated with steam to make
them swell, at which stage they are treated with
chemical solvents such as methylene dichloride,
steam or carbon dioxide to remove the caffeine.
The beans may be steamed to remove any
residual solvent that could be toxic or
carcinogenic, and then roasted to produce the
typical coffee aroma and taste.
Member States of the EU have recently agreed
that foods containing caffeine as an ingredient
must be labelled as containing caffeine.  Products
containing levels of more than 150 mgs caffeine
per litre will, by July 2004, have to be labelled
Ôhigh caffeine contentÕ and the exact amount
present stated on the label.  Thus Ôhigh energyÕ or
ÔstimulantÕ drinks that usually contain 320 mgs
per litre will need to be labelled as Ôhigh caffeine
contentÕ.
The International Olympic Committee lists
caffeine as a stimulant and athletes may be
disqualified if the level in urine is greater than 12
mgs per litre of urine. 
Prevalence and Availability
Caffeinated drinks are sold without restriction in
grocery shops, supermarkets and vending
machines.  They are widely used at rest breaks
during the working day.  It is usual for tea or
coffee to be offered as hospitality to visitors and
virtually every restaurant or caf in Ireland offers
a choice of tea or coffee.
The annual consumption of caffeine worldwide is
equivalent to 70 mgs per person.  This overall
level of course masks much higher consumption
figures in different countries depending on the
preferred beverage.  A recent survey of food
consumption in the Republic and in Northern
Ireland showed that 91% of those surveyed drank
tea and 55% coffee.  
Imports of tea into Ireland are believed to have
remained relatively constant over the past 10
years at approximately 10, 595 metric tonnes.
Net imports of coffee beans are thought to
amount to 7.7 metric tonnes.  Irish people spent
the equivalent of €145 million on coffee, tea and
cocoa in 2000 compared to the equivalent of €103
million in 1991.  
It is believed that the average Irish person drinks
5 cups of tea per day.  It is not known how much
coffee, either from freshly ground beans or as
ÔinstantÕ, Irish people now drink.  Also since
average consumption of cola drinks cannot be
established with certainty, it is difficult to
estimate the average daily consumption of
caffeine.   On the basis of tea consumption the
average Irish person probably consumes about
250 mgs of caffeine per day.  To this figure must
be added an individualÕs caffeine intake from:
¥ freshly made coffee, 75-150 mgs per cup,
depending on whether it is percolated
espresso 
¥ instant coffee, 70 mgs or more per cup
depending on the size of the cup and the
amount of powder used
¥ 330 ml can of cola, 17-55 mgs depending on
the brand
¥ milk chocolate,  6 mgs per bar in addition to
40 mgs theobromine 
¥ hot cocoa, similar content to milk chocolate
¥ caffeine-containing analgesics, 50 mgs per
tablet
¥ caffeine-containing tonics, variable amounts.
According to a Food Safety Promotion Board
Report, caffeine consumption in 1995 was
approximately 214 mgs per day for a typical
male.  Given the consumption of caffeine
containing beverages in addition to other
products this figure appears to be an
underestimate. Reported intakes in Britain and
the U.S.A. are 278 mgs per day and 380 mgs C
ha
pt
er
 6
 - 
C
af
fe
in
e
35
respectively.  All these levels should be compared
with the standard pharmacologically active
stimulant dose for caffeine of 200 mgs.  
Mood Altering Effects
Caffeine stimulates the nervous system.  In
moderate amounts, 150-250 mgs or two cups of
coffee, the drug increases wakefulness, reduces
fatigue and postpones the onset of sleep.  Mental
activity is increased and people can perform
physically exhausting work for longer.  At higher
doses the heart muscles are stimulated, blood
vessels in the brain narrow, and more air is
drawn into the lungs.  Caffeine is also a weak
diuretic, therefore it increases the excretion of
urine.  Theobromine is a stronger diuretic than
caffeine. 
Adverse Effects of Use 
People who drink seven or more cups of strong
coffee a day may feel anxious and irritable, and
have muscle tremors and headaches.  The
stimulant effect may also cause chronic insomnia,
but all these disturbances will clear up once
caffeine intake is reduced. 
It has been claimed that gastric secretion is
increased by caffeine, raising stomach acidity,
thereby increasing the risk of peptic ulcers.
Doubt has recently been cast on this belief
because decaffeinated coffee can produce similar
effects.  
The reported link between heavy coffee
consumption and heart disease may be due more
to other aspects of the userÕs lifestyle, such as
cigarette smoking, rather than to coffee.  Cigarette
smokers eliminate caffeine from the body more
quickly than non-smokers, they must consume
more caffeine to achieve the same effects as non-
smokers.  As a result smokers tend to drink more
coffee than non-smokers.  Most recent studies
appear to show that there is no reason to
implicate caffeine as a risk factor for heart
attacks.  
There is an association between coffee
consumption and increased cholesterol levels
although results vary between different studies.
There is strong evidence to suggest that methods
of preparing fresh coffee which involve boiling
the beans for a long period rather than using a
filter are more likely to cause an increase in
cholesterol levels.   The chemicals responsible
appear to be two compounds, cafestol and
kahweol, which are different to caffeine.  
A number of studies have been carried out to
establish whether there is any association
between caffeine consumption and problems
during pregnancy.  It is known that caffeine can
cross the placenta and so the foetus and newborn
baby are exposed to the drug.  The results of the
research are reassuring in general.  Studies of
over 32,000 mothers indicate that any problems in
their babies are largely due to the smoking habits
of women who were heavy coffee drinkers.  It
appears that there is no acceptable evidence that
caffeine causes birth defects in humans at current
levels of use. Data from tests on animals indicate
birth defects due to caffeine consumption during
pregnancy.  Despite the fact that these findings
are not conclusive, concern over the effects of the
drug on unborn babies led the U.S.A. authorities
to advise pregnant women to limit their caffeine
intake. The breakdown and elimination of
caffeine is reduced threefold in the mother during
the late stages of pregnancy.  Unpleasant
symptoms of jitteriness and nervousness may
occur when a pregnant woman continues a level
of caffeine consumption that would have had no
effect at other times.  This does not appear to
have any short or long-term effects on the babies
in such cases.  In Ireland it is generally
recommended that consumption of caffeine in
excess of 300 mg per day during pregnancy or
while breastfeeding, should be discouraged.  This
would involve drinking no more than 4 cups of
regular coffee, or 6 cups of tea, or 8 cans of cola
or 4 cans of a 'high energy' or 'stimulant' drink
per day. 
In children small single doses of caffeine have
either no effect or small inconsistent effects on
mood, learning and co-ordination.  High levels,
such as the equivalent of 4-5 cans of a cola drink
or 150 mg per day for a 10 year old, can increase
irritability, nervousness and anxiety.
The effects of more than 1g of caffeine (or 15 cups
of coffee) taken at one time, include disturbances
of the senses, such as ringing in the ear, together
with insomnia, tremors, increased heartbeat and
gastric irritation.  Restlessness and excitement
may progress to delirium.  Approximately 10gs is
the lethal dose.  Deaths due to caffeine poisoning
from coffee, tea or soft drinks are unlikely, as they
would involve the consumption of approximatelyC
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75 cups of coffee, 125 cups of tea or 200 cola
drinks at one time.   However, eleven deaths due
to overdoses, suicidal and accidental, following
the consumption of appetite suppressants and
Ôpick-me-upsÕ containing large amounts of pure
caffeine have been reported in the medical
literature.  
Caffeine is known to be mutagenic, it produces
changes to the genetic material in cells so that
they are permanently different to their
predecessors.  These changes are linked to the
subsequent development of cancer.  Other
chemicals produced during the roasting of coffee
beans may also have cancer-inducing effects
when tested on cells.  However, most of the
studies in animals and in humans indicate that
caffeine use is not linked with cancer of the
mouth, oesophagus, stomach, liver, breast, nor
does it cause leukaemia.  Some studies have
indicated an increased likelihood of women
developing benign fibrous lumps in the breast
(fibrocystic disease) if they consume more than
250 mg caffeine per day as coffee.
All types of tea contain antioxidants, which
compensate for the presence of caffeine.   Green
Tea is particularly rich in these chemicals and for
this reason is promoted for prevention of cancer.
Evidence from some animal studies supports this,
but while there is some evidence of benefit in
humans, a direct causal relationship remains to
be established by research. Studies in animals and
in humans also suggest a relationship between
lower cholesterol levels and increased Green Tea
drinking.  Given the lower life expectancy in
Ireland linked to high rates of death from heart
disease, it is difficult to see much evidence to
support a beneficial effect of Black Tea in
protecting from heart disease, particularly when
average consumption of 5 cups per day is so
high.  
Dependence
Tolerance to the effects of caffeine develops and
there is a well-established caffeine withdrawal
syndrome, which can be noticed after regular use
of about 300 mgs a day.  After stopping caffeine
intake the long-term user feels less alert and
relaxed, more irritable and drowsy, and suffers
from headaches, which can often be severe.  This
tiredness and irritability can be experienced if
people miss their morning coffee.  Psychological
dependence can develop to the extent that people
find it hard to stop drinking coffee even for
medical reasons.
Caffeine and Other Drugs
Combining caffeine with alcohol does not reduce
breath alcohol levels nor does the caffeine
completely counteract the impairment of driving
ability caused by alcohol.  Medically, caffeine is
often incorporated with analgesics to increase
their effectiveness.  A recent study conducted at
U.C.D. has suggested that caffeine combined with
MDMA ('ecstasy') worsens the hyperthermia
(overheating) caused by MDMA, by contributing
to dehydration and may aggravate the
neurotoxicity of MDMA to serotonin producing
nerve cells. 
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Introduction
The misuse of volatile solvents by young children
and teenagers is a recent worrying trend,
although the use of chemical vapours and fumes
to obtain a mood altering experience is believed
to go back to pre-historic times. 
Solvents are chemicals, which change from liquid
form into gases or vapours at ordinary room
temperatures.  Solvent misuse is the deliberate
inhalation of gases, chemical fumes or vapours in
order to get a ÔhighÕ or ÔbuzzÕ similar to the
intoxication produced by alcohol.    
A variety of terms are used to describe the
practice, such as Ôglue-sniffingÕ, Ôsolvents abuseÕ
or technically Ôvolatile substance abuseÕ (VSA).
The term, Ôglue sniffingÕ, has been widely used in
the media but it is inaccurate for two reasons;
firstly a wide range of common household
materials, apart from glues, give off gases or
vapours which can produce mood altering effects
and secondly, the material is actually deeply
inhaled through the mouth rather than sniffed.
The range of products that can be misused is very
large.  The four main categories are: 
¥ adhesives and thinners such as glues, model
cement, paint thinners, nail polish remover
¥ dry cleaning products such as dry cleaning
fluids, paint stripper, typewriter correcting
fluid and thinners, fire extinguishers, printing
industry solvents, shoe dyes and conditioners
¥ aerosols such as hair lacquer, room and body
deodorant sprays, paints, painkilling and
inspect sprays, plaster removers
¥ fuels such as petrol, lighter fuel, domestic and
camping gas cylinders.  
Amyl and butyl nitrite are often sold as ÔpoppersÕ
in clubs, discos and Ôsex shopsÕ to individuals
who believe that inhaling them expands
creativity, stimulates music appreciation,
promotes a sense of abandon in dancing and
intensifies sexual experiences.   Amyl nitrite is
used medically to treat cyanide poisoning and
because it dilates blood vessels it is used in
angina attacks.
Solvent users employ a variety of techniques and
devices to heighten the mood altering effect from
these products by increasing the concentration of
vapour and/or excluding air, for example by
using a plastic bag over the head.   Misusers may
inhale the product from a soaked rag, a coat
sleeve or lapel, a handkerchief, cotton wool,
pillow or from a bottle.  
For many products it is the vapour given off by
the product that is used and the product itself is
not ingested into the body, for example glue.
However, the reverse is often the case with gas
fuels and aerosols that are sprayed or released
from the container directly into the mouth and
lungs.
Legal Status
It is an offence for any person to sell, offer or
make available any substance to persons under
18, which they know or have reasonable cause to
believe is likely to be inhaled for the purposes of
causing intoxication.  Persons found guilty of this
offence under Section 74 of the Child Care Act
1991 are liable to penalties of a fine of up to
€1,270, 12 months imprisonment or both.  This
section of the Act also permits a Garda to seize
any substance in the possession of a child in a
public place which the Garda has reasonable
cause to believe is being abused by the child.
Any product seized in this way may be destroyed
on the instructions of a Garda Superintendent.  
The Criminal Justice (Public Order) Act 1994
makes it an offence for someone to be intoxicated
in a public place to such an extent that they are a
danger to themselves or to others.  The word
'intoxicated' refers to solvents or other substances
as well as to alcohol and other drugs.  The fine
for such an offence is not more than €508.
Prevalence and Availability
There are no statistics on the full extent of solvent
misuse in this country. It is known to be
primarily an adolescent phenomenon although it
has also been reported in younger children and in
adults.  Studies of large numbers of users show
that children from every social class and family
background can become involved.   
Surveys indicate that the highest levels of
experimentation with solvents are in 15 and 16
years old age group. The SLçN survey reported
that only 0.3% of adults (18-64 yrs) had used
solvents in the past year but that in young adults
the figure was 1.4%.  Experimentation with
solvents by young Irish adolescents remains very
high with different surveys reporting various
rates of use.  A rate of 10-22% was reported in theC
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Chapter 7 - Solvents
HBSC survey.  A significant number of young
people are regular users because in the same
survey over 5% had reported use within the
month preceding the survey.  Studies of Dublin
based young people show figures of 7% for recent
use among 14-15 year olds.  The ESPAD Study
reported that 9% of the 15-16 years olds surveyed
had used solvents by the time they were 13, there
was no difference between the rates for boys and
girls.  
Given such high levels of use, it is worrying that
young Irish teenagers are less likely than other
European teenagers to see any great risk in using
solvents once or twice and over one fifth saw no
risk in the regular use of solvents.    
Many of the products misused are readily
available in shops and in the home.  One study
suggested that the average home could contain
up to 30 of these products.  Many products are
cheap to buy or easy to steal.  If one product or
brand is unavailable then another can be easily
substituted.  For many young teenagers, solvents
are more easily available than alcohol.  
Mood Altering Effects
Inhaled solvent vapours are absorbed through
the lungs into the blood stream and rapidly reach
the brain.  The early effects are very similar to
those of alcohol, involving stimulation of the
nervous system followed by depression and if
enough is taken, unconsciousness.  The solvent
user displays many of the signs of drunkenness
such as slurred speech, unsteady gait and lack of
control.  
Other effects are distinct to solvent misuse. The
mood altering effect is felt very quickly, and once
the misuse has stopped, disappears within a few
minutes to a half an hour.  Distorted vision and
faulty judgement of space occurs, this frequently
involves visual and auditory hallucinations,
which may be pleasant, but which can also be
very frightening.  Judgement becomes impaired,
leading to aggressive and uncharacteristic
behaviour, particularly if alcohol is used at the
same time.  The hangover involves headaches
and poor concentration, and has been described
as being less severe than the alcohol hangover.   
The fact that the effects are short-lived allows
solvent users to conceal their activities even
though the smell of solvent may last on their
breath for up to a day.
Adverse Effects of Use
Deaths from solvent misuse are rare in relation to
the numbers thought to be engaging in the
behaviour, but the risk is always present.  A
major concern in relation to the sudden solvent
misuse deaths that occur is their unpredictability.
Death can occur even the first time solvents are
used.  The average age of those known to have
died was 15 although the ages of those who died
have ranged from 10 to 26 years.  It is difficult to
determine the exact number of deaths due to
solvent misuse that occur each year.    
It is known from a survey of newspaper reports
that butane gas has been involved in most of the
recorded deaths, followed by aerosols and
typewriter correcting fluid.  Glue has apparently
been implicated in only one death in the past few
years.  Misuse of gas, aerosols and typewriter
correcting fluid may cause heart failure if the user
becomes stressed or engages in strenuous
physical activity such as running away from an
adult.  The direct spraying of aerosols and butane
gas resulting in the freezing of the larynx and
airways seems to be a particularly dangerous
practice.  It would appear that glue is less
hazardous, possibly because it is solid and is
therefore not ingested directly the way that
aerosols are.  
Many deaths are accidental and are related to the
intoxication associated with the practice.  Some
users become unconscious and choke when they
inhale vomit.  Others have been suffocated when
they placed a plastic bag over their heads and
were unable to remove it due to being either too
intoxicated or unconscious.  The risk of fatal
accidents increases when solvents are misused in
dangerous locations such as high buildings,
derelict sites, railway embankments, river or
canal banks.  Such accidents are more likely to
happen if the user is alone, because no one is
available to summon help in an emergency.  
The side effects of the nitrite poppers include
severe headache, rapid heartbeat, low blood
pressure, acute psychosis, coma and in rare cases
sudden death.
Studies of industrial workers continuously
exposed to low concentrations of solvents suggest
that the liver, kidneys and brain can be damaged.
Although the medical evidence is inconclusive at C
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present, it is known that some chronic users do
suffer physical damage to their heart, brain,
kidneys and liver.  The extent and duration of
misuse required to produce such harm is
unknown.
Dependence
For most children solvent use is a group activity
and usually a passing fad.  A very small minority
of these go on to become solitary users.  Solitary
users find it difficult to give up the habit.
Whether this dependence is psychological or
physical in origin is largely unknown.  
Most habitual users develop tolerance to solvents
and must inhale larger quantities to get the
ÔbuzzÕ.  Withdrawal symptoms, which include
sleep disturbance, nausea, stomach cramps,
general irritability and facial tics, may take some
weeks to occur.  
There is no firm evidence to suggest that solvent
misuse leads to the misuse of illegal drugs such
as cannabis or heroin.  Solvent users are more
likely to move onto misuse of alcohol than illegal
drugs.
Behavioural Problems associated with Solvent
Misuse
A range of anti-social activity and behavioural
problems can arise from solvent misuse.
Solvents, like alcohol, depress the part of the
brain that controls judgement and self-control.  It
is easy to understand therefore that any existing
violent tendencies could be released under the
influence of solvents in the same way that some
adults can become aggressive and violent after a
few drinks.  
Shoplifting, other thefts and burglary are used to
obtain money to buy solvents or more frequently
the products themselves are stolen.
Family disruption is a common problem.  This is
frequently due to having to deal with a child
intoxicated with solvents, assaults on members of
the family and the failure of the child to return at
night.  Legal difficulties resulting from
involvement in anti-social behaviour can also
cause problems.  Many parents are also
frightened that their other children may imitate
the behaviour and become involved in solvent
misuse.  
Other effects from solvent misuse include
absenteeism from school (ÔmitchingÕ), followed by
a deterioration in their school performance with
many chronic misusers dropping out of school
altogether.  When solvents are misused regularly,
sleep patterns are disturbed and there is loss of
appetite and weight.  ÔGlue sniffer rashÕ is
frequently found as a result of repeated
application of plastic bags to the nose.  
Long-term misusers may become depressed,
moody and suspicious, forgetful and lose
concentration, with a consequent deterioration in
their ability to function normally in school, at
home or in the community.  These problems clear
up in most children a short while after the
sniffing stops.  
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Introduction
Cannabis is one of the oldest plants cultivated by
humans.  Archaeological evidence from
excavations of a Stone Age village on Taiwan
suggests that the plant Cannabis sativa has been
used from earliest times.
The Cannabis plant is a very adaptable annual,
which can grow in most parts of the world
including Ireland.  In its chequered career, it has
been grown for its long fibres known as hemp
fibre and used to make ropes, clothing and paper,
for its seed (hempseed), used as a source of oil
(for hemp cosmetics) and most notably for the
intoxicating resin produced in glandular hairs
found predominantly on the leaves surrounding
the flowers and fruits.
The Cannabis plant produces over 400 different
chemicals, the most characteristic of which are
the 60 known cannabinoids.  The most important
of the cannabinoids are the
Tetrahydrocannabinols usually referred to simply
as THC. The other important cannabinoid is
Cannabidiol referred to as CBD.  The potency of
cannabis is usually expressed in terms of its THC
content because this is the main psychoactive
component responsible for the desired euphoric
effects.  However, other cannabinoids can modify
the effects of THC by either influencing its
absorption or as in the case of CBD, its calmative
effects balance the euphoric effects of THC.  
The cannabinoid content of a plant is influenced
by a number of factors such as the type of
cannabis plant; its gender (female plants produce
more THC than males); how and where it has
been grown and harvested and how it has been
stored.  Three types or varieties of cannabis
plants are usually recognised, all of which are
similar in appearance, these are:
¥ the drug type in which THC predominates at
more than 1% and CBD is virtually absent
¥ the fibre or hemp type in which CBD
predominates at more than 0.5% and THC is
virtually absent. EU Regulations governing
growth of hemp state that the THC content
must be less than 0.3%.  In 1999 there was
45,000 hectares of hemp grown under license
and subsidy throughout Ireland and the EU.
¥ an intermediate type where equal amounts of
THC and CBD are found.    
Drug products made from these plants fall into
three types that vary enormously in THC content.
The three types are herbal cannabis, hash and
hash oil. 
Herbal Cannabis- This is the simplest product and
is frequently known as  ÔmarijuanaÕ, ÔgrassÕ,
ÔweedÕ, or ÔganjaÕ.  According to international
studies it contains between 0.5-5.0% of THC.
Stronger forms of herbal cannabis have been
developed using different methods.  Selective
breeding and special growing techniques have
resulted in the development of high yielding
strains such as ÔskunkÕ, Ôpurple hazeÕ among
others.  The Sinsemilla technique, where low
THC-yielding male plants are culled, allowing
unfertilised female plants devote their energy to
producing THC, is also used to increase potency.
This type of cannabis, also called ÔnederwietÕ or
ÔDutch weedÕ because it was developed largely in
the Netherlands, contains up to 20% THC; it has
become available in Ireland in recent years.  
Analysis of a small number of herbal samples at
the Department of Pharmacognosy, T.C.D, has
shown that their THC content has increased from
1.4% in 1981 to an average of 6.2% in 2000.  This
is high by international standards, for example
marijuana in the USA averaged 4.2% THC
content in 1997.  The highest percentage recorded
in Dublin was 9.5%, which is similar to the UK
figure and slightly above the average Dutch
value of 7.5%.  
Hashish - Based on Garda seizure data, Herbal
Cannabis is less widely used in Ireland than the
second form of cannabis, namely Hashish or
Hash.  This is a resinous material, which is
squeezed or scraped from the flowering tops of
the plant and then compressed into blocks, slabs
or bars and allowed to solidify.  Nowadays most
hashish comes across from Morocco but it can
also come from the Middle East and the Indian
sub-Continent.  Internationally hashish is
reported to contain between 7 and 14% THC
although amounts up to 20% have been
encountered.  Hashish samples analysed at the
Department of Pharmacognosy, T.C.D, had THC
content ranging from a very weak 0.2% up to
6.3% with an average content of 4.2% THC.  This
compares with 7% in the USA and 5% in UK
samples.  However, the average Irish content has
almost doubled since 1981 when values of 2.3%
were recorded.   
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Chapter 8 - Cannabis
Liquid Hashish - The third product is more rarely
seen and is prepared by solvent extraction and
distillation.  This Ôhash oilÕ or Ôliquid hashishÕ
varies in THC content from 15-50% and is the
most potent of all of the cannabis drugs.  
The way in which cannabis is stored and the
length of time it is stored also affects the content
of THC.  THC is unstable in the presence of air
and light, which break it down to inactive
chemicals.  Cannabis that is more than two years
old is usually very low in THC.  
It has been said that no two samples of a
cannabis drug are similar because of its chemical
variability.  To this variability must be added that
of the varying amounts of drug consumed in a
typical ÔjointÕ or ÔspliffÕ.  Based on data from the
Garda Forensic Science Laboratory on the amount
of resin or herb in a typical ÔjointÕ, the THC
content could vary from 3.5-Ð21.8 mgs with an
average of 16.2 mg for a Ôherb jointÕ and from 0.4-
8.2 mgs with an average of 4.3 mg for a Ôresin
jointÕ.  The significance of this range is that a dose
of 2-5 mg of THC is believed to be the minimum
required to produce psychoactive effects in
humans.  
Legal Status
All cannabis products are controlled by the
Misuse of Drugs Act 1977.  Cannabis is included
in Schedule 1, which prohibits its medical and
non-medical use.  It is therefore illegal to grow,
produce, supply or possess any of the drugs
except in accordance with a licence from the
Minister for Health for research or analysis.  It is
also an offence to allow premises to be used for
cultivating, supplying or smoking cannabis.  
The penalties for possession of small amounts of
cannabis herb and cannabis resin for personal use
in Ireland are less than for drugs such as heroin
and cocaine.  The penalties are for a first offence,
a fine of up to €381 imposed by the District Court
or up to €635 in the Circuit Court.  For a second
offence, the District Court can impose a fine of up
to €508, which rises to €1,270 if imposed by the
Circuit Court. It is only in the case of a third or
subsequent offence that the District Court can
impose a jail sentence of 12 months or a fine of
€1,270 or both.  If the case is heard before a judge
and jury, the maximum penalty can be an open-
ended fine, 3 months imprisonment, or both fine
and prison sentence.  Cultivation, supply and
possession of the isolated chemicals
(cannabinoids) are treated more severely. 
Prevalence and availability
Cannabis is the most widely used of the illegal
drugs in Ireland.  Information from the SLçN
survey of 6,539 adults aged 18 years and older
shows that 20% of those surveyed reported ever
having used cannabis.  This is higher than the
14% reported by the Health Research Board in its
Knowledge, Attitudes and Beliefs (KABI) study.  
Age has a major effect on reported use of
cannabis because 33% of 18- 24 year olds said
they had ever used the drug.  They are also more
likely to use the drug more frequently, 15% in the
month prior to the survey compared to 5% for all
adults.  Use rates by schoolchildren mirror those
of adults.  The 1995 ESPAD Study of substance
use by 15-16 year olds reported that 37% of Irish
children reported ever using cannabis though this
had dropped to 32% in the 1999 survey.  The
Health Behaviours in School Children Study
reported that 29% of 17 year olds had ever used
cannabis.  Other studies indicate rates ranging
from 16-26% of school children having
experienced the drug at least once.  Some of the
differences in the figures are probably due to 
differences in the way the studies were carried out.  
Frequent use indicated by use within the month
preceding the survey, shows that a significant
number of people use the drug frequently.   The
lowest value was 9% in 13-18 year olds in a
Western Health Board study in 1994 rising to 19%
in the 1995 ESPAD study.  Other surveys record
frequent use in 11-15% of those surveyed.  The
1999 ESPAD study shows that among 15 year
olds, 7% used the drug once or twice in the
month, while 3% used three to five times and 5%
used it six times or more.  There were slightly
different percentages for boys and girls with
other studies contradicting one another in that
one suggested that males under 25 were twice as
likely as females to have used in the past month
while another reported little gender
differentiation.  No information is available on
the number of Irish people dependent on
cannabis.  
Prosecutions relating to cannabis, cannabis resin
and growing cannabis plants have been reported
from all Garda Divisions and still account for
approximately 60% of prosecutions under theC
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Misuse of Drugs Acts.  The price for different
cannabis products ranges from €120 - 130 per
ounce (30 gm) of South African herb to between
€5 -10 per gm of Moroccan hash.  A gramme of
herb might be expected to give approximately
four ÔjointsÕ while a gramme of resin would
probably be enough for eight or nine ÔjointsÕ
based on the average content reported by forensic
scientists.  
Mood Altering Effects
Research in the 1990Õs showed that cannabinoids
act by binding to specific receptors found on the
surface of certain cells located chiefly in the brain
and in the immune system.  These cannabinoid
receptors have been named as CB1 and CB2.  CB1
receptors are found in the parts of the brain that
control movement, memory, stress responses and
complex thought as well as pain perception,
control of nausea and vomiting.  CB2 receptors
are found predominately in the spleen, in white
blood cells and in other parts of the immune
system, although it is not yet clear what role they
play in immune responses.  This is because an
ÔendocannabinoidÕ that binds to the CB2 receptor
has not yet been found in the human body.  
Endocannabinoids occur naturally in the human
body but are much less active than THC.
Anandamide (from the Sanskrit word for bliss Ð
ananda) is found in large amounts in areas of the
brain that control learning, memory, movement
and co-ordination as well as other parts of the
body like the spleen and heart.  Anandamide
binds to the CB1 receptors.   These
endocannabinoids are the object of much research
at present as scientists try to find out how and
why they act as they do and as they seek to
produce new medicines, which provide the
benefits of the cannabinoids without the harmful
side effects.
The mood altering effects of the cannabis drugs
depend on a number of factors including the
strength of the cannabis, the length it has been
stored, the amount used, the way it is taken and
the experience, mood and expectations of the
user.
When smoked, cannabis exerts effects within
minutes and these last for up to two hours.
When eaten in the form of 'space cake' or drunk
as a tea, it takes one to two hours to have an
effect, however, because the dose of THC is not
easily controlled unpleasant reactions are more
likely.  Inexperienced users may have difficulty
recognising the effects particularly of low
potency forms.  
The mood altering effects sought, referred to as
the 'high', include talkativeness, hilarity,
euphoria, relaxation and a feeling of slowed time.
The major physical effects are increased heart rate
and lowered blood pressure.  These are likely to
have little significance for healthy young people
but could constitute a risk for those with existing
heart disease or for older adults who are in a
high-risk category for heart disease such as
tobacco smokers.  Cannabis drugs also interfere
with short-term memory and learning abilities.
Even simple arithmetic skills can be disrupted for
24 hours after a high.    
Adverse Effects of Use
Inexperienced cannabis users or experienced
smokers using unexpectedly large amounts of
high potency cannabis (for example Ôskunk),
report unpleasant side effects such as fearfulness,
confusion, severe panic and anxiety, which while
very frightening, rarely require medical attention
and usually respond to reassurance.  Other
symptoms may resemble a psychosis and include,
confusion, amnesia, delusions, hallucinations,
agitation and hypomania.  These may require
hospitalisation but usually subside as the THC is
excreted from the body.  No overdose deaths
from cannabis or THC have ever been reported
and are not likely to occur.
The ability to carry out complex tasks such as
driving or using machinery is impaired by
cannabis use.  Increased distractibility combined
with impairment of motor coordination leads to
situations where cannabis is a contributor to road
traffic accidents and workplace accidents.
Evidence of the negative impact of cannabis on
driving ability is available from simulator studies
and surveys of US teenagers showing that they
were three times more likely to have been
involved in an accident if they were cannabis
smokers compared to non-smokers.  Additional
evidence comes from the detection of
cannabinoids in drivers involved in fatal
accidents or stopped for impaired driving, where
either no alcohol was detected or the
concentration of alcohol was below the legal
limit.  Of particular importance is the detection of
THC metabolites in blood samples, which would
be indicative of more recent use whereas C
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detection in urine could be due to the slow
elimination of drugs consumed 2-3 weeks
previously.  The World Health Organisation
(WHO) recently concluded that "there is sufficient
consistency and coherence from experimental
studies and studies of cannabinoid levels among
accident victims to conclude that there is an
increased risk of motor vehicle accidents among
persons who drive when intoxicated with
cannabis.  The risk is magnified when cannabis is
combined with intoxicating doses of alcohol".  
In Ireland cannabis is, at 32%, the most
commonly detected drug other than alcohol in
samples from drivers suspected by the Garda of
impaired driving.  In other countries cannabis has
also been implicated in train crashes and the
evidence points to impairment among train
drivers, signal operators, motor cyclists,
operators of heavy machinery, air traffic
controllers and pilots.  In a study with a group of
pilots given a cannabis joint and then tested in a
flight simulator, the cannabis caused a significant
drop in flying performance that persisted for over
24 hours after the 'high' when most of the pilots
were unaware that their performance was
impaired.  The combination of cannabis and
alcohol appears to be more damaging to driving
ability and co-ordination than either drug alone. 
The increasing prevalence of regular use of
cannabis drugs by adolescents and young adults
and new research on its health hazards have
prompted continual concern about the public
health impact of long-term use of cannabis.
While many studies in animals have consistently
demonstrated toxic effects, studies of human
cannabis users have frequently provided
contradictory and controversial findings.  Recent
authoritative international reviews point to some
of the health problems that can arise when
cannabis is smoked on a regular basis.  
Researchers report that prolonged and frequent
cannabis use leads to subtle and selective
impairment of cognitive functioning, which may
be apparent as high levels of distractibility in the
classroom and poor memory function.  Australian
research suggests that the use of cannabis three
times per week or more frequently, results in a
state of chronic intoxication, probably due to the
accumulation of cannabinoids which, because
they are fat soluble, persist in all parts of the
body including the brain for up to four weeks
after a single dose.  As a result of this chronic
intoxication there is a general slowing of
information processing leading to sluggish
mental performance.  It is believed that the use of
cannabis for more than three years may lead to
long-term changes in brain function.  This shows
up in the form of memory problems, difficulties
with concentration or with distractibility.  If users
cut down their use or stop altogether then mental
proficiency will improve, but according to the
WHO may not recover completely.  Binge use, for
example twice per week, of large amounts of high
potency drug or use for five years or more at a
rate of even once per month may lead, according
to researchers, to a compromised ability to
function to an individualÕs full mental capacity. 
When burned, cannabis leaves produce amounts,
similar to those found in tobacco, of carbon
monoxide believed to be a major contributory
factor in the development of heart disease in
tobacco smokers.  The tar from a cannabis 'joint'
contains significantly more cancer-inducing
chemicals, 1.5 times more of one key compound,
than a standard cigarette.  Because of differences
in smoking techniques for joints and cigarettes, at
least four times more tar and five times more
carbon monoxide are inhaled by a cannabis
smoker compared to a cigarette smoker.  Because
the number of cigarettes smoked per day is much
greater than the number of joints smoked per day
by individuals, exact comparisons of the relative
harmfulness of both types of smoking are
difficult.  The fact that many cannabis users also
smoke tobacco on its own or mixed with the
cannabis also makes comparisons difficult.  What
is clear however is that chronic heavy cannabis
smoking impairs lung function and causes
symptoms of chronic bronchitis such as coughing
and wheezing and that such smokers are more
than twice as likely to suffer from bronchitis
compared to non-smokers.  
The smoke and tar from a joint can cause
malignancies in isolated human and animal lung
cells.  Pre-cancerous changes have been detected
in lung biopsies from marijuana smokers and at
even higher levels among individuals who used
both tobacco and cannabis.  The medical
literature now contains case reports of cancers of
the mouth, larynx, tonsils and oesophagus in
young adult cannabis smokers including some
who never smoked tobacco.  Large-scale surveys
in the US have given contradictory results withC
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one study of 1421 cases of cancer in those aged
15-49 showing no increased risk but another case-
controlled study found an increased risk of
respiratory tract cancers in cannabis smokers.
Most recent overviews of the health effects of
cannabis emphasise that cannabis smoke is an
important risk factor in the development of
respiratory diseases, including cancer. Cannabis
increases the workload of the heart and people
who suffer from heart disease, angina and blood
pressure are particularly vulnerable to its effects
on the heart.
THC is known to suppress some aspects of the
body's immune system and to stimulate other
aspects.  Cannabis smoke also has damaging
effects on a key group of immune cells in the
lungs that protect them against bacteria and
tumour cells.  It is increasingly recognised that
those who only smoke cannabis have increased
susceptibility to infections, such as pneumonia.
This has particularly dangerous consequences for
those with compromised immune systems, for
example, transplant, AIDS or cancer patients.  It
is known that HIV positive individuals who use
cannabis regularly, appear to be at increased risk
of opportunistic infections and of Kaposi's
sarcoma and that cannabis use has been
associated with increased mortality among men
with AIDS.
The general consensus among psychiatrists is that
cannabis use does not cause mental illness but
that it may trigger schizophrenia in vulnerable
individuals and may exacerbate existing
symptoms.  Therefore, those with pre-existing
mental illness may be at particular risk from
cannabis use.   
Continuous use of cannabis can have an effect on
reproductive health such as decreased sperm
count, mobility and viability, interference with
ovulation and with pre-natal development.  The
documented short-term reduction of reproductive
hormones following cannabis use is likely to
decrease fertility at least in the short-term this
may be relevant to couples trying to conceive.  
Heavy users of cannabis may suffer from apathy
and loss of ambition, the so-called ÔamotivationalÕ
syndrome.  However, it is very difficult to
establish the exact relationship between this
condition and the use of cannabis.  Research does
highlight that regular cannabis use increases the
risk of dropping out of the educational system
and of subsequent job instability.  The evidence
suggests that it is young people whose
educational ability is borderline who are most at
risk from frequent use of cannabis.  It is doubtful
if research can ever show that cannabis use
causes people to lose motivation, although it does
show a link between the two.
Dependence 
A cannabis dependence syndrome may occur in
long-term regular users of cannabis and
internationally it has been suggested that 1 in 10
of those who ever use cannabis will meet the
criteria for cannabis dependence.  Dependent
users report that they have difficulty in
controlling their use of the drug, that they
continue to use it despite interference with work
performance and complaints by significant others
about their behaviour and that they experience
withdrawal symptoms when they try to stop
using the drug.  These symptoms include
restlessness, anxiety, insomnia, anorexia,
depression, muscle tremors, changes in heart rate
and blood pressure, sweating and diarrhoea.     
It is believed that the risk of cannabis addiction is
similar to that for alcohol but much less than for
nicotine and heroin.  Up until recently it was
believed that the dependence on cannabis was
psychological and that physical dependence did
not feature.  However, new research on the
cannabinoid receptors has resulted in the
development of antagonists which block the
effects of THC and which precipitate abrupt
withdrawal in animals dosed with the drug.  In
contrast to the slow elimination of the drug over
a 2-3 week period under normal circumstances,
which allows the body to adapt without physical
symptoms, abrupt withdrawal results in dramatic
signs such as hyperactivity and disorganised
behaviour.  This means that cannabis now meets
the criteria for physical dependence as well.
Cannabis and Pregnancy
It is believed that cannabis smoke is as harmful to
foetal development as tobacco smoke.  The baby
is exposed via the placenta, and after it is born
via breast milk. Most of the international studies
give inconsistent results, but reassuringly there
has been no increase in birth defects, the major
effect appears to be low birth weight.  Evidence
does suggest that children exposed to cannabis in
the womb may display behavioural and C
ha
pt
er
 8
 - 
C
an
na
bi
s
45
developmental difficulties during the first few
months of life.   Between the ages of 4-9 years,
such children have shown attention, memory and
learning deficits compared to children not
exposed.  Equally the effects are less than those
resulting from exposure to maternal tobacco
smoke.  Babies born to mothers who smoked
cannabis were, according to one report, ten times
more likely to develop acute non-lymphoblastic
leukaemia than babies whose mothers did not
smoke cannabis.
Cannabis as a Ôgateway drugÕ
Cannabis, together with alcohol and tobacco, is
recognised as one of the 'gateway' drugs, the use
of which predicts subsequent use of other drugs.
It is known that most people who experiment
with cannabis do not go on to use heroin or
cocaine, but statistically, heavy frequent users of
cannabis are much more likely to use heroin than
those who have never used cannabis.  
Most studies have consistently found that there is
a regular sequence of drug misuse in which early
use of tobacco and alcohol are likely to result in
heavy use of those substances. Cannabis use
typically follows such heavy use of the legal
drugs and it precedes the use of opiates and
cocaine.  There is some tentative but by no means
conclusive pharmacological evidence to support a
link in that cannabinoids affect the dopamine
reward system in the brain.   International
experience suggests that those teenagers who
become heavy daily cannabis users at an early
age are at higher risk of progressing to other drug
use because of behavioural, family and school
problems which were noticeable before they
began to use cannabis.
Cannabis as a medicine
Advances in knowledge of how cannabinoids
interact with specific receptors bring about the
possibility of designing medicines, which would
affect tissues and cells containing those receptors.
This has coincided with an upsurge of interest in
revising and extending the medical uses
historically associated with cannabis.  
One medical use that is generally recognised and
accepted, is the anti-nausea and anti-vomiting
effect of cannabis for patients undergoing cancer
chemotherapy.    Other potential uses include
pain relief in cancer and non malignant
intractable pain, relief of the spastic symptoms in
multiple sclerosis (MS) and other dystonias,
appetite stimulation as a response to wasting in
AIDS, and also as medicines for epilepsy and
glaucoma.  
While there is scientifically valid evidence that
cannabis and THC are effective in relieving
symptoms in some patients, there is equally valid
evidence that they are not effective in other
patients with the same conditions, particularly
M.S. and pain.  Many of the studies have
involved too few patients to provide meaningful
data.  However, new research underway in the
UK aims to clarify the exact benefits of cannabis
and its chemicals by comparing them to dummy
drugs (placebos) and to existing drugs used to
treat the same conditions.  
Aside from the potential benefits to be gained
from relieving the symptoms associated with MS
and severe pain, the safety of cannabis drugs and
medicines will require careful consideration
especially since the side effects reported in some
studies appear to be unacceptable to older
patients in particular.  There would also be
concern about the immunosuppressant and
carcinogenic effects of smoked cannabis in AIDS
and cancer patients.  Indeed most of the recent
authoritative overviews and commentaries about
'medical marijuana' have drawn attention to the
hazards of the smoked drug and much research
now centres on ways of delivering cannabis-
derived medicines to patients that do not involve
the combustion of plant material.  
Making either natural or synthetic cannabinoids
available to Irish patients would require
rescheduling cannabis from Schedule I of the
Misuse of Drugs Acts to Schedule II alongside
drugs such as morphine and cocaine.  The
cannabis medicines would also require a Product
Authorisation from the Irish Medicines Board
based on the standard criteria of Quality, Safety
and Efficacy.           
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Introduction 
Amphetamines are synthetic stimulants first
produced in 1887, but not used medically until
the 1930Õs.  During the Second World War and the
Vietnam War, amphetamines such as
dexamphetamine (Dexedrine¨) were used to
increase the performance and endurance of
soldiers.  Several million people in parts of East
Africa and South West Arabia are believed to be
dependent on Khat, the fresh leaves of which
when chewed, release cathinone, an
amphetamine-like drug into the body.
In the 1950Õs and 1960Õs amphetamines were
widely prescribed as slimming tablets and used
to treat mild depression.  They are now
recommended only for the treatment of
narcolepsy (pathological sleepiness) and
hyperactivity in children.  The non-medical use of
amphetamines was very popular among
teenagers during the 1960Õs, when large
quantities of Ôpurple heartsÕ were taken to stay
awake at parties and dances.  Another popular
drug was methylamphetamine
(methamphetamine) or ÔspeedÕ.  Amphetamines
were controlled in 1970 in an attempt to reduce
their availability because of diversion of
legitimate supplies onto the black market.
Amphetamines may be taken by mouth,
dissolved in water and injected, sniffed up the
nose or smoked.  A new smokeable form of
methylamphetamine hydrochloride is called ÔIceÕ
or ÔCrystalÕ or ÔGlassÕ because of its transparent,
sheet-like crystals.  This very strong form of
ÔspeedÕ is sufficiently volatile to vaporise in a
pipe so that it can be inhaled through the lungs.
Ice is manufactured in illegal laboratories either
from a chemical called phenylacetone or from
ephedrine, a drug chemically related to the
amphetamines, used in some cough and cold
products.  Ephedrine, as a starting material
produces the most potent form of Ice, which is
why it and phenylacetone are coming under
stricter legal control.  
A number of other drugs such as
methylphenidate (Ritalin¨), phenmetrazine
(Preludin¨) and fenfluramine (Ponderax¨) have
amphetamine-like effects; the latter two are
usually used as slimming agents though exercise
and diet may be more effective for losing weight,
while methylphenidate is mainly used for
narcolepsy and hyperactivity.
Legal Status
The Misuse of Drugs Acts control most of the
amphetamine-type drugs.  Their unauthorised
production, supply or possession is an offence, as
is allowing premises to be used for producing or
supplying the drugs.  The Medical Preparations
(Control of Amphetamines) Regulations 1970 also
prohibit the manufacture, preparation,
importation, sale and distribution of various
amphetamines.  Amphetamines are not available
for normal prescribing by doctors.  The Minister
for Health has power to grant a licence to allow
the supply of amphetamines to a patient who
requires it for treatment.  Such supplies cannot be
obtained from normal pharmacies but only from
a central depot.  The rationale is to reduce the
leakage of legal amphetamines into the black
market through forged prescriptions, excessive
prescribing or burglaries from pharmacies.
Prevalence and Availability
Prior to the strict control measures, amphetamine
misuse was a significant problem in Ireland.  One
study conducted in 1969/70 indicated that over
11% of boys in a Dublin remand home had taken
amphetamines.  Six months after the regulations
were introduced this had fallen to 0.6% of the
boys.  It is generally accepted that the non-
availability of legal amphetamines had
dramatically reduced the misuse of
amphetamines in Ireland until recently.  The
medical use of amphetamines had also declined
from over 2,000 prescriptions in 1972 to 339 in
1990.    
In recent years there has been a gradual increase
in amphetamine use as indicated by surveys
which show that 8.8% of 18-24 year olds had
used these drugs in the past year.  Among school
children the experimentation rate varies from 2-
5% with up to 3% reporting more frequent use.
Demand for treatment has also shown an upward
trend from 0.5% of first-time attendees at
treatment centres to 2.1% in 1999.  Street prices
average around €12 per gramme which is enough
to prepare 3 ÔwrapsÕ of powder, although the
amount of amphetamine in the powder has
dropped from 4-7% in 1995 to 3% in 1999.
Mood Altering Effects
The effects of small doses of amphetamines taken
orally are very different to the effects of high
doses injected intravenously.  A moderate dose of C
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Chapter 9 - Amphetamines
less than 30mgs stimulates the nervous system,
arousing and activating the body in the same
way as natural adrenaline prepares the body to
face emergencies and stress.  Breathing and heart
rate speed up, blood pressure increases, the
pupils widen and appetite is suppressed.  The
user feels more active, more alert and energetic.
There is a lessening of fatigue and an increase in
mental activity, with better concentration and
clearer thinking.  The change in mood leads to a
general feeling of well being.  Some people may
experience irritability, confusion and dizziness
after repeated small doses.  
High doses taken by injecting, sniffing or
smoking give rise to a ÔrushÕ of pleasurable
experience.  Some ÔspeedÕ users go on a binge or
ÔrunÕ of injections lasting several days.  They
become overactive, boastful and indulge in
repetitive behaviour such as repeated cleaning of
shoes.  High doses can produce panic,
hallucinations and feelings of being persecuted.
The effects, including the adverse effects of
methamphetamine, persist for 18-24 hours
compared to a few minutes when cocaine is
smoked.  
Adverse Effects of Use
Regular users of high doses are liable to develop
an Ôamphetamine psychosisÕ which resembles
schizophrenia with thought disorders,
hallucinations and feelings of being persecuted.
These latter feelings may lead to hostility,
aggression and violence as individuals defend
themselves against imaginary enemies.   The
psychosis usually disappears when drug use
stops, but in many people it may persist for some
considerable time, unlike the similar psychosis
which develops with cocaine.  Long-term use can
lead to psychotic behaviour involving paranoia,
hallucinations and violence.  More recently
evidence has emerged that methamphetamine is
neurotoxic and that brain cells producing
dopamine and serotonin are affected.
Injectors of amphetamines are at risk of infection
as outlined in Chapter 2.
Methamphetamine has much greater effects on
the brain than amphetamine.  The immediate
effects can include irritability, anxiety, increased
body temperature, euphoria, insomnia, anorexia,
paranoia and aggressiveness.  
One of the catchphrases of the 1970Õs was Ôspeed
killsÕ, because it was widely believed that long-
term use of amphetamines would be fatal.  In fact
amphetamines have caused very few deaths.
Violence rather than toxicity has been the major
cause of death among amphetamine users.
However, the hazards of injecting, and the lack of
sleep and food debilitates the heavy user,
lowering resistance to disease and can lead to
serious damage to health.  Death can occur due to
the hyperthermia or from convulsions or from
strokes and general cardiovascular collapse. 
Dependence
Tolerance to many of the effects of amphetamines
develops rapidly, with some users able to take up
to 15 gms per day compared to the normal
stimulant dose of 10 mgs.  When the drug is
discontinued a user will feel deeply depressed,
fatigued and sleepy and extremely hungry,
because the amphetamine has merely postponed
fatigue and depleted the bodyÕs own reserves of
energy.  This feeling is called the ÔcrashÕ.  Severe
psychological dependence can develop because
of the pleasant effects experienced.  
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Introduction
MDMA is named after its chemical name
MethyleneDioxyMethamphetamine.  It is widely
known as Ecstasy because of the happy sociable
emotionally open feeling it causes in users.
MDMA is often labelled a 'designer drug' but it
was in fact first synthesised and patented in
Germany between 1912 and 1914.   The US Army
tested it in 1953 as part of its chemical weapons
programme.  In the mid 1970's an American
medicinal chemist called Shulgin rediscovered
the drug and after testing it on himself he
reported its empathetic effect, this led to its use in
psychotherapy where it was used to facilitate
communication in relationships.  It was also used
to create emotional openness in those with
suppressed memories of rape or child abuse and
in the terminally ill.  Media stories highlighting
the 'love drug' connotation led to recreational use
which was at a low level until the drug became
inextricably linked with dance events involving
'Acid house', 'Rave' and 'Techno' music genres
which apparently started on the island of Ibiza,
which by 1986 was known as XTC island.  
It is a difficult drug to classify, being neither a
true hallucinogen like LSD nor a true stimulant
like amphetamine itself.  Some researchers have
coined the term 'entactogen' to describe its
apparently unique effect including closeness to
others, facilitating relationships and creating
empathy.  MDMA and related entactogens such
as MDA, MDEA ('Eve') and MBDB are not
available pharmaceutically.  All supplies are
produced illegally in backstreet laboratories using
as starting materials the known carcinogens
Safrole and Isosofrole found in a number of plant
oils or using Piperonal.  Europe is the source of
80% of the MDMA consumed all over the world
with the main production sites, according to
Europol, found in the Netherlands.  Production
has also been detected in France, Germany, Spain,
the UK and Belgium and those involved were
believed to have links to Dutch criminal
organisations.  Gardai seized one laboratory
producing MDA some years ago.  The illegal
synthesis also brings with it significant
environmental hazards since the production of 1
kilo of MDMA results in up to 20 litres of
chemical waste. 
Legal Status
MDMA and related compounds were included in
Schedule 1 of the Misuse of Drugs Acts in 1987.
They have no medicinal use and cannot be
prescribed by doctors, sold or distributed and it
is also illegal to possess them.  The chemicals
used to produce the drug (precursors) are strictly
controlled and monitored under both EU and
National Regulations.  
Because of concern about the emergence of
different types of new synthetic drugs especially
those chemically related to MDMA and
amphetamine-type stimulants (ATS), the EU
adopted a Joint Action on New Synthetic Drugs
in 1997.  This involves an early warning system,
information exchange and risk assessment of any
new drug that appears on the market.  To date,
the Scientific Committee of EMCDDA has
conducted five assessments.  The first drug called
MBDB is controlled in Ireland but not in some
other Member States.  The risk assessment led to
a decision to monitor its presence on the market
and it was discovered that it had disappeared so
no further EU action was taken.  A compound 4-
MTA known as 'flatliners' was recommended for
common control throughout the EU, as was
PMMA.  Two further drugs, Ketamine and GHB,
were assessed but since they are controlled under
medicines legislation in most EU countries no
further controls were deemed necessary.
Prevalence and availability
MDMA is sold mainly as tablets with a variety of
different logos imprinted on them.  Over 200
logos have been observed in Europe, including
many Disney characters, $ and € signs.  The main
'brands' appear to be those bearing the Mitsubishi
triple diamond logo but other popular ones
include 'shamrocks' and 'doves'.  Some ecstasy
tablets may contain MDMA mixed with MDEA or
with MDA or the tablets may contain one of those
MDMA analogues on their own.  Tablets typically
cost between €10 and €15 depending on where
they are bought.   
Concern has been expressed about toxic
contaminants in bad batches of ecstasy but there
is no scientific evidence that rat poison or heroin
have been added to MDMA tablets.
Internationally it is known that only a relatively
small proportion of the 17 million tablets seized
in Europe contained other substances such as the
stimulants ephedrine, amphetamine,
methamphetamine or caffeine.  On occasion
hallucinogenic drugs such as DOB and Atropine
have been found.  More recently some tablets C
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Chapter 10 - MDMA (Ecstasy)
with a 'Mitsubishi' or 'E' logo have been found to
contain a mixture of PMA and PMMA, two
amphetamines that have been placed under
control.  In Ireland it is believed that Ketamine
has been found in some ecstasy tablets.  
In genuine MDMA the drug content can vary
from 30-150 mg, where 100 mg would be
considered a 'normal' dose.  A study of 100
'Mitsubishi' tablets in Dublin showed a MDMA
content of 59-98 mg with an average of 79 mg
whereas tablets with a 'bird' or 'dove' logo ranged
in content from 98-123 mg, an average of 110 mg.
Remarkably, given media descriptions of them as
being double strength, some 'shamrock' tablets
had only 77 mg of drug in them.
MDMA is an excellent example of the
unpredictable nature of the drug scene because in
1990 there were no prosecutions relating to it but
now it accounts for about 25% of all prosecutions
under the Misuse of Drugs Acts.  The 1999
ESPAD survey of substance use reported that
MDMA was perceived by Irish 15-16 year olds as
being very or fairly easy to obtain although there
was a significant drop in the percentage holding
that view compared to the 1995 study.  That 1999
study also reported that, at 5%, the percentage of
European 15-16 year olds who have tried ecstasy
was highest in Ireland, although this is
approximately half the figure reported in the 1995
report. The SLçN survey indicates that 2.4% of
adults had used MDMA in the year prior to the
survey but 18-24 year olds at 8.1% were more
likely to have used it.   
Mood Altering Effects
The effective dose of MDMA is in the region of
100 mg depending on body weight.  The effects
start about 30 minutes after swallowing the drug,
reach their peak after about 90 minutes and then
plateau for 2-3 hours before starting to subside
for the next hour or so.  After-effects can be
experienced for 3-24 hours later.  The sought after
effect is that of being relaxed but energetic, happy
and calm with a warm friendly feeling towards
others.  Aggressive, violent feelings are
suppressed; there may be increased self-
awareness and increased perception of visions
and music.  No true hallucinations occur at
Ônormal doseÕ levels and while it is not a true
amphetamine type stimulant, it does release
energy to allow young people to dance to 'techno'
music for long periods of time.
In addition to these effects MDMA causes a rise
in blood pressure, heartbeat and body
temperature.  People with a history of blood
pressure, heart disease or asthma, should not use
this drug.  Other physical effects include a
tingling sensation on the skin, jaw stiffness and
grinding of the teeth.  Many users report
experiencing a dry mouth, tremors, palpitations
and sweating after using the drug.  There are also
reports of anxiety, confusion and difficulty in
concentrating.  Surveys of recreational users
indicate that while sexual desire is enhanced,
sexual performance in men is impaired.  When
the effects subside there is frequently feelings of
tiredness, drowsiness, lack of energy, heavy legs,
insomnia and irritability, which can last from 24
hours to a week.
Adverse Effects of Use
Little is known for certain about the effects of
combining MDMA with other drugs.  Alcohol,
because of its dehydrating effects may increase
the risk of overheating and prolongs the duration
of the MDMA effects.  While ecstasy use reduces
subjective feelings of drowsiness after drinking
alcohol, it does not reverse the well-known effects
of alcohol on driving and other motor skills.
Deaths resulting from MDMA use are relatively
rare but since they involve young people they are
particularly tragic.  Accurate information on the
exact number of deaths that have occurred is not
available.  One scientific paper reported on 15
deaths in Ireland between 1996 and 1997.  A
study of toxicological reports from coroners
inquests conducted in the greater Dublin area
from 1998 to 2000 showed that ecstasy was
involved in only one death.  It should be noted
that because the study was focussed on opiate-
related deaths, other ecstasy related deaths would
not necessarily be included.  
Deaths can be due to a variety of causes ranging
from delusional behaviour to heart attacks,
strokes and asthma attacks.  Most deaths have
resulted from heatstroke known as hyperthermia.
The drug causes a rise in body temperature, it
can be up to 41oC in some users.  This is
aggravated by the heat and overcrowding at
many dance events and by the body heat
naturally generated by prolonged dancing. Death
subsequently occurs due to muscle breakdown,
clotting inside the body and kidney failure.  
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It is not known why some users suffer such an
extreme effect and others do not.  Initial
suggestions that 6-9% of the population who are
classifiable as slow metabolisers of drugs
generally, were those most susceptible to the
hyperthemic risks, have not been supported by
research findings.  There is a similar lack of
knowledge concerning the causes of the reported
cases of hepatitis where deaths have occurred
due to liver damage and in others where
transplantation has been necessary a short time
after exposure to the drug.  
Attempts to reduce the effect of hyperthermia led
to ecstasy users being advised to drink large
volumes of fluid.  In some instances this has led
to death due to water intoxication.  This has been
linked to a direct effect of MDMA resulting in the
increased production of a hormone called
Vasopressin or ADH.  The effect of Vasopressin is
fluid overload after excess water consumption
because the kidneys do not function, resulting in
cerebral oedema (swelling of the brain), coma
and death.  Other serious complications of
MDMA use include cases of convulsions, stroke
and severe chest pains.
Many of the side effects while unpleasant are
mild and would be expected from an
amphetamine-type drug.  Nausea, disorientation,
visual distortions and lack of coordination may
be caused by larger than normal doses.  Since the
drug is similar to amphetamine, appetite
suppression is common and frequent use linked
to frequent dancing is likely to result in anorexia
and weight loss. 
Many users report feelings of depression after
moderate use of the drug with some meeting
criteria for clinical depression within 5 days of
having used the drug.  This effect is the most
commonly reported side effect by most users,
83% in one UK study of 469 users said they
experienced a mid-week 'low mood'.  Reports
from psychiatrists indicate that regular MDMA
use is associated with chronic psychiatric
symptoms such as psychotic episodes, panic
disorder and depersonalisation, which continue
after drug use has stopped.  It is not yet known
whether these are pre-existing conditions
triggered off or worsened by MDMA or if the
drug actually causes the problems.  
Because MDMA was never officially used as a
medicine and because its frequent widespread
use by large numbers of young people is so
recent, reliable information on the long-term
effects of the drug has only emerged in recent
years.  Substantial numbers of users have
reported unpleasant after effects and compulsive
use referring to 'ecstasy fatigue' and a 'crash'
involving a dose-related hangover in the form of
tiredness, lethargy, feelings of loss, sadness and
dread in the days following MDMA use.
Evidence is also emerging that repeated use of
MDMA causes immune system dysfunction.  It is
likely that this would increase an individualÕs
susceptibility to infections but the research is still
at an early stage. 
Studies in rats and in monkeys have shown that
doses of MDMA comparable to those used by
humans can cause damage to certain brain cells
(neurones), which produce a key chemical
messenger or neurotransmitter called 5-HT or
serotonin.  The significance of this for human
users is that low levels of serotonin in the brain is
linked to depression, which can occur after short-
term use.  On the basis of the animal evidence
MDMA and its relatives have been listed as
neurotoxins but until recently human evidence
has been largely indirect.  Such indirect evidence
includes the reported high level of depressive
symptoms reported by users and the low levels
in the spinal fluid of users of 5-HT breakdown
products. 
The first direct evidence that MDMA was
selectively neurotoxic to serotonin producing
brain cells came from studies using PET scans of
the brains of 14 individuals who had used
MDMA 25 times or more which were compared
to similar scans from individuals who had never
used the drug.  In the user group the scans
showed significant reduction in the number of
serotonin transporters, which is probably related
to damage to serotonin nerve endings, compared
to those who never used the drug.  A Dutch
group, who also indicated that women might be
more susceptible than men but why this might be
so has not been clarified, has confirmed this US
study.  Another key unresolved question is how
reversible is the damage to the nerve endings.
There is both animal and human evidence that
the damage is partially reversible with animal
studies showing that there is some regrowth of
the cells but that it is abnormal and incomplete.
The studies also show that decreases in the
densities of the brain cells persist for more than C
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seven years after exposure to MDMA in squirrel
monkeys.  These same studies led to reports that
single doses of MDMA induced signs of
neurotoxicity in monkeys.  For humans,
increasing the dose consumed and use of MDMA
in hot crowded dance venues, which increases
the risk of hyperthermia, may, on the basis of the
animal experiments, increase the neurotoxicity.  
Apart from the linkage with the depressed mood
reported by many ecstasy users, the effect on the
nerve cells has also been linked to memory
deficits in users.  Most studies of memory and
learning in MDMA users have shown significant
impairment of verbal and spatial memory, word
recall, arithmetic skills, verbal recognition and
information processing speed.   Ecstasy users
themselves describe how daily tasks have been
impaired by their drug use.  Some of these results
have been confounded by the fact that the vast
majority of ecstasy users are polydrug users of
alcohol, cannabis and amphetamines.  Most of the
studies have found selective impairment in
MDMA users compared to non-users of any
drugs but intriguingly some researchers have
linked the deficits to the use of cannabis by those
MDMA users.
Concern has been expressed about the
consequences of MDMAÕs reputation as a Ôlove
drugÕ.  The emotional openness it creates could
be a factor in unsafe sex practices with the
attendant risks of Sexually Transmitted Infections
and unwanted pregnancy.  There is little
information available on the effect of MDMA
during pregnancy, as the usual studies have
never been performed to establish whether it is
safe or not.  One study reported in the Lancet
found an increased risk of congenital
abnormalities including heart defects in children
born to mothers who had used the drug but these
findings need to be confirmed by other studies. 
Dependence
While it is generally believed that MDMA is not a
drug of addiction, it must be borne in mind that
it is an amphetamine and as such has the
potential to cause psychological dependence.
Tolerance to the effects does develop and in many
countries, including Ireland, there are now
frequent reports of users having to take several
tablets, 10-15 tablets at a time reported in some
studies, in order to experience any positive
effects.  A minority of users can be classified as
dependent on MDMA using standard criteria
described in Chapter 2.  
Other Dance Drugs
These are so-called because of their association
with the dance scene and a 'clubbing' lifestyle.
MDMA is the major drug but others have
included LSD and the general anaesthetic
Ketamine.  
Ketamine is now used only in veterinary
medicine as a tranquilliser and anaesthetic,
medical use in humans has been discontinued
largely because of the hallucinations and
aggressive behaviour that affected patients.  Most
illicit supplies are diverted from the legitimate
pharmaceutical industry.  The drug can be
recovered from injection vials by removing the
water.  The powder can then be made into tablets
with typical ecstasy logos or it can be 'snorted' or
injected.  Street names for Ketamine include
'Vitamin K', 'Special K', 'Kit Kat' and these are
used when the drug is being promoted in its own
right to young people.  In addition to the
hallucinations, Ketamine can also cause
numbness, blackouts and temporary blindness.  
Another anaesthetic sold as 'Liquid Ecstasy' is
sodium oxybate, known also as GHB from its
chemical name Gammahydroxybutyrate.  In
addition to concern about its misuse potential
and the convulsions and deaths that have been
reported when it is mixed with alcohol, there is
increasing unease about the role of GHB in drug-
assisted sexual assault.  Because GHB is an
odourless colourless slightly salty liquid that
causes unconsciousness very rapidly, it is a
particularly harmful drug in this context.  
Both Ketamine and GHB have been subjected to
Risk Assessment by the EMCDDA but common
EU controls were not considered because both
materials are subject to medicines legislation
already. 
C
ha
pt
er
 1
0 
- M
D
M
A
(E
cs
ta
sy
)
52
Introduction
The name LSD, as well as its slang term ÔacidÕ is
taken from the chemical name Lysergic Acid
Diethylamide.  LSD is synthesised from Ergot, a
fungus that grows on rye and wild grasses.
Ergotism or ÔSt AnthonyÕs FireÕ a disease
involving hallucinations, gangrene and death,
occurs when flour contaminated with ergot is
eaten, outbreaks have occurred sporadically
throughout history.  Some of the symptoms of
ergotism resemble those of an LSD trip.  LSD was
first synthesised in 1938 in Switzerland, but its
hallucinogenic effects were only discovered by
accident in 1943.  the drug was used at one time
in experimental psychiatry, but at present such
use is almost non-existent.  Nearly all LSD is now
prepared by illegal synthesis in back-street
laboratories.
In the early 1960Õs in America and later in the rest
of the world, LSD was publicised for non-medical
purposes and became the chemical cornerstone of
the ÔFlower PowerÕ hippy movement, where it
was used to precipitate semi-religious mystical
experiences.  In the late 1980Õs it became
popularly associated with so-called ÔAcid-HouseÕ
music.
LSD is a semi-synthetic product, but ritual use of
the seeds of the Morning Glory plant, which
contain chemicals closely related to LSD, was
part of the religious observances of the Aztecs of
Central America.  Indeed, many plants containing
hallucinogens have been used for centuries for
religious purposes by primitive cultures mainly
on the American Continent.  Many of these drug
rituals survive to the present day, including the
use of the Peyote cactus, which contains
mescaline and the Magic Mushrooms containing
psilocybin.
LSD is classed as an hallucinogen, meaning that it
causes a ÔtripÕ involving changes in the
perception of time and space which result in
unreal sensations, the appearance of visions, the
hearing of voices and delusions.  It is an
extremely potent drug and the minute amounts
required for a ÔtripÕ can be formed into small
tablets (microdots), absorbed onto blotting paper,
or peel-off black stars, or cartoon figures.  ÔTabsÕ
of LSD are generally pieces of thin cardboard that
have been impregnated with the drug and
allowed to dry. Various logos appear on these
tabs such as ÔstrawberriesÕ, ÔplanetsÕ, ÔflyingkeysÕ,
and ÔbatwingsÕ. The strength of these
preparations is unpredictable and often materials
sold as LSD do not contain any LSD at all.  The
strength of the LSD ÔtabsÕ available in Ireland is
not known but information from the USA
suggests that LSD samples there have less than
half the drug of samples tested in the 1960Õs and
1970Õs.
Modern chemistry has produced a range of
synthetic hallucinogens in addition to LSD.
These include MDA, DMT and PCP
(phencyclidine) or Ôangel dustÕ once used as an
anaesthetic, but which now has a bad reputation
for releasing violent behaviour or causing
prolonged coma.  PCP is usually sold as one of
the more exotic hallucinogens, such as synthetic
THC, mescaline or psilocybin.  It is not widely
used in Ireland.  The name ÔAngel DustÕ has more
recently been used for a different drug,
clenbuterol, which is illegally used a growth
promoter in cattle.  Clenbuterol does not cause
hallucinations.
Legal Status
LSD and other hallucinogens such as DMT,
mescaline, and psilocybin are controlled in
Schedule 1 of the Misuse of Drugs Act, which
prohibits medical and non-medical use.  This
means that they can only be supplied or
possessed for research or analysis by a person
holding a licence from the Minister for Health.  It
is an offence to produce, supply or possess these
drugs.  It is also an offence to allow premises to
be used for the production or supply of these
drugs. 
Prevalence and Availability
It is generally believed that the popularity of LSD
declined from the mid 1970Õs until the late 1980Õs
when it became more popular as part of the acid
house music scene.  Survey data shows varying
rates of experimentation and more regular usage.
The SLçN survey indicated that 1.4% of the adult
(18- 64yrs) population had used the drug in the
preceding year.  Among younger adults (18-
24yrs) however the figure was 5.1%.  One study
of school children nationally showed that 3.7% of
17 year olds had used LSD within the month
prior to the study.  The 1995 ESPAD study
showed that 3-13% of those surveyed had ever
used the drug.  It is noteworthy that the
corresponding figure in the 1999 ESPAD study
had fallen to 5%.  The number of prosecutions for C
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possession has fallen significantly in recent years
as has the number of doses seized by the Garda.
It is believed that a single dose (ÔtabÕ) of LSD
costs about €6.
Mood Altering Effects
An LSD trip begins about an hour after
swallowing the drug.  It peaks 2-3 hours later and
the effects usually wear off after 12-15 hours.  The
effects are difficult to predict because they
depend on the experience and expectations of the
user and where the drug is taken.  The physical
effects are less important than the mental and
emotional effects and include increased heart rate
and blood pressure, widening of the pupils and a
rise in temperature.  Users generally report
changes in body images, distorted shapes and
sizes and intensified colours.  Users may have the
feeling of hearing colours and seeing sounds due
to sensory crossover.   Distortions in sense of time
and of place occur.  Psychological tasks such as
learning, remembering and concentration are
impaired.
Emotional reactions vary, but include heightened
self-awareness, mystical experiences and insight
into childhood memories.  These mood changes
may be extremely pleasant or extremely
frightening.  The latter, known as a Ôbad tripÕ may
take the form of severe terrifying thoughts,
feelings of loss of control and fear of going mad
or dying.   A person may have good or bad
experiences on different occasions or even during
the same trip.
Adverse Effects of Use
It is believed that the ratio of unpleasant ÔtripsÕ to
pleasant ÔtripsÕ is high.  Unpleasant reactions are
likely if the user is mentally unstable, anxious or
depressed and can include anxiety, fear,
depersonalisation (feelings of floating outside
oneÕs body), depression, disorientation and panic.
Serious panic and anxiety or even psychotic
reactions can occur, but can be dealt with by
reassurance.  Occasionally tranquillisers may be
required.  Prolonged mental illness such as
schizophrenia or depression, may be triggered off
by an LSD trip.  
Good ÔtripsÕ are also not without risk, with
people being injured because of delusions about
being able to fly or walk on water.  The exact
extent of fatal accidents and suicides caused by
LSD is unknown.  Fatalities due to overdosage
are non-existent.  
ÔFlashbacksÕ, short vivid re-experiences of a
previous trip, can occur weeks or even months
after the initial trip.  These can cause
disorientation, anxiety and distress and can be
dangerous, in certain circumstances if one is
driving, operating machinery, working at heights.
Dependence
No physical dependence or compulsive drug-
seeking behaviour occurs, but tolerance develops
which may tend to reduce frequent use.  
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Introduction
The use of mushrooms and other plants for their
vision-inducing (hallucinogenic) effects dates
back, according to archaeological evidence to
about 500 BC in Central America.  The Aztecs of
Central Mexico consumed sacred mushrooms
called Teonanactal (divine flesh).  The mushroom-
induced visions and voices were their way of
communing with the spirit world.  When the
Spanish conquered Mexico in the 16th century
they tried to eliminate the practice, but the cult
has survived to the present day.  The main
mushroom used in Mexico is Psilocybe mexicana,
which contains the drugs psilocybin and psilocin.
Numerous other species of mushroom grown in
North America and Europe also contain these
chemicals that are related to LSD. 
Psilocybin-containing mushrooms do not feature
in European history, although witchcraft is
believed to have involved hallucinogens from the
potato family such as deadly nightshade.  The
use of mushrooms for 'recreational' drug use has
increased gradually since the mid-1960's as a
more 'organic' alternative to LSD.  At present a
number of different types of mushroom are
known to produce psilocybe.  These are chiefly
from the Paneolus and Psilocybe families,
especially Psilocybe semilanceata, known as the
Liberty Cap.  The ritual medicine men or
ÔShamansÕ of North East Asia and Siberia used
Fly Agaric, an unrelated mushroom.  In this case
the chemical responsible is probably muscimole.
Legal Status
The Misuse of Drugs Acts control the substances
psilocybin and psilocin.  Because they are
recognised as having no use in medicine, they are
included in Schedule 1, which prohibits the
possession, production, supply and the act of
allowing premises to be used for their production
or supply by anyone (including doctors) except in
accordance with a licence issued by the Minister
for Health for research or other special purposes.
There are no legal restrictions on harvesting,
preparation and use of Fly Agaric.
Prevalence and Availability
There is no way of knowing exactly how many
people use, or have used, Ômagic mushroomsÕ.  A
survey of school children in the Dublin area
indicated that 4% had taken them.  Relatively
small seizures of the drug have been made in
recent years.  As a result, there have been few
prosecutions.    In addition, there has been a
reduction in the number of Drug Clinic patients
reporting use of the drug.  Most of the
mushrooms are collected from the wild, but
botanical records are sketchy on the exact species
that grow here.  It is believed that it is the Liberty
Cap that is the most commonly used.  It also has
the highest content of Psilocybin.
Psilocybin mushrooms may be eaten raw, cooked
or brewed into a tea.  Drying may also preserve
them.  The amount of Psilocybin varies with the
species, location, maturity and size.  Therefore,
dosages are variable, not least because varying
amounts of mushrooms (8 - 300) are taken.  Thus,
while it is believed that 20-30 mushrooms seem to
be the usual dose, the actual amount of
Psilocybin taken is unknown and the effects
therefore difficult to predict.
Mood Altering Effects
The effects of Psilocybin-containing mushrooms
are similar to a mild LSD experience.  The
experience therefore is variable and dependent on
the user's mood, environment and intentions.
The experience is not as unpleasant as an LSD
trip. The effects include euphoria and hilarity,
together with dilated pupils, increased pulse rate
and high blood pressure. The effects come on
quicker, generally after about 30 minutes and
start to wear off after about 4 hours, compared to
15 hours for a dose of LSD.  The hallucinations
are usually visual in nature but auditory
hallucinations can also occur.  There are reports
of people having the sensation of objects
changing shape and heightened awareness of
sound and colour.
Adverse Effects of Use  
Users commonly report nausea, vomiting and
abdominal pain, but it is possible that non-
psilocybin poisonous mushrooms may have been
taken as well as liberty caps.
A number of users in Britain reported bad ÔtripsÕ
involving feelings of depersonalisation, panic,
anxiety and even psychotic reactions.  Some users
were aggressive and hyperactive, with many of
those requiring medical attention reporting their
experiences as frightening, and including tingling
of the limbs and flushing.  Such bad trips can be
dealt with by friendly reassurance and generally
wear off after about 12 hours with no lasting
effects.  Some users do have recurrent panic and C
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anxiety attacks often triggered off by alcohol.  A
number of users indulge in rash behaviour, such
as running in and out of traffic, wandering naked
along a railway line, or trying to walk between
tube stations.  In the latter case a 16 year old boy
was killed when struck by a train. 
Psilocybin mushrooms are not poisonous, but
there is the ever-present possibility of picking
poisonous mushrooms by mistake and a number
of fatalities have been reported from other
countries.  Distinguishing hallucinogenic
mushrooms from poisonous, often deadly
relations is a complicated task, requiring
reference to relevant botanical texts and some
expertise in the classification of mushrooms, and
it is not a task to be performed while
hallucinating.
Little is known about the long-term effects of
extended, frequent use. 
Dependence
As in the case of LSD, tolerance rapidly develops
and it may take twice as many mushrooms to
repeat the experience.  Cross-tolerance occurs
between LSD and Psilocybin.  There are no
significant withdrawal symptoms and no
physical dependence, although some people may
be psychologically dependent.
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Introduction
Sedatives are used medically to calm people
down and to help them sleep at night.   The most
important of the older sedative drugs are the
barbiturates such as Seconal¨  and Amytal¨.
Because they have side effects and because quite
small amounts can result in an overdose, they
have been largely superseded by the minor
tranquillisers.   However, one barbiturate,
phenobarbitone, is still widely used in the
prevention of epilepsy.
Tranquillisers fall into two main groups:
¥ major tranquillisers, such as Chlorpromazine
are used for serious mental illnesses
¥ minor tranquillisers are used to control
anxiety and stress and at night to induce
sleep.   
Minor tranquillisers are the most frequently
prescribed, particularly the benzodiazepine type.
Benzodiazepines can be divided into the
Anxiolytics (anti-anxiety drugs), such as
Diazepam, Loreprazepam and Chlordiazepoxide,
and the Hypnotics (sleep-inducing agents) such
as Flurazepam, Nitrazepam and Triazolam.  The
division is not absolute because many of the
anxiolytics can also act as hypnotics.   Sometimes
the benzodiazepines are classified as short acting,
such as Triazolam, Temazepam and
Loreprazepam or as long acting such as
Flurazepam, Nitrazepam and Diazepam.  
The benzodiazepines are used to help people
cope with disabling distress caused by insomnia,
anxiety, panic, epilepsy, muscle spasms and pre-
surgical stress. Both the barbiturates and the
tranquillisers are usually taken by mouth but
some people may inject either dissolved
barbiturates or the liquid form of certain
benzodiazepines.  Newer drugs include
Zolipidem and Zopiclone, which though
chemically different to the benzodiazepines have
many of the same sedative effects and also
similar risks of adverse psychiatric effects and of
dependence. 
Legal Status
All tranquillisers and barbiturates are regulated
under the Control of Sale Regulations and as
such can only be sold by a pharmacist, in
accordance with a doctor's prescription.   They
are also controlled under the Misuse of Drugs
Acts.   Therefore it is illegal to possess them
without a prescription or to sell them or to give
them to someone else.
Flunitrazepam and Temazepam are recognised as
being especially liable to misuse, particularly by
opiate misusers and as a result are subject to
much stricter controls on prescribing and
possession.
Prevalence and Availability
The use of barbiturates has declined in medicine.
While no exact figures are available, it is known
that the prescribing of these drugs almost halved
in the five years to 1978 and there is every reason
to believe that the decline has continued.   
While 52 people were charged with the
possession of barbiturates in 1981, there have
been no such prosecutions since 1985.   
There have been no national surveys of the
overall use of tranquillisers in Ireland.  Most of
the information that is available has come from
the General Medical Services Scheme, which
covers approximately 30% of the population.
Between 1995 and 2000 the number prescriptions
for benzodiazepines rose from just over 1.2
million to approximately 1.6 million.  The WHO
uses the concept of Defined Daily Doses (DDD)
per 1000 of the population per day as a basis for
comparing prescription trends for this group of
medicines.  The DDD has more than doubled
since 1973 when it was estimated to be 50, the
corresponding figure in 2000 is believed to be 116.
It has been estimated that 11.5% of the adult GMS
entitled population are using prescribed
benzodiazepines at any one time.  In the case of
hypnotics the DDD figure is 62, with much of the
increase being due to the non-benzodiazepine
hypnotics such as Zopiclone.  Women are more
likely to use these drugs than men and use in age
group 60-70 years is much higher than in other
age groups.  It is believed that prescribing within
the GMS accounts for 60-70% of total usage of
these medicines in Ireland but no detailed
information on the extent of private prescribing
of benzodiazepines is available at present.
Survey data shows a relatively low level of use,
with the SLçN study reporting that 1.2% of
adults having used hypnotics and sedatives in
the 12 months prior to the survey.  The reported
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Chapter 13 - Sedatives and Minor Tranquillisers*
* Generic drug names are used throughout the chapter. For
information, at the end of the chapter a table identifying some
common registered trade names is included
lifetime use in the ESPAD studies was 7% in 1995
and 5% in 1999.   
The level of alleged over prescribing of these
drugs has been linked to their use by opiate
addicts.  In this context the emergence of a Ôblack
marketÕ is somewhat surprising.  Garda seized
more than 15,000 tablets, containing
benzodiazepines, in 1999.  An increasing number
of clients attending Drug Treatment Services
report using benezodiazepines either as their
major drug or as their second drug of choice.  
Mood Altering Effects
Barbiturates depress the central nervous system
in the same way as alcohol.   Small doses may
make people feel relaxed and sociable as if they
had taken one or two drinks.  With larger doses
the sedative effects predominate.   A person,
having taken a moderate to large dose, will often
be unsteady, with poor control of speech and
body, rendering them liable to injury.   They may
appear to be drunk without any smell off their
breath.   Some may become aggressive as can
happen with alcohol.   The effects last from 3 to
12 hours depending on the dose.   
Adverse Effects of Use
Large doses can cause unconsciousness and
eventually respiratory failure and death.   The
fatal dose is very close to the medical dose.
Overdose deaths, particularly when alcohol is
drunk at the same time, have always been a
major medical problem.
Tranquillisers depress mental activity, making
people less alert, but the usual dose does not
make people as sleepy or impair intellectual
function as much as the barbiturates.   The most
commonly reported side effects are drowsiness,
forgetfulness and a decrease in the ability to carry
out complicated tasks such as driving because of
the sedation, impaired memory and reduced co-
ordination.   
The benzodiazepines are known to disturb
control of steering and reaction time in both
laboratory and road tests.   In addition, the
amnesia produced can cause some drivers to
forget routes and impair their ability to read
maps.   It has been suggested that medical doses
may double the risk of a traffic accident.   If these
drugs are taken with alcohol the damaging effect
on co-ordination and performance will be even
greater because the combination of the two drugs
will magnify the effects of each drug. A review of
the literature on Drugs and Driving prepared by
the Health Research Board EMCDDA reported
that benzodiazepines are the most frequently
detected legal drugs in drivers after alcohol.  The
Medical Bureau of Road SafetyÕs data for Ireland
confirms this with 25% of cases testing positive
for this group of drugs.   
Another problem is the possibility of a hangover
effect following a hypnotic, sleep-inducing dose
the previous night.   The damaging effects tend to
disappear after a few days when short-acting
drugs are taken.  The damaging effects continue
for longer when a drug such as Nitrazepam is
used.   Patients are advised to avoid all those
activities which require concentration and co-
ordination, such as driving, use of machinery, use
of complex automated systems in the chemical,
power and other industries, air traffic control
systems during the first few days of treatment
with Benzodiazepines and with Zopiclone.  
Any of the benzodiazepines in a high enough
dose can induce sleep.   Some long-acting types
such as Nitrazepam and Flurazepam can have
effects lasting into the following day.  Some
shorter-acting types have effects that last from 3
to 6 hours.   
Use of benzodiazepines may cause confusion and
disinhibition in some users leading to a loss of
self-control, recklessness and even violence.
Falls and fractures are a hazard due to poor co-
ordination.   One USA study indicated that
benzodiazepine users use more healthcare
services as a consequence of accidents and
injuries than patients who do not use these
agents.   
The benzodiazepines are safe in the sense that
lethal doses are very large.   Single large doses of
these drugs have been taken on their own with
little or no long-term consequences.   However, if
they are combined with alcohol, then a fatal dose
is reached at a much lower level.
Benzodiazepines use may precipitate suicide in
depressed patients.   In cases of bereavement,
psychological adjustment may be inhibited.
There is evidence that memory is impaired but
this usually relates to the period after the drug is
taken, which is why they are used preoperativelyC
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and in dentistry.
While some residual amnesia may occur and
some chronic users have lower scores in some
psychological tests, it is not yet known for certain
whether long-term use impairs intelligence.
Dependence
Tolerance develops to the effects of these drugs
and may increase the risk of dependence because
of the need to increase the dose.  Benzodiazepines
are thought to lose their ability to induce sleep
after a fortnight's continuous use and may be
ineffective against anxiety after four months.   
If drug use is suddenly stopped, withdrawal
symptoms such as tremor, sweating, headaches,
sensitivity to light, sound and touch, insomnia,
nausea, vomiting, anxiety, depression, muscle
spasms, vertigo and a feeling of continuous
movement appear several hours after a short-
acting drug.   Serious withdrawal effects include
psychotic reactions such as hallucinations,
depersonalisation and paranoid delusion as well
as convulsions.  The psychotic reactions are not
life threatening as with the convulsions, which
cause fatalities when people were withdrawn
from the older barbiturate type sedatives, but
may be unpredictable in their onset and may last
from 2 weeks to a year.   
In some cases the withdrawal symptoms may
resemble the original pre-treatment complaint
and there may be a temptation to continue the
treatment.   However, many doctors feel that
patients should be withdrawn from tranquillisers
as soon as possible by gradually reducing the
dose, rather than abruptly stopping it altogether.
It is now recommended that these drugs should
only be used to treat severe disabling anxiety and
insomnia using the lowest possible doses and for
the shortest possible time which should not
exceed 4 weeks.   When a benzodiazepine is used
to induce sleep its use should be intermittent, for
example every third or fourth day over a couple
of weeks.  In this context it is worrying that
information from the General Medical Services
(GMS) Payments Board suggests that more than
two thirds of those being prescribed
benzodiazepines are taking them for much longer
than four weeks.
There is no evidence available to suggest that any
one drug is more responsible for the development
of dependency than another.   Dependence is
more likely to occur in the elderly whose
metabolism is reduced and where there is
dependence on other drugs especially alcohol.
Dependence is also a risk with Zopiclone
particularly when the dose is increased and it is
used for longer than four weeks. 
Co-Abuse of Benzodiazepines and Opiates
The co-abuse of benzodiazepines (ÔBenzosÕ) and
opiates is linked to much lower success rates in
drug treatment programmes and a greater risk of
HIV infection.   There is much concern about the
increasing misuse of these drugs, particularly of
Diazepam and Flunitrazepam among opiate
addicts in Dublin.  In one study involving
urinalysis, approximately 50% of all the samples
tested positive for benzodiazepines.  In many
cases the doses being used are up to 20 times
normal.  Flunitrazepam in combination with
opiates, causes disinhibition, leading to
unhygienic injection practices and also criminal
behaviour resulting from feelings of invincibility
and sensations of being invisible.  Sometimes
drug use is deliberate in order to instil confidence
prior to committing acquisitive crimes.  
However, the increased risk of death through
overdosage when opiates and benzodiazepines
are combined is the most worrying aspect of all.
Between 1998 and 2000, benzodiazepines were
implicated in the highest number of drug related
deaths in the greater Dublin area.  A detailed
investigation of coroners reports by Ray Byrne of
the Addiction Research Centre at TCD shows that
179 of the designated drug related deaths in those
three years involved either Diazepam, 68% of
benzodiazepines cases, or Flurazepam in
combination with an opiate such as heroin or
methadone.  Consumption of alcohol at the same
time adds to the risk of death. 
Drug-assisted Sexual Assaults
The amnesic effect of benzodiazepines has been
highlighted as a factor in many cases of alleged
Ôdate rapeÕ, in particular Rohypnol¨ (ÔRo-RoÕs or
ÔRoofiesÕ).  Because forensic evidence can be
difficult to obtain, there are no statistics on the
extent of what is now called drug-assisted sexual
assault.  
Another drug implicated in drug assisted sexual
assaults is the anaesthetic gamma hydroxybutyric
acid (GHB).  The fact that this is an odourless, C
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colourless, virtually tasteless liquid has raised
concerns internationally that it is a more likely
suspect than coloured tablets which need to be
dissolved.   An EU Scientific Committee on Drugs
has recommended to the EU that this problem
needs to be studied in much greater detail
notwithstanding the fact that most assaults,
sexual or otherwise, involve alcohol.  
*Table of generic drug names and some registered
trade names.  
Generic Registered
drug names of common Trade
sedatives and names
tranquillisers
Diazepam Valium¨
Lorazepam Ativan¨
Chlordiazepoxide Librium¨
Flurazepam Dalmane¨
Zolipidem Stilnoct¨
Temazepam Normison¨
Flunitrazepam Rohypnol ¨
Zopiclone Zimovane ¨
Nitrazepam Mogadon¨
Triazolam Halcion¨
Chlorpromazine Largactil ¨
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Introduction
Cocaine is a powerful stimulant, which is
extracted from the leaves of the coca bush. It is
similar in effect to amphetamine. Coca leaves
have been chewed, at least since the 6th century
A.D., by the Indians of the Andean regions of
South America to relieve hunger and fatigue, for
minor medical complaints and generally to make
life and work bearable in the cold inhospitable
mountainous regions of Bolivia, Colombia,
Ecuador and Peru. The coca leaf contains less
than 1% of cocaine and is chewed with a
combination of lime and starch. Nine million
kilogrammes of legally grown leaves of the plant,
once known as ÒDivine Plant of the IncasÓ are
used every year in Peru alone. At that time coca
chewing was a sign of high status in Inca life, but
it is now associated with the poorer classes, a
direct contrast with the chic jet-set image of
cocaine hydrochloride in western societies. 
Cocaine was first extracted in 1855 and it became
a widely used local anaesthetic, stimulant and
tonic. Up until 1910 Coca Cola¨ contained
cocaine, but since then decocainised leaves are
used to flavour this popular drink. The extracted
cocaine is sold for medical use as an anaesthetic
in eye, ear, nose and throat surgery and in
Brompton Cocktail, a mixture of cocaine,
morphine or heroin, alcohol and syrup, used to
relieve the pain of terminal cancer.
Cocaine known as 'coke', 'snow', or 'charlie' has
had a reputation as a rich manÕs drug because of
its expense. The raw material is cheap, 1 tonne of
coca leaves costing about $2,000 in South America
would provide 2 kg of cocaine at a wholesale
price of $40,000. The profits from illegal
production in some South American countries
have a major corrupting influence on those
countries. The illegal cocaine industry may
employ up to 1 million people from the Andean
region in the growing, processing and transport
of the coca leaves and the refined cocaine.
Columbia produces approximately 75% of the
world's cocaine hydrochloride from coca base
originating in Peru and Bolivia as well as from
local coca bush cultivation, which has increased
substantially in recent years.
Legal Status
In America controls were introduced in 1914,
partly because of fears about many patent
medicines being laced with dangerous cocaine
and opiates and partly because of racist-inspired
fears. In Britain controls were introduced during
the First World War as part of the Defence of the
Realm Act in 1916, to protect soldiers on leave. 
In Ireland at present cocaine and coca leaf are
controlled by the Misuse of Drugs Acts. Coca leaf
is included in Schedule 1, because it has no
recognised medical use, so it can only be
supplied or possessed by persons holding a
licence, for research or analysis, from the Minister
for Health. Cocaine and its salts are included in
Schedule 2. Therefore, they can still be prescribed
by doctors and dispensed by pharmacists, but it
is illegal to produce, possess or supply the drug,
except on prescription. It is also illegal to allow
premises to be used for producing or supplying
cocaine. It is an offence to grow the coca plant,
except under licence from the Minister for
Health. 
Prevalence and Availability
Cocaine has become less expensive and more
available in Europe because of increased
production, particularly in Colombia where
cultivation has increased by about 20% in recent
years compared to significant reductions in
Bolivia and Peru. In Bolivia about 12,000 hectares
of coca is cultivated legally to meet demand from
native chewers of coca leaf. About 2% of leaf
production is legally exported to flavour cola
drinks and to manufacture pharmaceutical grade
cocaine hydrochloride. The bulk of the coca leaf
production, approximately 200 million tonnes, is
used to produce almost 1,000 tons of cocaine each
year of which about 540 tons reaches the black
market. Prices in Dublin at ´90-100 per gramme
appear to be midway between reported European
prices of ´ 24-170 per gramme. The purity is
believed to have fallen from 62% to 38% in the
past few years. While Customs and Garda have
seized significant amounts in the last few years,
prosecutions under the Misuse of Drugs Acts
relating to cocaine account for approximately 2%
of all drug prosecutions. The numbers seeking
treatment has also remained low, 2% of the total
number presenting for drug treatment for the
first time in 1998. This reflects the low level of
reported experimentation with cocaine that most
surveys show is between 1-2% for school children
and for adults. Some studies indicate that cocaine
use is more prevalent in those individuals who
report problem drug taking and whose drug use
has extended from opiates to cocaine as well as C
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Chapter 14 - Cocaine
benzodiozepines.
Cocaine smoking first became popular in Peru
where coca paste containing between 40 and 90%
cocaine is readily available. ÔCrackÕ is a cheap
high-strength form of cocaine base made by
mixing cocaine salt with bread soda, which has
attracted enormous attention in recent years.
ÔCrackÕ, so called because of the noise when lump
or ÔrockÕ is heated, is not a new drug but rather a
new way of delivering the drug. Because it is the
base, it is volatile and can be smoked in cigarettes
or in glass pipes. EMCDDA states that there
appears to be a clear distinction between the
users of cocaine powder and smokers of ÔcrackÕ
or free- base cocaine. The latter tend to be from
marginalized groups such as homeless youths,
prostitutes and heroin users whose use of ÔcrackÕ
is out of control. There is, however, some concern
that attempts to rebrand ÔcrackÕ cocaine as 'rock'
or 'stone' for smoking with tobacco in some EU
countries may create a more up-market image
and weaken informal social controls which tend
to limit crack smoking. ÔCrackÕ has exacerbated
the problem of cocaine because of its low cost,
ready availability, high doses and speed of action
which is comparable to that obtained by
intravenous injection.
Street cocaine is usually ÔcutÕ or diluted with
lactose (milk sugar), with mannitol or with legal
local anaesthetics such as procaine and
lignocaine. The powder can be inhaled into the
nostrils by snorting through a straw, after 20 - 25
mgs has been laid out in narrow lines on a
mirror. Because the material is bought on the
black market, it is impossible to know exactly
how much cocaine is being taken. Even
experienced cocaine users are unable to
distinguish the effects of cocaine from lignocaine.
Mood Altering Effects
The effects of intranasal cocaine start very
rapidly, after 3 minutes, and last for only about
twenty minutes. They include stimulation,
reduction in hunger and thirst and a superhuman
feeling of great energy and alertness. Many users
report an almost orgasmic-like intensity of effects.
However, disturbing effects when high doses are
taken or when a person doses repeatedly to
maintain the short-lived effects replace the
pleasurable effects of low doses.
Smoking of ÔcrackÕ or free-base cocaine, is a
method of use that produces a shorter but more
intense high than ÔsnortingÕ the drug. 
Adverse Effects of Use
Large doses can cause anxiety, depression and
fainting. Occasionally a binge or ÔrunÕ of cocaine
over a period of days can result in bizarre,
aggressive and violent behaviour, with severe
persecution complexes.
Excessive doses can cause death through heart
failure or lung damage. While fatalities have been
reported with intranasal use, they are most likely
to occur when the drug is smoked or injected or
as a result of what has become known as the
Ôbody packer syndromeÕ, where attempts are
made to smuggle cocaine packed in condoms and
subsequently swallowed. If the condom bursts or
stomach juices leach the cocaine out a lethal dose
can be absorbed into the blood stream. In a
number of such cases the packages, which are
also often inserted in the rectum, have had to be
removed surgically.
Research into cocaine use in Dublin suggests that
alcohol and cocaine is a popular drug 'cocktail'.
The combination is converted in the body to
cocaethylene, which lasts longer in the brain and
is more toxic than either drug alone.
ÔCrackÕ and free-base are much more likely to
cause fatalities in young, otherwise healthy
people, as a result of strokes, heart attacks, clots,
damage to the heart muscle or to the lungs.
Women are reported to be the heaviest users of
ÔcrackÕ and it has been reported that many engage
in sexual activity with multiple partners while
using the drug, thereby increasing the risk of
Sexually Transmissible Infections, HIV infections
and also unwanted pregnancies.
American studies show that almost one in five
pregnant women have used cocaine during
pregnancy. Cocaine use during pregnancy puts
the baby at risk due to rupture of the womb
caused by a sudden rise in blood pressure. Other
problems are caused by a lack of oxygen, by
premature birth, as well as a low birth weight
and smaller size. While the full extent of prenatal
exposure to cocaine is unknown, some of the
more severe effects, which were predicted in the
early 1990's, have not been encountered. It now
appears that exposure to cocaine in the womb
may lead to subtle developmental defectsC
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relevant to school performance such as effects on
concentration.
After discontinuing regular use of any form of
cocaine, the user will feel tired and experience a
severe depression - the ÔcrashÕ -  which, together
with excessive eating and sleeping, is now
believed to be a symptom of withdrawal from the
drug. Many cocaine users become so depressed
that suicide attempts are a risk. Many cocaine-
users try to counteract this ÔcrashÕ by using
tranquillisers, alcohol or by injecting heroin and
cocaine mixtures called a Ôspeed ballÕ. With
chronic frequent use, increasingly unpleasant
effects develop, where the excitement is replaced
by restlessness, insomnia, weight loss, developing
into a paranoid psychosis with delusions of
persecution, violent tendencies, visual
disturbances called Ôsnow lightsÕ and unpleasant
skin sensations - called the Ôcocaine bugsÕ, where
there is a feeling of insects crawling under the
skin. These effects generally clear up once use is
discontinued.
Because cocaine constricts blood vessels, chronic
use could lead to damage to the membranes and
lining of the nose. In direct contrast to the
harmful consequences of cocaine use, there is
little evidence of any physical or psychological
harm from coca chewing, possibly because it is
released more slowly into the blood stream.
Dependence
Cocaine is not physically addictive in the usual
sense of the phrase, as there does not appear to
be any physical withdrawal symptoms. Cocaine
is described as capable of producing severe
psychological dependence because of the strong
cravings it produces leading to compulsive
patterns of use. Cocaine is known to be the most
reinforcing of the commonly available drugs
because test animals will self-administer it until
they die.
Tolerance develops resulting in higher doses and
more frequent use of the drug. Many researchers
report that predicting which cocaine users will
maintain control over the drug and which will
become compulsive and/or dependent users is
very difficult.
Smoking ÔcrackÕ or free base cocaine involves a
much higher risk of dependency and toxicity,
because of the higher doses, 100 mgs of free base
per ÔhitÕ, and the shorter onset of action, less than
10 seconds, leading to almost continual
consumption in binges which can last for up to
four days. This makes free-base and crack
smoking highly addictive and more smokers of
cocaine report more dependency problems than
intranasal users. However, intranasal cocaine
dependence also appears to be an increasing
problem where cocaine powder is freely
available. The Dublin study suggests that at
present cocaine use is intermittent among most
users who believe that their use is not
problematic for them.
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Introduction
Heroin (diacetylmorphine or diamorphine) and
other opiates are a group of strong sleep-inducing
painkillers, known as narcotic analgesics,
originally extracted from opium. Opium is the
dried milky latex extracted from the fruit of the
opium poppy. Opium contains morphine and
codeine, both very effective painkillers. Heroin is
easily manufactured from morphine in even the
crudest of laboratories. Freshly made heroin is a
white odourless powder but as it gets older it
darkens in colour and develops a smell of acetic
acid (vinegar).
Heroin was originally developed as a safer
substitute for morphine, whose medical uses as a
painkiller are limited by its dependence-
producing potential. Unfortunately heroin proved
to be nearly four times more potent and more
addictive than morphine. Both drugs are still
used in medicine to treat the severe pain of
terminal cancer and of heart attacks. In fact the
body rapidly converts heroin back into the parent
drug morphine. Heroin for medical use is not
available in Ireland though there is nothing in the
Misuse of Drugs Acts that prohibits the
prescribing of heroin. This is because, in an effort
to reduce the availability of heroin, licences are
not issued which would allow the drug to be
imported into the country.
Heroin often contains other drugs, either
produced during manufacture because of a fault
in the process, or added deliberately to make a
particular grade of heroin, for example some
types of Far Eastern heroin made for smoking
contain strychnine.
Codeine is widely used for less severe pain, often
in combination with aspirin and paracetamol. It
is also used in cough mixtures because it
suppresses coughing. Concern has been
expressed about young peoples misuse of cough
mixtures. It is not certain which of the
components in these preparations gives the
sought-after euphoria. A number of
manufacturers have removed codeine from their
formulas as a way of helping to reduce the
misuse potential of these medicines. Some
synthetic opiates are also used to suppress
coughs and in anti-diarrhoea preparations.
Extracts of opium are also included in various
anti-diarrhoea preparations.
A number of synthetic opiates have been
developed as painkillers. These include
pethidine, often used in childbirth, which was
widely abused in the initial stages of the
development of the drug scene in Dublin in 1968-
69. Dipipanone is another such drug developed
to treat severe pain and sold as Diconal¨ tablets.
Ireland had the dubious distinction of being the
first country in the world to report cases of
Diconal¨ misuse. Methadone is a synthetic opiate
usually used to assist in the treatment of opiate
addiction. 
Two other synthetic opiates are Dihydrocodeine
[DF 118¨and DHC Continuous¨] and
Buprenorphine [Temgesic¨ or Subutex¨].
Dihydrocodeine, used medically to treat
moderate to severe pain is chemically related to
codeine and it too can give rise to dependence of
the morphine type. Buprenorphine has typical
morphine-like effects but a longer duration of
action. It also blocks some of the effects of
morphine and as a result it may cause
withdrawal symptoms in some individuals who
are taking other opiates. Some studies have
shown that buprenorphine reduced self-
administration of heroin by addicts and as such it
is finding increased use as a ÔmaintenanceÕ drug
in addiction treatment.
Opiates can be swallowed or dissolved in water
and injected. Heroin can be sniffed up the nose
like cocaine or smoked from aluminium foil
called ÔChasing the DragonÕ. As with other drugs,
injection into a vein maximises the effects and
dangers.
Legal Status
The Misuse of Drugs Acts control opiates. It is
illegal to possess them, unless prescribed by a
doctor and supplied by a pharmacist. It is an
offence to import, distribute, produce or sell
them. The penalties for unauthorised possession,
according to the Misuse of Drugs Acts 1984, are a
fine of up to ´1,270 and/or 12 months
imprisonment if the case is heard in the District
Court. If a jury finds a person guilty the penalty
can be a fine, the amount of which is at the
discretion of the Court, or 7 years in jail, or both.
The penalties for illegal supply can be more
severe - in the case of a jury trial, a convicted
person could be sentenced to a maximum of life
imprisonment, or to a lesser period in jail and a
fine the amount of which is unlimited and set atC
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Chapter 15 - Heroin and other Opiates
the discretion of the Court. A fine of up to ´1,270,
12 months in jail or both can be imposed by the
District Court.
It is an offence to smoke opium, the only
prohibition on actual use of a drug in the Misuse
of Drugs Acts, to possess utensils for smoking or
preparing opium, to allow premises to be used
for preparing or smoking opium, and to cultivate
the opium poppy. All doctors may prescribe
opiate drugs for medical use although heroin is
no longer available. The other exception is
Diconal¨ whose use is now restricted to hospitals
only. Dihydrocodeine in the form of DF 118¨
tablets are included within the strict requirements
of the Misuse of Drugs Acts as is Buprenorphine. 
Certain non-injectable mixtures of codeine with
other drugs, as well as very dilute opiate
mixtures for cough or diarrhoea, are exempt from
most of the restrictions of the Misuse of Drugs
Acts but can only be purchased from a
pharmacist. Because of concern over the abuse of
certain cough mixtures, the Pharmaceutical
Society of Ireland has issued strict guidelines to
all pharmacists in an effort to reduce the
availability of these products to young people. 
Prevalence and Availability
Because heroin use is illegal, there is no accurate
method of determining the true number of
addicts. All the indicators available show that
since 1980, heroin availability, use and addiction
increased rapidly, particularly in Dublin.
Estimates of the number of addicts have ranged
from 6,000 to 13,000. Between 1990 and 1999,
7,559 Irish people sought treatment for the first
time for heroin or other opiate-related problems
mostly from the Dublin area. These other opiates
could include morphine sulphate tablets (ÔMSTÕs
or ÔNappsÕ), methadone and dihydrocodeine.
Virtually all the heroin used is illegally
manufactured and imported, mainly from the so-
called Golden Crescent of Afghanistan and
Pakistan but also the Golden Triangle of Burma,
Laos and Thailand. Black market heroin can cost
between ´200-250 per gramme. At street level it is
diluted or 'cut' to increase its profitability using
materials such as flour, lactose, talcum powder,
glucose and caffeine. It is usually sold in ´20 bags
of gear which contain 4 doses of drug. The purity
of heroin on the Irish market dropped from 45%
to 33% between 1995 and 1999. Diconal¨ tablets
are now virtually unavailable due to the
effectiveness of the prescribing restrictions and
this is reflected in their virtual disappearance
from drug statistics.
Mood Altering Effects
Heroin when injected produces a very rapid
'rush' lasting less than a minute, and involving
warm flushing of the skin and sexual excitement.
There is a mistaken impression that heroin gives
a more intense feeling of pleasure than other
opiates, but it seems that this reputation is due
more to the rapid onset of action compared with
the slower action of morphine. The initial rush is
followed by a pleasant, dreamlike state of
peacefulness and contentment; pain is reduced,
as are aggressive tendencies and sexual drives.
Much of the euphoria seems to occur early in the
addict's career, and those truly addicted
experience little euphoria. The side effects of
opiates include reduced sex drive, constipation,
palpitations, rashes and itching, especially of the
nose. 
Adverse Effects of Use
Moderate doses of pure opiates produce a range
of physical effects, such as analgesia, suppression
of coughing, and depression of bowel activity
leading to constipation, depression of respiration
and dilation of blood vessels giving a feeling of
warmth. At higher doses these drugs induce
sleep, followed by coma. Death from respiratory
depression can occur, especially if the opiate is
combined with other depressant drugs such as
alcohol and benzodiazepines, if there is a loss of
tolerance, or unexpectedly high potency and is
more likely to happen when the drug is injected.
One hundred and fifty seven deaths have been
reported between 1998 and 2000 in which an
overdose of heroin was implicated, frequently in
combination with alcohol and benzodiazepines.
However, this figure does not include deaths
from other causes, such as HIV or from suicide. It
is believed that opiate users have an overall
mortality rate of up to 20 times higher than
people of the same age in the general population. 
Physical damage from long-term use of opiates is
usually associated with unhygienic injection
techniques rather than damage to organs in the
body. There are no serious diseases attributable to
chronic narcotic use that would parallel the
damage to the liver and lungs caused by alcohol
and tobacco. Studies of a small group of middle-
aged addicts who were using pharmaceutical C
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quality heroin for between 20 and 43 years
revealed evidence of brain damage but the exact
influence of heroin is as yet unclear. Because
opiates suppress the coughing reflex, some
chronic users may have lung problems including
bronchitis. Some researchers have suggested that
opiate dependants are abnormally susceptible to
infections due to an effect on their immune
systems.
The way the drug is used causes most medical
problems, including blood poisoning and
infection of the heart valves from using non-
sterile water and syringes. Adulterants that do
not dissolve can cause abscesses, clots in the
lungs, gangrene and loss of limbs. Types of
heroin that do not dissolve in water, such as
South West Asian type 1 and Chinese no.3, have
caused problems when addicts have used lemon
juice, vinegar, car battery acid or citric acid in
efforts to dissolve the drug. In Australia, France
and Scotland fungal infections leading to
blindness have resulted from the use of
contaminated lemon juice. In summer 2000, 8
people died in Ireland from a gangrene-like
condition caused by a germ called Clostridium
that contaminated the heroin they dissolved in
citric acid and then Ôskin poppedÕ into muscle
tissue rather than injected into a vein. The
sharing of the injection equipment - the ÔworksÕ
(needle, syringe, filter spoon and tourniquet) by
several people can result in the transmission of
viral hepatitis such as Hepatitis C, which can
cause liver cancer. Hepatitis C can also be passed
on through contact with body excretions and by
sexual contact. IV opiate misusers (ÔmainlinersÕ)
are a high-risk group for HIV infections, which
can result in the development of AIDS.
Injection of heroin was the main route of
administration in Ireland in the late 1980's with
88% of those seeking treatment in 1990 reporting
that they injected. By 1996 that percentage had
dropped to 49% as most users reported smoking
or 'chasing' the drug but by 1994 the number of
those injecting had reportedly risen to 69%,
perhaps because those who previously smoked it
had developed tolerance to such an extent that
the relatively more ÔefficientÕ way of using the
drug by injection became inevitable.
Given the high levels of injecting reported by
Irish heroin users it is hardly surprising that
levels of infectious diseases associated with such
injections remain significant. Levels of Hepatitis B
among injecting drug users in Irish prisons is
reported to be approximately 18%. For Hepatitis
C, figures for Dublin show that it ranged from 52-
89% among drug users in treatment compared to
a seropositivity rate of 5.8% for HIV. Cases of
AIDS in drug users account for nearly half of the
349 people who have died from AIDS since 1982.
The combination of disease, malnutrition, crime
and self-neglect through compulsive involvement
with the drug and the risk of overdose creates a
serious health risk to add to the social harm and
legal problems associated with being an addict.
Dependence
The first experience with heroin is often
unpleasant because of nausea and vomiting. This
feeling is often sufficient to deter many people
from using heroin again. Others continue to use
the drug, becoming occasional users. Others
become regular users and others become
compulsive users. There is evidence that repeated
use of heroin does not invariably lead to
compulsive daily use. One US study estimated
that about 23% of those who experiment with
heroin become dependent on it. 
Tolerance develops rapidly to the effects of
opiates. Heroin dependants are able to take
amounts that would kill a non-tolerant person.
Some US soldiers in Vietnam were reported as
using 2.5 gms of pure heroin daily. It is likely that
even the heaviest of heroin users in Dublin are
using only a fraction of that amount each day.
Tolerance disappears rapidly when use is
stopped and overdoses are most likely to occur
following this loss of tolerance by a user who has
been detoxified in hospital or in prison. They
then cannot use the high doses they formerly
could tolerate.
Dependence, both physical and psychological,
though not inevitable, is a very frequent and
likely result of continuous use of opiates,
particularly if they are injected. The length of
time taken for dependence to develop is affected
by the physical and mental make-up of the
individual, and by the quality and frequency of
drug consumed. Dependence can occur after a
few days. More serious dependence can take
weeks or months to develop. Withdrawal
symptoms, called 'cold turkey' because of the
chills and gooseflesh that are part of withdrawal,
begin 4-12 hours after the last dose of the drug.C
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They reach a peak after one and a half to three
days and then subside. The seriousness of the
symptoms depends on the mental state of the
individual and on the extent of drug use. It is
likely that most addicts using weak adulterated
heroin do not have the full symptoms, and for
many the effect would be similar to severe 'flu'.
Withdrawal symptoms can include yawning,
tears, running nose, sneezing, tremors, headache,
sweating, anxiety, irritability, insomnia,
spontaneous orgasm, loss of appetite, nausea,
vomiting, diarrhoea, cramps and muscle spasms.
It is relatively easy to detoxify an opiate
dependant but relapse rates are quite high, partly
due to the fact that some withdrawal effects last
for months with strong feelings of discomfort and
loss of well being.
The high relapse rates after withdrawal effects
have subsided also suggest that psychological
dependence is more important than physical
dependence in the compulsion to continue use.
Studies of large number of American soldiers
who were heavily dependent on heroin while in
Vietnam do not seem to support the belief that
Ôonce an addict, always an addictÕ. The studies
indicated that contrary to popular belief these
soldiers were able to stop their heroin use and
stay off it when they returned to the USA.
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Introduction
Methadone is a synthetic opiate best known for
its role in the treatment of opiate dependence
either as a detoxification aid or as a maintenance
or substitution therapy.
Methadone was first synthesised in Germany
between 1937 and 1938 and was patented in 1941
although its painkilling properties were not
discovered until 1942. The pharmaceutical
company Hoechst developed it as Polamidon¨. It
was never as popular medically as Pethidine,
which had been discovered two years later by the
same researchers based in the now notorious I.G.
Farbenindustrie. After the Second World War that
company was dismantled and its various patents
were divided up among British and American
pharmaceutical companies, chiefly Eli Lilly. These
companies began to commercialise Methadone as
an analgesic and as a cough suppressant. In fact
Physeptone Linctus¨ or 'Phy' as it became better
known, was actually licensed for medical use in
chronic cough rather than as a treatment for
opiate dependence. Although it was originally
claimed that the drug carried little risk of
addiction the first cases of dependence were
noted in the mid 1950's. 
The use of Methadone in opiate dependence
treatment programmes resulted from the
pioneering work of Vincent Dole and Marie
Nyswander in the USA, based on the fact that
Methadone was effective by mouth and that it
had a long duration of action. Dole and
Nyswander found that once they had stabilised
the dose for a given patient they could maintain
them on that dose for long periods of time
avoiding withdrawal symptoms and the resort to
blackmarket opiates. The use of Methadone
Maintenance Treatment (MMT) spread within the
USA and to the rest of the World. In Ireland
Methadone was at first mainly used in the
detoxification of opiate users in abstinence based
treatment programmes rather than as a
maintenance treatment. The rapid spread of HIV
among injecting drug users in the 1980's and
1990's resulted in a change of emphasis where
MMT became central to strategies to reduce drug
injecting and sharing of needles and syringes and
as a response to the numbers seeking treatment
for their opiate use in more recent years.
Legal Status
Methadone and its various preparations are
controlled under the Misuse of Drugs Acts and as
a result it is illegal to possess it without a valid
medical prescription. Only Pharmacists may
dispense those prescriptions, which means that
anyone else selling or supplying it is committing
an offence.
In October 1998 the Methadone Protocol Scheme
was introduced to regulate access to Methadone
Maintenance Therapy (MMT). Drug Treatment
Centres may only supply methadone under the
control of a specialist to individuals on the
Central Drug Treatment List. Individuals who
have been stabilised in a Treatment Centre and
deemed suitable by their specialist, may have
their Methadone prescribed by a recognised G.P.
and dispensed in a designated Community
Pharmacy under the General Medical Service
(GMS) Scheme. 
Prevalence and Availability
The introduction of the Methadone Protocol
Scheme sought to increase access to MMT and at
the same time limit the diversion of Methadone
onto the blackmarket. Prior to 1998 the most
widely prescribed brand of Methadone was
Physeptone Linctus¨ which contained 2 mg
Methadone in every 5 ml teaspoonful of brown
linctus. After the introduction of the new
Protocol, only Methadone mixture 1mg/1ml,
which is green in colour, was permitted. The
more concentrated green form meant that
patients had to swallow much smaller volumes of
liquid each day. In order to avail of MMT,
individuals must be entered on the Central Drug
Treatment List operated by the Eastern Region
Health Authority (ERHA); have their treatment
started by a specialist in a Drug Treatment Centre
and their Methadone dispensed within the
Centre. Once they have been stabilised and if
considered suitable they may be transferred to
the care of a recognised G.P. who will prescribe
Methadone for them either at the G.P.'s own
surgery or in a Satellite Clinic. That prescription
can only be dispensed at a designated
Community Pharmacy, which keeps the patient's
treatment card bearing their photograph for the
duration of the treatment. The Methadone is
dispensed free of charge under the General
Medical Services (GMS) Scheme.
The number of G.P.s and Pharmacists involved in
the Scheme has steadily increased and by the end
of 2001 there was 169 G.Ps and 243 Pharmacies. ItC
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Chapter 16 - Methadone
is reported that the cost to the GMS of
Methadone prescribing and dispensing was ´ 5.66
million in 2000 and ´ 3.78 million in 1999. By the
end of 2001 it was estimated that 5,865 people
were entered on the Central Drug Treatment List.
As a result the amount of Methadone required
worldwide has according to the International
Narcotics Control Board (INCB) increased
significantly in recent years to 42,000 kg from
19,500 kg in 1996. The estimated amount for
Ireland is 131 kg per year.
There has always been concern over the diversion
of prescribed Methadone onto the blackmarket
through over-prescribing or through individuals
selling their 'take home' doses to obtain money to
buy heroin. A study of Methadone-related deaths
found that two thirds of the deaths in 1999 in
which Methadone was implicated were in
individuals who were not on the Central Drug
Treatment List. In 2000 there were 19 cases
handled by the Garda in which not only
Methadone mixture but also Methadone tablets,
which are not legally available in Ireland, were
involved. Blackmarket Methadone is believed to
sell for about ´125-150 per 500 ml bottle.
Mood Altering Effect
Methadone is described as a Mu opiate receptor
agonist. This means that it binds to the same
receptor site as heroin and morphine to cause
effects such as pain relief, mood alteration,
drowsiness, cough suppression, constipation,
nausea and vomiting, pinpoint pupils, respiratory
depression, tolerance and physical dependence,
which are all common to these drugs.
Methadone has a number of advantages
compared to Morphine and Heroin in that it is
effective when taken by mouth. It has also less
severe constipating, sedating and vomiting effects
and causes minimal euphoric effects. Withdrawal
symptoms are less severe but last longer than
with the natural opiates. This is related to the
length of time the drug spends in the body.
Typically it takes the body 3-4 hours to get rid of
half the dose of Morphine and Heroin whereas
the corresponding figure for Methadone is 25
hours. This means that an adequate single daily
dose of Methadone will 'hold', that is prevent the
development of withdrawal symptoms in an
addict for up to 24 hours, whereas Morphine and
Heroin would have to be used several times a
day because they are so short acting. Deciding on
what constitutes an adequate dose of Methadone
is a difficult and contentious issue and is based
on variables such as the amount and purity of the
street heroin used, the individual involved, their
body weight and on a clinical assessment. In the
USA minimum doses of 60-80 mg are
recommended but on this side of the Atlantic
authoritative sources suggest that a dose between
15 and 45 mg for someone injecting a quarter
gramme per day would be appropriate whereas
for someone injecting 1 gramme the dose could
range from 35-100 mg of Methadone. Some
researchers believe that higher doses help retain
more people in treatment than lower dose
regimes and there is good evidence to suggest
that increased time spent in treatment is the best
predictor of ultimate success.
Adverse Effects of Use
The most serious risk associated with Methadone
is death. As an opiate it causes respiratory
depression and the lethal dose for an adult who
has not developed tolerance is about 50 mg. For
children it is about 10 mg. Symptoms of an
overdose include drowsiness, cold clammy skin,
breathlessness leading on to blueness of the skin
and lack of breathing, fluid in the lungs,
convulsions and death. Medically it is suggested
that the risk of death is highest during the first
two weeks of treatment, which is why careful
monitoring of dose levels is so important. The
risk then falls significantly after that period
Between 1998 and 2000, over 140 deaths were
reported in which Methadone was implicated. It
is perhaps surprising that less than 4% of those
deaths involved Methadone alone. The vast
majority involved a combination of Methadone,
alcohol and Benzodiazepines. All three drugs can
cause respiratory depression, therefore combining
them increases the risk. There are many causes of
death from Methadone and indeed other opiates
including overdosing by taking Methadone
prescribed for someone else.
The link between fatalities and combinations of
Methadone and other drugs highlights the fact
that interactions between Methadone and other
drugs may have a significant impact on many of
those in MMT. Chief among these is the antibiotic
Rifampicin used to treat TB and which increases
the speed at which Methadone is broken down
and removed from the body, thus lowering blood
levels and necessitating an increase in Methadone
dosage. Similarly the AIDS drug AZT increases C
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the metabolism and will affect doses. Conversely
Cimetidine used to treat ulcers and possibly to
deal with the itching associated with opiate use,
may reduce the breakdown of Methadone
leading to increased blood levels and signs of
overdose. Alcohol and Benzodiazepines are key
culprits and it is known that many of those in
MMT use Benzodiazepines which have been
prescribed for them or which they have bought
on the blackmarket. Many of those on MMT
report sleep problems and the Benzodiazepines
would have been prescribed in response.
However, their effectiveness in inducing sleep
lasts for no more than 2-4 weeks but the
problems they cause last longer. Many
Methadone users however use Benzodiazepines
such as Diazepam, Temazepam or Flunitrazepam
either orally or more dangerously still, by
injection, to overcome the low level of euphoria
(Ôturn onÕ) from Methadone. Some are believed to
use the tranquillisers to blank out the world or to
give them confidence. As a result they became
chaotic, aggressive and with a high risk of
developing HIV or Hepatitis because of their
behaviour. It must also be remembered that
dependence will probably develop with the
tranquillisers leading to withdrawal symptoms
such as panic attacks that may trigger off further
drug use.
Co-existing liver disease such as Hepatitis B and
C may also affect blood levels of Methadone
because it is normally broken down in the liver. It
is generally believed that where liver function is
impaired but stable no problem should develop.
Abrupt changes in liver status could however
change blood levels.
One area of concern to many on MMT is that of
pain-relief for medical conditions unrelated to
their drug use. It is generally recommended that
non-opiate analgesic such as aspirin,
paracetamol, or non-steroidal anti-inflammatory
drugs (NSAIDs) such as Ibuprofen, should be
used. 
Loss of tolerance is believed to be another key
factor because while tolerance builds up very
quickly, it also disappears very quickly, possibly
within 1-2 weeks of someone being detoxified in
hospital or in prison or spontaneously on their
own. In such circumstances the individual can no
longer take doses of Methadone or any other
opiate to which they were accustomed without
serious consequences. Deaths have been reported
in children who managed to open their parentsÕ
Methadone or who drank it from baby bottles
used by their parents to measure out their Ôtake
homeÕ dose.
A range of other side effects have been reported,
the most distressing of which seems to be
excessive sweating, the exact cause of which is
unknown. Other side effects include constipation,
loss of sexual drive and reduced or absent
menstruation. However, despite the lack of a
menstrual cycle, pregnancies have occurred while
women were on Methadone. Some people,
especially asthmatics may be allergic to the
tartrazine dye used to colour the Methadone
mixture green.
Sedation, 'goofing off' or going 'on the nod', is a
common side effect particularly in the early
stages of treatment lasting until the dose is
properly adjusted and the body develops
tolerance to that effect. That drowsiness does
have an impact on an individual's ability to drive
and to work normally. While 7% of those
suspected by the Garda as driving while under
the influence of a drug tested positive for
Methadone, studies in cancer patients given large
amounts of opiates for pain relief indicated that
they did not represent an increase risk on the
road. With Methadone it is known that learning
and memory performance can be impaired
during the initiation of treatment or if the dose is
increased but it is generally believed that neither
driving nor the use of heavy machinery or even
video programming is impaired once someone is
stabilised and tolerant and they are not topping
up their prescribed dose with other opiates,
tranquillisers or alcohol.
Like most opiates there is no significant evidence
of long-term organ or tissue damage arising from
Methadone used over long periods of time. For
many of those on MMT the most frequent causes
for concern are dental problems and weight gain.
It is not clear why MMT might contribute to
tooth decay. One reason could be the high sugar
content of some brands of mixture, although
sugar-free forms are also available. The liquid in
the mixture may, because of its acidic nature,
affect the enamel of the teeth. In addition many
opiate users, in general, have poor oral hygiene
leading to dental problems and it is felt that
using low sugar diets and making sure that traces
of the mixture are removed through rinsing orC
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brushing immediately after use can prevent tooth
decay. The high sugar content of some products
might contribute to the weight gain experienced
by many users but seems unlikely since a 50 ml
dose of Methadone mixture provides around 85
calories. It is more likely that the weight gain is
due to increased appetite; the availability of
money that would previously have been spent on
heroin to buy food; poor diet; reduced stress or
the reversal of previous malnutrition due to self-
neglect while on street drugs. Some low-sugar
formulations may contain sorbitol, which could
be a contributing factor to the embarrassing
flatulence described by some Methadone
patients. Risks during pregnancy are a major
concern with any drug or medicine. In the case of
Methadone, one of the first groups offered MMT
in Ireland were pregnant addicts. It is reassuring
that no increase in the level of congenital
abnormalities has been reported in babies born to
women on Methadone while they were pregnant.
The major risk seems to be low birth weight and
withdrawal symptoms that start within two days
of birth. These include irritability, hyperactivity,
poor weight gain, sneezing and fist sucking
which can be successfully treated.
Dependence
Methadone is an addictive drug like any other
opiate. Tolerance develops slower than with other
opiates but it does happen. When people stop
using Methadone withdrawal symptoms begin
about 1-2 days after the last dose and may last for
at least 10 days. Typical withdrawal symptoms
include yawning, sneezing, sweating, chills, fever,
goose bumps, insomnia, diarrhoea, vomiting,
deep pain in the back and in bones as well as
jerky muscle spasms at night. 
A variety of detoxification programmes have
been developed, some involving narcotic
antagonists that block the effects of opiates. These
include Narcan¨ used in the emergency
treatment of overdoses and a longer acting form
Nalorex¨ as well as a drug originally developed
to treat high blood pressure called Lofexidine but
which can help eliminate many of the withdrawal
symptoms.
Effectiveness of Methadone Maintenance
Therapy
The use of an addictive drug in people dependent
on opiates has been controversial. However,
objective reviews and evaluations have
consistently shown that MMT leads to reduced
heroin and cocaine use, reduced criminal activity,
reduced spread of HIV and increased
employment levels in a cost effective manner. It
has not reduced the spread of Hepatitis. The risks
and disadvantages, not least the fact that
Methadone is not a 'cure' for heroin addiction, are
well recognised and have lead to attempts to
develop alternatives to Methadone.
One alternative was a long acting form of
Methadone called LAAM, which had the
advantage that patients needed to take it only
every third day. This would have had a major
impact on take home doses and diversion onto
the black market. Unfortunately, safety concerns
over LAAM's effect on the heart have led to
restrictions being placed in its use.
More recently a drug called Buprenorphine has
attracted attention as an alternative maintenance
drug. It was originally used in low doses as a
painkiller under the trade name Temgesic¨ and
misuse of it developed in Dublin. Nowadays
much higher doses are used in the USA and
France in a product called Subutex¨.
Buprenorphine is a mixed opiate
agonist/antagonist, meaning that it can cause
typical opiate effects and block others giving a
better safety profile because it causes less
respiratory depression. Clinical trials have shown
reductions in illicit opiate use; increased retention
in treatment and reduced craving. Compared to
Methadone there is less sedation and limited
withdrawal symptoms though Methadone
patients are less likely to test positive for illegal
opiates. Buprenorphine patients are more likely
to drop out of treatment but find detoxification
easier than with Methadone. While French
experts suggest that death rates are lower with
Buprenorphine than with Methadone, deaths due
to Buprenorphine in combination with
tranquillisers have been reported, as has an
increased level of injection of Buprenorphine in
France.
Heroin maintenance has been available in the UK
for many years and has recently been studied in
Switzerland, with more detailed trials underway
in the Netherlands. Evaluation of the Swiss
studies were not able to establish if the positive
effects recorded by users themselves were due to
the heroin or to the intense psycho-social therapy
and support provided. It is clear that the
effectiveness of maintenance or substitution C
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programmes, are greatly increased if counselling
and other social supports are part of the overall
programme. 
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The information in this booklet has been
compiled from a variety of national and
international publications, papers and reports.
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